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ROLE OF THE RMIN-MGIOTMSIN-^ALDOSTERONB SYSTEM IN NORIliAL 
AND HYPERTENSIVE PREGNANCY
R.J. WEIR
Statement regarding my personal contribution to these studies
Owing to their number and complexity, it would have been impossible 
for one person to have performed all the laboratory te cliniques utilised 
in these studies. I have had to rely^therefore^on the willing 
co-operation of my laboratory colleagues (see page l) to carry out 
the biochemical estimations. I did, however, contribute to the 
bioassay measurements of renin and renin-substrate which, in our 
unit, are performed by a team of workers. I also collaborated with 
Mr. M. Tree in the development of the method for measuring plasma 
renin-substrate.
My major personal contribution to the studies described in this 
Thesis was to design and set up the investigations, to supervise 
the clinical aspects (choice of cases, history taking, physical 
examination, blood pressure measurement and blood sampling), to co­
ordinate the laboratory data and to analyse the results. The 
drawing of the graphs (apart from Figures 2 to 5) and the writing 
of the Thesis were entirely my personal work.
yTHE BOIiE OP THE BENIN-ANGIOTMSIN-ALDOSTERONE SYSTBi 
IN NOBÏAL AND HYPERTmSIVE PEECmNCY.
R,J, Weir,
SUMMAHT
In view of the potent vaso-pressor action of angiotensin II 
and the powerful sodium-retaining effect of aldosterone, an investigation 
has been made of the role of these substances in normal and hypertensive 
pregnancy#
Initially, the renin-angiotensin-aldosterone system was examined 
in a large number of normal pregnant women. This study mainly 
involved the estimation of the plasma concentrations of renin, 
renin-substrate, angiotensin II and aldosterone# Measurements were 
also made of plasma and urinary electrolytes; plasma proteins, 
colloid osmotic pressure and osmolality; blood urea; serum creatinine; 
plasma volume and haematocrit - some of these factors having been shown 
to be associated with changes in the renin-angiotensin-aldosterone 
system in non-pregnant situations# Many of these substances were 
measured concurrently and a number were estimated serially during 
pregnancy and the puerperium. Plasma concentrations of cortisol, 
corticosterone, 11-deoxycorticosterone (DOC) and progesterone were 
also measured in a number of women.
The circulating levels of renin, renin-substrate, angiotensin II 
and aldosterone were found to be increased above the normal non-pregnant 
range in many of the women studied* The mean plasma concentrations of 
renin-substrate, angiotensin II and aldosterone increased significantly 
from the first to the third trimester, whereas mean plasma renin
?concentration fell significantly over the same period although it 
remained above the normal non-pregnant range. Following delivery of 
the foetus and placenta, plasma renin, angiotensin 11 and aldosterone 
concentrations returned to normal non-pregnant levels within two weeks. 
The administration of the oestrogen stilhoestrol to suppress lactation 
was thought to account for the continuing high level of renin-substrate 
up to six weeks post partum* The plasma concentrations of cortisol 
and 11-deoxycorticosterone were generally elevated in the last trimester 
but most of the values for plasma corticosterone concentration were 
within the normal non-pregnant range throughout gestation*
Â significant positive correlation was found between plasma 
renin and aldosterone and between plasma renin-substrate and 
angiotensin II in the first trimester but not thereafter, while 
plasma renin-substrate and aldosterone showed the only significant 
correlation when cases at all stages of pregnancy were analysed* 
Therefore, in spite of the marked changes which occur, the relationships 
between the four major components of the renin-angiotensin-aldosterone 
system appear to be more complex in pregnancy than in other physiological 
and clinical situations* A speculative explanation for this lack of 
relationship might be the presence in the circulation of "chorionic 
renin" which could be inactive in the generation of angiotensin II but 
which might possibly be involved in the secretion of aldosterone by 
another pathway as yet unidentified*
The present study has shown that in normal pregnancy a positive 
correlation exists between plasma sodium and aldosterone concentrations, 
suggesting that the increased aldosterone secretion is a primary event
influencing sodium balance rather than a secondary effect of 
established sodium depletion* Limited balance studies in two 
women showed no evidence of marked sodium retention or excretion at 
any stage of gestation* However, it is possible that the raised 
circulating levels of aldosterone may be part of the maternal 
adaptive process to prophylactically conserve sodium in the face 
of a tendency to sodium loss caused by the increased glomerular 
filtration rate, the diversion of fluid and electrolytes to the 
foeto-placental unit and the natriuretic and anti-aldosterone 
effect of increased progesterone secretion*
In a small study, symptoms in early pregnancy did not appear 
to be related to concurrent plasma levels of renin, renin-substrate, 
angiotensin II, aldosterone or sodium but they did show a negative 
correlation with plasma potassium concentration* %pokalaemia 
may therefore contribute to some of the symptoms in the first 
trimester*
The renin-angiotuQsin-aldosterone system was also investigated 
in women who had developed hypertension (B*P* 140/90 or over) with 
albuminuria after the 24th week of pregnancy. The results were 
compared with those from normal pregnant women matched for age, 
parity and gestation* The mean plasma concentrations of renin, 
renin-substrate, angiotensin II and aldosterone were all significantly 
lower in the hypertensive compared to the normotensive group* Plasma 
electrolytes did not differ significantly but blood urea and serum 
creatinine were both increased in the women with hypertension*
4* 1
A study of the effect of oestrogeu-progestogen oral 
contraceptives on the renin-angiotensin-aldosterone system vas 
thought to he pertinent to the larger study of pregnancy* 
Normotensive women taking oestrogen-progestogen oral contraceptives 
demonstrated an increase in plasma renin-substrate concentration 
similar to that found in normal pregnancy and this was shown to be 
due to the oestrogenic component* Plasma concentrations of renin, 
angiotensin II and aldosterone showed no significant change* In 
women who developed a raised blood pressure (140/90 or over) while 
taking oestrogen-progestogen oral contraceptives, plasma renin and 
renin-substrate concentrations were similar to those in the 
normotensive women, while mean plasma angiotensin II concentration 
showed a slight rise of borderline statistical significance*
In normal pregnancy, therefore, profound changes occur in the 
renin-angiotensin-aldosterone system which may be related to the 
maintenance of maternal fluid and electrolyte homeostasis* These 
changes are less marked in women with hypertensive disease of 
pregnancy and it seems possible that in this condition the system 
is being suppressed by an excess of circulating minéralecorticoid 
which has yet to be identified*
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DmuiDocsiau
m N m w m G i m m s m - A u w s r m m E  mwKriwsoiPS m  
m e k m m m m  siTimiws
IiMKKSAIOKÏ MSraODS
c m e r m  i
"Tho îliacoveüy of #o toxin in toxacmi© cases by tuesns of a 
perfected phjî'siologicai chemistry will point to its satidote”* 
l^fessor Aaond- Bonüi, F’Tosidrntial Address to the OWtetrioel 
Society of LoWon# 19%%*
%lsorteasioa in pregnancy remains one of tSie major eatisea of 
maternal end foetal mortality* ^e fact that nttmorouo investigatora 
over the years have failed to unravel ita caaee lends fascisiatioai to 
this condition, which has aptly been called **dic EranMioit dor 
TïjieorieE'* - the disease of theories (Boyd, 1938)*
Isi recent years, one of the theories in vogue has been that 
raised blood pressure in pregiiancy be associated with changes
in the renin-angiotensin-aldosterone syatau, eogiotensin II being a 
powerful vasoconstrictor and aldosterone having o potent sodium- 
retaining effect* Ijbwovor, altliough the relationships beti^ oea 
plasma renin, reiin-substreto, angiotensin II and aldosterone have 
now been defined in a mmiber of physiological and pathological 
situations, thoir relationships in normal pregnancy have yet to bo 
clearly elucidated, ^ lile tîieir role in pregnancy lî^ o^rtension has 
remained mainly speculative* ■ '
3fei the Blood Pressure Ifeait at the Westorsi Infirmary,
Glasgow, mothods have been developed for measuring plaoma 
concentrations of renin, reuiu-subatrato, angiotensin II, aldosterone 
and ot!»©r minoralocorticoids* The purpose of the imrk presented 
here was to apply those methods to a detailed stu% of the physiological 
relationships of renin,'renin-substrate, angiotensin II and aldosterone 
in noimol pregnancy and to follow this by an oxainination of thoir 
possible patliological role in pre^ aonoy hypertension#
7»
Women taking oostrogon-progestogesi oral oontraooptivos 
could ho considered as a partial model for the effects of 
the steroid sox hormones secreted during pregaïoiicy* âs 
hypertension iujs^ he induced by these preparation, it was ■ 
thou#Kt that an investigation of the changes in the raiin- 
asigiotensin-aldosterone system ia Tjomen talsihg contraceptive 
steroids might he applieahle to the larger prohlem of 
hypertcnsiirc disease of prege.ancy*
o.,
Q u m u i  2
mMTioNmiFs m  
SITUATIONS*
Eciiin» ronin-sttbstrato and fmgiotensjba*
Ikmim was found aa a pressor substance present ia e%ti%ùtà 
of renal cortex by Tlgerstedt and Bergman (l^s) and Bickering 
#nd PrinsKietal (1938) uad 1# tîiougïit to be secreted by tho 
juxtaglemorular cells of the kidney (see Brom%, Davies, Lever 
end Robertson, 1966a)* A renin-like scbstmce has also been 
demonstrated in salivary glands and arterial walls (see Brown 
ot ai, 1966a), md in uterus, placenta and mmiotic fluid (see 
Chapter 6*B)#
In the plasma renin reacts with m  alpha-8 globulin 
(renin-substrate, cmgioteasinogen) to fora a decapeptido, 
angiotensin I, lAich is subsequently converted to an oetapeptide, 
angiotensin II (Figure 1). The oetapeptide is. then broken doim 
into peptide fragments by blood and tissue peptidases 
(angiotesîsinases) (see Page and Baiipus, 1961} Lee, I969)*
In most situations it appears likely that chaigos in the 
eoncGntration of the enssyme renin control the level of 
circulating angiotensin (Figure a) but theoretically it is possible 
that substrate coneentratioa luay also be a factor limiting the rate 
of formation of angiotensin* Evidence for this has been given by 
Helmor and Judson (196?) and Skinner, bombers and %iuonds 
(19691 1972), but it has been disputed by Gould, Skoggs and 
W m  (1966*
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%Ihe rale of 'these sahatancos both in health and cliaeoee 
reiaaias incomplGtely uaderstoodj ,hnt ca far as is Immm* renin 
itself has no direct physiological effect» its Tarions actions 
being mediated by angiotensin# Althou^ i the decapeptide. 
angiotensin X may have pharmacological effects on .certain, . 
tissues (Oarri^ re' mid Biron» 1970) and tîic S *S îieptapeptido 
frai^ nents niay stimulate aldosterone secretion .(BlaisM’/est» 
Coxian* Benton,.- Ihnder» Scoggins and Wri#t, 1971) the 
oetapeptide form, angiotensin -11» has the issajor physiological 
■fend pharmacological actions*
ihigiotonsin II has a profound influence on the control 
of electrolyte, and water metaholisia and of hlood xjressnre*
It Easy prm%ïoté acdimm retention and po'tassim excretion 
Indirectly hy its ability to stimulate aldosterone secretion 
(see next section), ïïi addition to its vasoconstrictor end 
pressor effect, it alters tiae excretion of sodium md imtor 
by the kidneys and saay also stimulate. the release of antidiuretic 
hormone emd catechelc^ iiines and provoke thirst ;.(aeo Broi*h- et al, 
1965ag Brom» leaser, hover and Eohertson,,: '" We,,'; 19#;
Fitsaimns and Simons» 19#; Bonjour and-3%lvin»':'l97B; - Brown, 
Chinn, Gavras, BocMe, lover, McGregor, MortW.'#id EOhert^ on, 
397%)* Although many of these effects are inter-related and 
are involved in the overall. fluid and electrolyte halance of 
the body, it is its effect on alclosterono secretion which will he 
considered in détail in this study*
10.
Benin. Esifiioteneia ond aldoaterone.
Aldosterone is a Very potent steroid homtono secreted 
by #e sona glooeruloaa cells of the adrenal cortex. It 
was first isolated in 1955 (Simpson, Tait, Wettstoin, Neher, 
v m  Bwf and Beichstein)* Its main effeit is on the renal 
tubules where it promotes sodium reahsoixition and causes 
increased potassiw excretion* It also decreases the 
ratio of saliva, sweat and gastro#$ntestinal secretions (see Fraser, 
Brown, CMnn, Wver and Beherteon, 19## Brown, Fraser, Bever end 
Ilohertoott, 1978b).
*Ki0 cmtrol of aldosterone secretion has been discussed in 
detail by Fraser et al (19#) and Brown et al (1978b), with 
particular reference to stimulation by AOfH, sodimi depletion, 
potassium loading mâ rmin/engiotonsin,
Altîiough it still remains to be daionstrated tîmt the 
concentrations of renin or angiotensin II in #e plasma «re 
within a range capable of affecting aldosterone secretion 
(Bloir-West, Coghlau, Benton, Funder and Scoggins, 1978#
Boyd, Adamson, Arnold, James end Peart# 1978# Brown et al,
1978b# Davisf 1978), there is strong circumstantial evidence 
to suggest that aldosterone production may be governed, at 
least in part, by changes in circulating levels of renin and 
migiotensin II (see Brown ot al, 1968$ Fraser et al# 1969#
Brom et al, 1971e# 1978b). Angiotensin II my also effect 
the -rate of clearance of aldosterone from the circulation (see 
Fraser et al,- 1969).
1 %
A reïatimisblp between EVldoatorono mû. «sigioteasin II 
in msm hm been reported by sewraî workers idio bavo 
demonstrated iacreoaes aldosterone seerotioia and excretion 
(Genest, Nowaeszynskii KoAw, Sander and Biron, I960; laragb, 
Angers I ’Kelly and biebormm, 1960$ Biroa, Koiv,- Nowacsyi'iski, 
Broullet and Gonost, 1901$ Ames, Borkowski, Sicinoki and 
Laragii, 1#5), and in plaeaia concentration jjFraoor, James,
Brown, Isaac, Iiovor and Hobertson, 1965) follov?ing systemic 
infusion of angiotensin II (Figure 5),
Correlated changes in concurrent plasma renin^ angiotensin II 
and aldosterone concentrations have been shown in several 
situations, particularly those associated with sodium depletion 
(Figure 6), (Fraser ot al, 1965$ Frasor, James, Brown, Davies, 
Dover and Bobertson, 1966$ Fraser et al, 1969). A positive 
correlation between plasma rcnin/engiotoasia and aldootorone 
concentration has also been demonstrated in coses of renal 
liyportoBsioa and hypertension associated with chronic renal
■ ' • ■ ' . ' I
failure (Figure 5) (Biwm, Dusterdieck, Fraser, Lever, Bobertson, 
Tree and Weir g 1971b).
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U i m W O W  MIIOBS
ïïho siïhôtmces eaalysesl in tlio stndioa to ho âescriheâ vero 
meoomrGë os follqrirss*
Plaoma renin conooniyatioa»
By "the ùns^ mQ kinetic method of Brmm# Bavieo, Levert 
Robertson and Tree
In tlaio teoimi^ uo raiin is extracted from plasma by 
adaorption on dietliyimmmoethyloellnlose$ elated# oJiû acidified 
to remove traces of angiotoasinaooo* M  important function of 
this proceoa is the roaoval of substrate# activators and ii#ibitors. 
It is then incubated mtli a standard preparation of aagiotensiaBse** 
free substrate obtained from os oorum* îbe asa^ iotensin fomed is 
measured by its pressor effect on m  maostbetisod rat preparation 
compared to etandurd oetapeptide angiotensin II. initial
velocity of aEigiotensin formation in the incubation mixture is in 
those oirciiEîstasiees a measure of the renin concentration of the plasaic 
ïlôcoveries ore low (40^ S) but consistent, Replicate 
estimations from a stock plasma pool during the period of tliis 
study showed a mean of 24,97 units/i* (S,B, 1 3,98) # a R 62,
The normal range in non-pregnant subjects is 4 20 imits/L#
A number of otiaer methods measure i)los:m renim activity 
rather than concentration (see Lee# 1969)# These toclmiquos 
usually involve destrs.iction or ineotivatioa of angiotensinasos# 
followed by incubation of the plasma sample for a fixed period# 
usually 3 hours# The migiotmsin famed is tîiea a measure of
tho roniii activity of oomplo* As it bo affected by 
aubstrate proeent in the plasma# it gives a different Mué of 
infosmtiOB eumiparoâ wiili the method for renin coneoiitratioa* 
l&em plasma renin substrat© concentration can be measured 
separately# estimation of plasma rei^ ia concentration is likely 
to be umre infomative than measuresient of plasma renim activity# 
Estimation of plasma renin concentration or activity 
be affected by any activator or inhibitor reaiaiaing in the 
ineWaated seaple and by failure to estimate losses of renin or 
substrate during the process of angiotemsinase doatr^ &otion or 
inactivation# Also# some of the teolmiqms fail to detect renin 
activity in a proportion of normal subjects#
Plasma renin substrate, concentration#
By the moiihnû of Tree (197^ )#
The essence of this technique# as in a number of previously 
reported mo#ods (so© Lee# 1969)# is the conversion of the 
substrate to angiotensin I using a high eoncésitration of added 
reün# at the seme time preventing the degradation of the formed 
angiotensin by mamm of prior inhibition of plasma peptidases*
The blood collected at venepmictiwe is inmiediately mixed 
with an as'agiotonsin inhibitor solution containing etiiylene 
diamine tetra-acetic acid (BDTA)# o-phenantiirolinoMimnohydrate 
and neomycin buffer# The mixture is then incubated with a 
stmidord excess amount of Imnm ronia# The angiotensin formed 
is measured by its pressor effect on an anaes#ietised rat
14,
preparation compared to standard decopeptide angioteasia Ï*
The miioimt of angiotensin formed in tSio incubation mixture is 
‘fchaa a meaoare of the conceiitratioE of renin substrate ia tlio 
plasma#
Becovory of aubotrate tkeou# the method is 94^ , Replicate 
estimations of M  samples measured in 2 batches had coefficients 
of variation of 8,45# sad 10,70* The rang© in 30 normal 
non-pregaaat females was 0*45 1*2$ uM,
Differences in tcclmique arc likely to. co.ntrihut© to the 
i;ide variation in plasma renin substrate concentration xdvicli 
■iham' been reported previously for noriBal subjects (see Tree# 
1972)# Most of the methoda described, give no details of 
recovery data# only a few show that convoraioa of substrate to 
oagioteasin is complete# and none ooafiKTiis tSsat the assayed 
angiotensin is in tho sme molecular form as the standard*
Plasma eui^ioteaain II cmcmtration.
By the radioimmunoassay method of Msteirdiock and MoElwee (1971)*
M  this technique ongiotensinasos and converting ens^yaiG ore 
inhibited by adding tlie sampled blood quickly to an inhibitor 
aclution containing otliylen© dlmaine totra-acetie acid (liMâ) 
and e-phenonthroline in nemycin buffer* The angiotensin is 
then extracted by B m m  (II**) particles# eluted with mrionia and 
incubated with rabbit aatiserum containing antibodies against 
Asn&V&l^ -angiotensin II* Asnival'^ -miigiotenain II ioclinated 
with Hq^ '^ '^ I is used os Hio radioactive label*
10 <
Becovories from blood for this iecîmiqao woro 830 
(s#B$ i IE# a « #)* Ikïpîloatewithin on© assay varied about 
their mem by a.standard deviatioa of t 100# n =s 16* Peripheral 
venous .plomm concesitratious in 33 normal adults rcmged from g to 
33 pg/ml*
TW results obtaiuod by this m%#od are similar to those 
of other teoïusioues using extracted plasma#
hut Iwjor than those fountl with mextracted plasma (see Dîisterdieck 
mid MoBlwce# 1971)* Tïîis difference may be due to cross-reaetiou 
of autiseraai with renlu suhstraio in the uuextracted samples*^  
Bioassay methods#, idiich are iu general less satisfactory #ou 
radioimiiauoassoy tecîmiques# have shown either similar norâial 
levels to those fouud here (Mulrow# 1964^) or considerably higher 
values (Massaai# Fiakeiiimu#. Woroel# Agrest aad Paladiui # 1966)*
Plaoi^ aldoatggQue# corticosteroue and cortisol coucmtratious*
By a modification of the double isotope derivative toclmiquo 
of Fraser and James (1968)*
la this method# Emowu quantities of tîiê (^%) steroids 
#:der investigation are added as tracers to tiae plasma before 
extraction* The extraet is then acotylated id.# (%) acetic 
0iîSîyÊ,!rlde and the acetates subsequeutly subjected to prelimiaa^ * 
chromatograpMc purification with a thin-layer silica gel system* 
The labelled acetates of aldosterone# corticosterone and cortisol 
ore purified sejjarately by paper chrmuatograpîay and the 
final residues counted in a liquid scintillation spectrcmietor*
ï ' . 'i ' I 1} " : :
Beeovcrios# replicate estiiîiatioBs from a stock plasim 
pool and momiml ronges are. shcwas-c ,
llecovGïy of Replicate estimaticms Mormol
added steroid %%on-pre#Mmt
. 0 . Mem , &#!)* n ranges
Aldosterone. (ssag/l0Qml) 118* im 12.01 . 0*98 m ^  18.0
Corticostorono. (ng/lOOml) g#8# 98.1 . 0.46 i ■ 0.04 22 0,13 ^  2.30
Cortisol (ng/lO'^ l) 10D#3* 99.5 6.32 0.19 . 22 6.0 - 20*0
%B eomparison to isotope derivative methods# other chemical 
teolmiques in general do.not provide as great a degree.of 
sensitivity in the measurement ■ of the low concentrations of steroid 
hommes foimê in peripheral plasma* Even with the isotope 
derivative method used in this study# the seasitiiTity- is limited 
(i,e# to about 4 mug/lOO ml for aldosteroue)* This is mainly duo 
to the low specific activity of (3^l) acetic anhydride#
A simpler %fay of estimating aldostoroa© ie by eeasureEent 
of its daily excretion into the wine by flnorieetric# colorimetric 
or isotopio methods# Those techniques# îmwever# have main 
€lisadveatagea« (l) As a metabolite# urinary free aldosterone 
or its 3-osoconjugate represents only a minor proportion of tlie 
total daily socretien of aldosterone^  and (2) The quossitity of 
a single metabolite may vary disproportionately to the total 
secretion rate#
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Seeroiion rato meaauremtmts or© theoretically nioro 
acceptable, eiaco they give osi indirect estimate of the actual 
production of steroids by the adrenal gland integrated over a 
24-Sionr period* Tlioy are, however, more difficult to perform 
tïîan excretion rate assays (see Fraser et al, I969)#
Although plasma conecsntratioa has the disadvimtage of 
being a measuramejat at one poiï^ t in time, it is preferable to 
excretion and secretion rate aeasnrements in that sasapling is 
relatively easy aiad less time consuming aM con be repeated at 
short intervals* In addition, it cm he corrolatod with other 
euhstmices estimated in plasma token at #e same time*
Plaama ll-deOxycorticosterone (BOB) émicoBtration. ' '
%  the method of Wilson and Fraser (l97l)*
In this metliod (%) BOG is added to the plosim before 
extrb,©tica* T%fO thin-layer ohromatographic''systems are 
employed, and the amount of BOG in 'the sample is moasOrod by 
means of gas-liquid chromatography wl'th electron capture 
detection*
After addition of 3, 18# 13 and 20 ag* BOG to samples 
of a noraml pluGuaa pool, the means of duplicate recoveries 
were 93ïh 1000* 980 and 940 respectively, Replicate assays 
carried out oxi samples from three different pools of normal 
plaana gave mean BOG cencen'tratioas (in ng/lOO ml* *- 8*B,) 
aS 18.1 t 8.32 {n = 7), 13,0 Î 3.16 (a=8) oaO 6.7 ^  j,os (a = 7). 
Blasiaa samples from 20 normal ambulant subjects (14 male, ê female)
18.
taken beWeen 10*00 and 11.00 a#m., gave concentrations ranging 
from 4*1 to 17*2 ng/lOO ml*
This aetlnod has the advantages of gas-liquid chromatography 
which is on extremely effective purification tegjbnique, and of 
electron capture detection which possesses a high level of 
sensitivity. The use of a detector hy-pass valve largely 
overcomes the problem of contamination (see Wilson and Ba?aser*
1971). TÎÎO normal range found hy this method is very similar 
to tliat reported for a double isotope derivative teclmique 
(domes, Bippon and Arnold, 1969)*
Oilier megsurmients*'
Plasma progesterone concentration - Modification of tl.m 
competitive proteia-4)isiding method of Martisi| Cooke and Black (1978)#
' ‘ *
Plasm and urinary sodium ) # %pendorf flame photometer in first study;
4Ç- I-
Plasm and urinary potassium) autoanalyser in subsequent studies*
#
Plasma osmolality ## Advanced osmometer#
A. Autoanalyser*'
Blood and urinary urea 
Borum mü urinary creatinine]
Ploom proteins *- Biuret method in first study; paper
electrophoresis in subsequent studies. 
Urinary proteins ## Alhustix (Amos Ltd.) in first study; in
subsequent studies# turhidcwaetric 
method in most cases; Bshach's reagent 
in some cases mth marked proteinuria.
1%
Colloid oamotic pressure *# Bowe colloid osmomotor 
*
Plasma volimo MetSiod using Evmio Blue, as described by
%ttea and Ikiintiu (1963)*
Urinary osstriol # Autoanalyser (ne^ joâ of Borsiord aacl
Logeai, 1970).
CLINICAL METHOD*
Diet, posture, time of sampling and clinical details of 
the cases will bo given later for each
Blood pressui’o tms measured using a standard Qpliygmomauocîoter 
and cuff*
Blood samples wore taken from an mitecubital vein in every
cafjo.
STATISTICAL AMtS^ Sl^ *
Analysis of the data in the first study (dmpter 3*A) was 
carried, out by as Baglish Electric KEÈ? 9 digital computer progrmmwd 
for multiple regression analysis* Isi subsmpiont studies a Hewlett- 
Paeîsard 9S10A Desk Calculator was used, apart from a atep-wleo 
regression calculation carx'ied out in the second study (Chapter 5*B) 
by an ÏMI 360/3O computer# Whore #%)ropriate, results bo'timon 
matched pairs were compared using the Wilco^ ki test for pair 
differences (ilooumeir^ a Geigy Scientific Tables, Seventli Wition,
P. 198)*
*The mean of duplicate measureiaents wos used for statistical analysis*
s ü i a Æ
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The ciistinetion betweea plasna renin activity and plasma 
rcnim concentration hae alreadf been dram (see Chapter 3)* As 
plasma renin-substrate is markedly increased during pregnancy 
(aeo Chapter 5), estimation of plamia rmiin activity in tlii^  
situation is likely to be loss meaningful than meaanremoat of 
both plasma renin concentration and substrate concentration when 
sampled cononrroatly#
Previously reported results using these two different 
methods of measuring plasma renin will therefore be discussed 
separately*
PMem im m  ACfivi%
The disadvantages of #is method, tiiiich have been mentioned 
earlier (Chapter 3), should be kept in raind when interpreting 
the numerous published reports of changes in plasma renin activity 
ill momaal prognmcy (|PaaMti^,R«teaFito^|. Romero and CiiccM, 1# 4; 
Winer, 1965; Genest# de CIm#lain, Veyrat# Boucher, Tremblay, 
Strong, iCoiw and Morc-Aurele, 1965? Helmer and Judson, 196?; 
Goelhood ao.d Vender, 1968; Bconshoft, Ô^Gomell, Bayes and 
Schreiner, 1968; Gordon, Foraona end %mnds, 1969$ lambera, 1970;
Schmidt and Rosenthal, 1971$ Eolmt and CekëiaM, 1972,
S k in n e r  e t  a l ,  1 9 7 2 )♦
Bue to variations iîi technique, pes-toe, diet and time 
of sejàîpiisîg, it is not possible to FJake a direct cmiiparisoa 
of. '#0 levels of plasma renin activity fouucl by those different 
groups* However, all authors reported a gosicral in.erespe in 
plasma renim activity in normal progasmey, apart from one 
report (MaebasM, Mda, Toehiaaga, Abe, Miwa mû Wataaabo, 1964) 
#  which no signifient difference from the normal mn-pregsioat 
range was demonstrated* Consistent increases were fonad 
liy tîfo groups (Geelhoed mû Vender, 1968; Boonshafi et al,
1968), ttorese in #e o#er series a ^ myiuQ mviiber of women 
had levels within the aomaal uon-pregaant range* Parity did 
not appear to influence the changes in plasm rorain activity 
in mw of the series reported*
In  txm studies imolWing early pregsnmey (Conost et al,
1965 s Hôleer mû Judson, 1967), increased plasma renia activity 
was found as early as 4 weeks and 8 ifaeks gestation* However, 
the progressive rise in plasma renin wtivity heWeen the 4tSi 
and 21st week demonstrated hy Genest and his oolleagueo (1965) 
was not confirmed over the smiO period by llelmer and Juflson 
(1967)$ Gordon and Mo gwip (196#) found no significant 
differoncG hettfoen gestational periods from the 13# i/eek to 
tersn; and SçMidt and Rosenthal (l97l), found #e mean value 
for the last 10 weeks to be lower than that for the preceding
weeks of pregmmicy# A pessibi# of tlsose studios
la tWt #0 w&ea made m  w m i  at
diffeeeat atagw of pxwjgomciy, Sùrial maauwiamta doapisg 
pam@%AW M  #e smm m m u  mi#t be m m  mewingiM»
A mo&mol pliysiologioal toroœo &i plome reaia aoMvlty 
v m  e W m  to ©esm* in proguaat vsosmi who ohengcd from the 
eopimo to tlio upright poatmfo (Booncîiaft et cl, I£6S)» A 
larger âaeroaso ooowwod lu wmoo who iobîî e t o  salt diet 
(BûD"jf.shc'ift ot 4-ilîÿ &9#8), tlioro %ms a ooasidomMo overlap 
vitb the range tQiWAl in  mmmi <m ca ossrostriotod diet (Gonoot 
ot al, 1965# Gordon qt el, #6#)# Mo eigoifieent éiffereueo 
was GppawGBt m  treated with thiesiido diuretics (Helmor
#d jwooB, 196?)#
^ & Ë L Ê Ê j ^ a L
%>ports on the effeote of IdUoar ore ooaglioW«g, cm
shoMmg m  laereuse Is plamm renin activity (Geotoed
Vmdor, 196s} #;,d 0m  e decrease (Eol^ ior a%d 19%)#
After dolivORy of the foetuo and placenta, plosmu
activity reminea hi# in aone CBOon for up to 7 deyn, »mt had
(
fallom ie aoA«pvogamt levels by 8 imoka peat-pai'tma
(llelui3s? aid dWoom, 19%; Gaelhoeâ mià Vauêer, lü60)#
2li,
pîasa smm maammm»'
i}XUi0Xü(^ Â a coourato indication o f  oiroulating lovclp 
of ronW fa pre#cmoy, plama % W n  cmomtmtlm W?  W m  mo&
lose t&\rmQnttf studied # m  plama vcnin aeiivity in  this
1% a aW%y of 5$ normal tmmn at variom atogpoa of prcgwmcy,
piama s?eaia ocmomtratloa was foaod to im raised in 20 oosos 
Dàvd'üfâ, #B#, lÆvar cmâ Robortam, 1963)# %o  aampleo 
wore W m m  Im oiihor tha oitM% or lying position %'WU% tUo 
womoa on an «nrootriatod diet# Baorooood cirmlotlng roain 
iomls ocsnii^ rod at all otmgeo of proguouoy, several of tho 
highest values bel&g m  #p firaû tri^ nestor# There was ao 
pregreasive rise iu plamm reuia conoaitratiom ûmiuB p%%#mioy, 
mm contrast to .#a plasma milu activity mommmmtn of Gonoat 
aid hiiû colleagues
lu a m bacqu im t rhtmly (B ro m , D a v ies , Aook, Lcm w and 
Eaibc#Boa, (#6#) serial eatlmatlma of, plemm rooin 
wcro oaiwisd oat at intervals thronggiout pmgnmtey in sovm 
n o m c l w 3 o a  on mi m rc s tp ic to d  d ie t ,  M  each case ih o  plosam
rei'ila lovo?m were above #o nomel raago (4 to 20
oMts/iitre) on OGca8lO)3s$ ana ifommt Zmviitg a oonoentratioa 
of 5S imits/litro as early as 3 wMm after the loot menstrual 
period* As in #o pmocding study of a lasge nmbw of iWivitWl 
osfges (Bramt ot q.%., #65)* those serial .,in a o%Wll
ai%#or of women Shewed me oonsiGtont ohemgo In %,)lom2a imniu
ewiceiatraiioa early to term,' ■-
Using the seme metliod, eolle^ igues and I have GCafâmed 
those findings# Tho results of oar earlier reports (Ueir,
Faxntia, Eohertsoa, free, Eraser and Yom%, 197%; Weir, Faintia, 
Broim, Fraser, Lever, Robertson and Noting, 19Vld)will he 
described witli #ose of oai* euïisequeat larger study in Chapter 3#' 
Oar results have also Iseeu confirmed in a smaller study 
by Iiimhers (1970), who deiaoEstrated inoreased plasma renin 
ooncesitrations in  tiao last 8 weeks of pregnancy in all 6 o f the 
women studied by her*
SeruHS reniia concentration \mti shown to ho above the normal 
rnom-pregnmat range im 7 oases when measured in 14 mormal women 
031 am imcomtrolied diet between l6 and 39 weeks* ges’tatimi 
(Gould et al, 1966)* Tao authors did mot comiemt <m the levels 
at different stages of ps»ognaiicy, but on amaiysimg their results,
I have foimd that the hipest values occurred im the last 
trimes'ter# Mo adequate compariaon with the previous studies 
is possible as the remm coBcemtration was measured im serua, 
a different method was used, the mmmber of individual cases studied 
was small, and mo serial estimations limre made#
Effects of posture, mid ^ e t#
As far as'is kmowm, there have been mo reports cm 'the effects 
of chahgea of, posture or of sodimsa balance qu plasma ron iii 
eomceiitratiom' im pregmmxt ' xmmem#
Egfect-s of delivery*
Bsims a method similar to our oim, SIslmer, toilers tmd 
SymnàB (1968) found elevated plasma resslia eoucautrations at 
delivery :ui each of k uorjaoteasive woraeu. Ho other miessaal 
plasma smaples were obtained in tdiat was mainly a atuây o£ 
ren.ü>*Iike actiTlty in foetal and maternal tisssiiso (see 
Chapter 6t ïï)*.
Ghmms in # s  .imerporium*#W#ym*nwTnmi'i
Plasma Teirhi come entrât! eus measured in 10 tfomem wi#ia 
two oioutlis of gartutltieu t/ere fomid to be in liie normal nom- 
preguattt range (Bromi at ai, 1963). 3 women with increased
piasiiia roiiia ooncentratioas in late pregamioy, serial estiiaatiosis 
showed a fall after delivery of the foetus placenta, but In 
m m  case the rmlm level was still above the normal nmi-progaeat 
range after 4 days (Broim et al$ 1966b)* No marked olsasnge 
occurred post partu^ iw 3 women had plasma reaia coacentrcitions 
witîîisi the normal nou-preguant i?migo before delivei^*
PMSHâ -MTO BmSSM.^E CÛNOmMSXON.
DivSiidvantases of some of the methods used to measure plasma 
rtmin substrate eoueentratiou have been mentioned previously 
(sea Chapter 3)*
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In spit© of Mm&o possible disadvantages, reports of 
plasma renin substrate eoBOentratiou in normal x>re^ ia25cy have
ahoma a general eoBsist.©Boys-
Authors Normal non- 
pregnant ronge.
Baîigo in aor*£üaI 
progomicy.
Time of 
gestation.
Piokens et al (1965) 
{tig/mU)
510 - 1010
(memr 729)
. n îs £9
1930 - 3240 
(mean 2613)
a la 9
lost trimester
Gould et ol (1966)
(Bg/aa«)
463 880
a £3 93
2230 - 3860
u "î 14
Mot stated
lie.'iin-Dr & iTttdson (1967)
mean 425
560 - 2912
(mean 1444) 
n t= 22
8 woeÎEe - term
Lumbers (1970) < 2,0
a t?ü 5
0*5 " 7*S 
% - 7
32 weeke-term
¥eir et ai (1970^ ) ) 
Roberteon et al(l97l)| 
(mois X 1©'*^ , uM)
0,48 fm 1,27
{mom î3 0*79}
n ^ 27
1,0 - 5*0
n — 40
6 weeks — tersa
iSdnaer et al (1972) 
(ng/ml*)
mean ^  1*3 
S.B. ï 0,'»
n 9
1.2 - 12.0
J1 %! ^ 4
4 weeks — torm
Tho rosults described by Pickens end Ms colleagues (If65) 
are ves-y similar to those of Gould and her associates (#66)*
Moimor orné Judsos (#67), Wmver, reported a rather lower 
mmgo in normal pro^mit vommi# This could be duo to the 
iucluoioB of data from #0 earlji weeks of preguaney, but #eir 
mom 0É 425 ng/mlrn for mornal mou-pre#mit subjects is also lower 
tbasi that quoted in other series* This could be explained by 
a lot; recovery of mgioteusiu as a result of iuceiîqslete iaaotivatiou 
of mgiotesisiaases*
The earliest measurmimt ia Helmer m û  Jadsou*© study was 
at B weeks geatatiou, when a plasma renin substrate eouceatration 
of 830 ug/ml* was ahowu* Higher eireulating levels of substrate ■ 
wore found later iu pregpauey, but a |>rogreaQivo rise of plasma 
reato substrate during progpaacy could mot bo assumed from those 
data as only 4 meaoumaesats were made boforo 20 weeks’ gestatioa. 
However, a similaz^  trend was seen in the prelimimary results from 
our om studies (tloir ot cl, 1970b> Robertson, Weir, Busterdioek, 
Fraser cmd Tree, 1971. - to bo described with the subséquent 
larger study in Oha%)ter 5) #3id this has recently been statistically 
©oafirmed by Skiemor and his group (l9?2)#
Effects of Posture mid Diet*
As far os is known, plasma I'emim-substi'ate comceaitration 
is mot effected by changes ie posture or of oleetroiyto balamoo 
im the normal moe-pregmamt state (see Lee, 1969)* mid pregmamt 
woMoa are unlikely to ohou a different res%3cese# In obo study
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(ilelmea? mû Judson* 196?) tSiiazldo mcdicatioai in 7 woiBeii did 
not appear to influence tînc results#
Ohmiges cluring labour mû- iix the puerperiica*
E'j 4 cases studied hy Sîelmer cud Judsosi (1967) a transient 
rise in x>lasma renin substrate concentration occurred after 
delivery* Im a fm*ther 16 women the substrate level remaimed 
high for up to 5 days after delivery im most cases but had 
fallen to moraal mom-progmamt limits after 2 weeks#
BLOOD Æ #  meioTMsm cmcimmgiOM.
Two studies of circulating angiotensin levels in pregmmcy 
have been reported - that of Massoai^  Sasiguiaetti, Gallegos mid 
laisioadi (1967) and preliminary results of our oxm study 
(Rohertson et al, 1971)* Details ©f our results tJhich were 
obtained t;i# a s*adioiimB\moa3Say method, are given later 
(Chapter 5)*
Massmii and her colleagues used a cSicsaicel extraction 
procedure ccmhined with a hioassay which did not distinguish 
beWcen angiotensin I and II* Using arterial wSiole hlood 
samples from wmen wlio had rested cvemii^t, they found a range 
of 124 to 290 pg/mi (mean w 200 - 22 8*E, ) during #e #ird 
trimester in 9 norsiial pregnant suhjects* This compared witli 
a range of 0 to 193 pg/ml* (mem 120 - 24 8*E#) in 7 non- 
pregnant aormctenaive patients# Thus, 'although there was am
moverlap bo'Woea the groups, the cliffereac© in mean aagiotenain 
blood levels vas sigmificant (p < O.Og)# Samples taken trmi 
Q women botveen 3 and 3 days after delivery showed a fall ia 
aiagiotOBsia in 4 aacl a rise i n  4 cases, tlio m o m  level 
(219 Î 45 S*33# range 68 to 373 pg/^ l) not being significantly 
different from the late pregaancy estimation*
For technical reasons it is likely that those figures 
overestimated tlio level of cmgiotensin II* Amther criticism 
is.that the control group consisted of patients suffering from 
a variety of diseases lAich could possibly have influenced the 
blood m^ giotensin concentration*
Blood Ai^ iptensinases#
Various peptidases present in blood are copable of 
Inactivating circulating mgiotensin mid aro therefore Isiova 
as ”aagioteBsinaSGS*** The term however does not necessarily 
imply a specific action on angiotensin* Since v^ iriations in 
aagiotôBsinase activity'migM.affect the survival and hence 
the concentration of angioteushi, a numher of measurements 
of migiotensinase activity have been mad© in blood from normal 
xsrcgnmit women*
In 1947, Page found a progressive increase in plasma 
angiotôBBinase activity during gestation, the levels in 11 
women in the second half of pregnancy being up to 10 times the 
levels found after delivery* A gradual increase in angiotensinasc
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Gotiviiy from 2 months to term was also shorn by Berger and. 
Lassglians (1967) and Morondiisi and Mmigioni (1969)* ïîigla levels 
in late pregnancy hmo been confirmed in a mumbor of other studies 
(lliclsler, Lanier mid Thom, 1963$ Mogatsu, Gillespie, George,
Folk mid Gleaner, 1965; Talledo, 1967^  and ï^ abash, Bard mad Kline,
1969).
In contrast, other reports have shown no increase In 
angioteasinaoe activity even in late pregnancy (Slaus, 1962; 
Laadesaon, Biron, Castellanos, la Aissa and Wilson, 1963| Klaus 
and Biron, 1964)* Differences in smpling and in mothodoiogy 
may possibly explain #is discrepmmcy*
Fasculor and Renal Responses to Angiotensin Infusion*
A reduction in the pressor response to intravenous infusion 
of angiotensin is characteristic of ^ pathological conditions 
associated with high circulating levels of renin and presmmhly 
m'igioteasin (l(a%)lan and Silah, 1964$ Brom ot al, 1966a; Luhash, 
Muieson, Alicandri, GorfWml, Sieliierski and McUonsianglney, 1971? 
Chimi and Diisterdieek, 1972)*
It is not surprising, therefore, that the hlood pressure 
response to angiotensin infusion has been shown to be consistently 
lowes* in the last trimester of pi’egnaacy as compared with the 
non-pregnant state ’(Booh, Schroeder, Wagner and digee, 1956; 
Al3dnW(arim end Assali, 1961; Cheslcy, Tailed©, Bohler and Znspsm, 
19635 Talledo, îdiodea end Livingstone, I 966) ,  normal pragnaat 
women at #is stags of gestation requiring about 2*5 times more
tmgiotesîsm thon im first trimester wîioii tho Mood isreasur© 
response ta similar to noa«pregnani subjects (imAkainei,
Eisale, Jarvinon end VirmAo, 1964)* Page’s suggestion (#4#) 
that this might he due t© increased oirctilating levels of 
magiotensinases is sî.q)pox*iecî hy the Iot-;er pressor respomsos 
nearer toî^ m (Ahditl-lferim and Assail, 1961), when plasîua 
migiotonsinases are at their highest (see p3?evious section)* 
ângioteasiîi II îaay mémo hepatic, splaucliiiic and 
peripheral blood flow in mom-preguamt situations (do Boao, lao, 
Mottram, Pickering, Brotm, Soon, Peart md Sanderson, 1963g 
Brown, 19635 Iktorson, I966)* %  nomal pregnancy the blood
vcsseia appear to he lass responsive to this effect of 
gmgiotonsin, m  Wahers (1970) found that infuGccl angiotosnsln 
II caused a smaller reduction in blood flow to th.e hands in 
pregnant compared to mcn-pregnant women#
Pregnancy has also been s W m  to modify the renal responses 
to angiotensisi imfuslom, the urine flow end «odium excretion 
being reduced to a lesser degree in pregnmxt women In the last 
trimester cm%)arod to non-prognont controls (Uliesley, 19635 
Ghoslay, ¥ysm and Silvèrsiian, 1965)* Ghmigea of posture 
apparently have 110 effect on this diminished response (Cliesley, 
Sloan and ¥ym, 1964)# LuuMsàinen and his' eolleafpies (#64) 
have shorn a decrease in sodium excretion and creatiEiine clearance 
after angiotmsin infusion in women between' 9 and 15 weeks’ 
gestation, hut their results arc open to question as no 
significant changée occurx’sd in their non-pregnant controls#
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B. ALDOSÏBME M B  ÜTIÏEII MINiKl4LOCORTÏCOÏI)S IN
NOmiAL PREGNANCY,
The atlvîmtages and disadvantages of estimating aldosterone 
Gxeretionj secretion and plasma coneenti’ation have been discussed 
in Chapter 3* To date, most of the studies in pregnancy have 
involved measurement of excretion and/or secretion rates*
Before discussing these, it will he he.lj)ful to outline the 
possible effects of pregnancy on tiio metabolic clearance of 
aldosterone,
NMABOLIO GimimiCB ^ OF . AMOSgRpNE*
The ratio of iirinaay free aldosterone to the secretion rate 
of aldosterone was shown to be 0*29 ** 0,04 (s,î), ) in 6 normal 
X>regnmit women in the last trimester;(Jones, Lloyd-Jones, Rioadel, 
Tait; Tait, Bulbrook and Greenwood, 1999)* This was similar to 
the ratio of 0.24 - 0*07 (0*D*) in the noiv-pregnant group*
Jones and his associates therefore suggested that, although 
there appeared to be a change in the pattern of aldosterone 
metabolism in j^ rogiiancy (see next section), there was little 
difference in the overall rate of metabolism. These results 
wore subsequently confirmed by the some group (Tait, Little, Tait 
and Flood) 1962) in a comparison between 7 non-qsi’egnant and 
9 pregnant women in the last trimester* Similar clearance 
rates have also been demonstrated in a more recent study of
7 womeii mas? tom ùuü of 0 ooaea at 20 woolsa* goatatioa
(Bayord, Abüoéî# Tappor^ \k}MoBp ÏÏmmt^aki mû Migeosif I9?Ga).
T a it 03îâ Little (I96B) ropcwtoO tlmt tüero mo a dooroaso 
iia epIeiîolAîio eleasmoe of oldo& teyono în prog^ïcsiiey mul tlioy 
fôugiiosted that m  inopoeao iu  o x tiT ,-a p la e lm ie  oloqgaaoo oomwKod, 
üGüQO&ated xrlth # o  foatiss sail
Following the isolation of aldosterono (Simptmi ot el^ 1953) 
attojDpto t;ore made to i®p.licato tiiia lioraiOBo ia tlio pathogoBesis 
of pro-eolosoeia cikI eela^spsia (soe ^Imptov ?)* Naturally *
sjomoteaoivo progaeut wmon xmvo alno etWied# laitial report#
auggeutod that ttiooe %mmom had uriaery levolo similar to Bor^ 
pmoguout eahjoota (OeWoa, Gliort, îkigeûQwn maj B iip loy^ IP54;
VoDuiBgg Singer and Simpaem, 1954), hut iR^ rovomoat in toeWiquo# 
later revoelod iiicreeoed aldoeterono oxcretioE during norsiol in?0Q^ umcy 
(Barnes GBîl Quilligmi, 1956} Venwiag end Hyronfurth, 195j6)*
Uemg a mvo roliahlo method* Martiu omg Millo (1956) 
fomct urimry aldosterone to ho iaoroaaod in 33 out of 55 
norml pvognrnt wwaon, and as pregntmoy progrooood thoro was a 
teadeaoy for tho a'icloatorosne vaines to although the
seattor vaa greater* Similar raaulta were roported hy othes? 
gvGUpa (Koosoreh, Ifelff cm# Beer* 19371 Binaler tmd Rigby*
19571 Vommng* Primrose, Caligarie ej?4Î %renfwrth, 1957)#
5.V0 latoi* reports have show an alteration in the pattern 
of aldosterone metabolites excreted in the urine in pregnancy 
as compared with the non-pregnent state (Jones et al, 19595 
Tait and Little, 1968), Those workers found that the addition 
of a mild acid to the urine resulted in a greater release of 
aldosterone in pregnant compared with non-prognant women and 
they considered that this was due to increased formation of the >-0x0
4-ene conjugate of aldosterone in pi’egnancy. They suggested that 
this change in the pattern of metabolism of aldosterone in 
pregnancy might account, to some extent, for the increased 
urinary values found in earlier studies in ^ diich the analytical 
procedures measured aldosterone hydrolysed from the 3**oxo 4-ene 
conjugate#
Although those findings were not confirmed by another 
study (Watanabe, Meeker, Gray, Sims and Solomon, 1965), it 
remains possible that urinary aldosterone measurements in 
pregnancy may not accurately reflect changes in aldosterone 
secretion or plasma concentration#
ALDOSTimm SECRÆi5?IQM,
Measurements of aldosterone secretion rate by isotope 
dilution methods have been made by a number of groups (next 
page)#
The normal, non-pregnant ranges quoted by the first three 
of those groups were veiy similar and the values for normal
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prc-gnancy wore a im  appreximtrûiy tîiê smie*
Vfetmnabo ami his colleagues (1965)* however* found & 
larger variation in secretion rates, tfbioli l'âi^ y be a reflection 
of the larger nmber of immen studied by thm%i, They found an 
eldoetorone accretion rate of ng/doy in mxa \mBm at 15 weeks* 
gestation, ifMle in esiother ease recul to at 20 and 22 "mdlm were 
■S92 mid 933 w^dsy reenc-otively# The uto'oa eecretieu rate 
increased froni 859 ug/day to 1586 ng/dc^  between 26 xmclm mid 
toim* Imt a im&imd fluctuation occurred between those periods* 
m  2 other subjects, mth a constant dietary eoditm intacte of 
160 mE|/day, amial measurements of aldosterone secretion showed 
a considerable variation in  the last triracater, an Increase of 
10&8 ng/day occurring in one wman botweon 5^  and 36 weeks* while 
in the other a decraano of k3l ng/day vm found between 51 and 
33 wcolm#
Although Thomas ami Flpm (196%) fetmd lower aldeste&'on# 
secretion mtos thoa in the preceding studies, they claimed 
that those level a wore increased, hut did not quote a m m a l 
non-preguamt range for cornparison.
The study by .bayard and his a&aooiates (19?^ )) allowed even 
lower aldoBtorouc accretion rates in late pi%immtfy (38 to %0 
weeks ) l>ut once again the authors did not quote their <nm reogo 
for nomml non-'pregnant auhjccts* Ojie wmmi studied foy them 
nt 20 weaW* gestation had a eearetion rate within the late 
pregnancy range* They suggested that the diaoropancy between
38.
their rosul-to eiKl tiiose ilemonairatcd previoESly might bo duo 
to the of foots of positive oa aldosterone seorotioUf m  ..their 
patients had been supine for at least 10 hours before the atutiy* 
This is supported by one report (Balikiou, Brodie# Dole* Melby 
and Tait* IfO S )  Miieh showed m 8-i‘old iuorease in aldosterone 
aeeretion rate in nou^ progacuAt subjeota osi ehmgiug froai the 
lying to the ataxidiug position* Oa the other hmd* it is not 
supported by Sims (196%) aJio fomd #ut a period of reeumbeney 
of k to 5 days duration iu 5 noiml pregusnt woraen did ssot reduce 
aldosterone secretion#
FL4?M\ iyjjQsrmiMB cmcmfmTi#.
Four reports of plasma uldosterono concentrations in 
nomal pregnancy hove been published to date (stork* 1967s 
Doyurd ot si, 197#a; Weir et ni* 197%, 19?ld). The results 
of our tifo studios will bo described in Ghaptm* 3*
Sxk a  b r i e f  % "oport, S ta rk  ( 1967)  d m o n s tra te d  ho  
difference ia mean plemc aldosterone concentration between 
pregnant md non**pro|piant women, but no ;#k(r#er details am  
available*
Doing a double isotope darivative teclmiquo* Bayard and
his colleagues (1978a) measured plasma aldosterone concentrations 
in 5 nomal prognmt ymmx b&tweoa 38 and ho weeks* gestation.
(hi an unrestricted diet, ixlaavm aldostoroAie ranged from 
1*7 to 9*0 aug/lOO ml (mem. 3*5 In one o#or woman
39i
at 20 weelis gestation, plasma aldosterone concentration 
was %*7 mug/lOO ml* Tlie authors suggested that those 
levels were about twice as high as the values for non-pregnant 
ifomen (mean 2*16 ug/lOO mg) reported by another group 
(Balikian et al, 1968)* Strangely they do not compare 
their results ifith a non-pregnant range from their oim 
laboratory, yet in a previous study hy the same group 
(Bayard et al, I970h) four normal non-pregnant subjects on an 
unrestricted diet had a range of 1*7 to 16*2 mug/lOO ml*
(mean » 6*1 mug/lOO ml) after lying for one hour* These 
levels increased to 5.8 to 17*0 mug/lOO ml (mean « 9*% mug/lOO ml) 
on standing. Unless a further fall in plasma aldosterone 
concentration might be expected to occur after lying for more 
than 10 hours, then the non-pregnant values i/ere higher than 
those found by the same authors in pregnancy, but they moke no 
comment about this*
AbDOSTmom AND , BAMCE m  PmxmNCY*
Aldosterone is a very potent inineralocorticoid and, 
as was outlined in Chapter 2, its major physiological role 
appears to be in the control of electrolyte and fluid balance*
The relationship between aldosterone and electrolyte balance 
in pregnancy has therefore been the subject of a number of studied*
in 1957 Hinsler and Eigby found a correlation bettfocn 
aldosterone excretion and the urinary NasK ratio in the last
trimester, but two other reports failed to confim this, 
nor did they demonstrate a correlation between plasma 
sodium concentration and aldosterone excretion in late pregnancy 
(Bachborn, Koczorok and Wolff, 1957} Jones et al* 1959)*
Watanabe and his colleagues (1965) took the endogenous 
creatinine clearance as an Index of the quantity of sodium 
presented to the renal tubules by gloiuoitilar filtration, and 
found no correlation betimen this endogenous creatinine clearance 
and the aldosterone secretion rate in women taking 120 to 190 m%  
sodium daily in the last trimester*
The effect of sodium depletion.
An increase in aldosterone excretion in normal pregnant 
women has been reported following sodium restriction (Barnes 
and Quilligan, 1956} Kumar, Feltham and Oomall, 1959) and the 
administration of a thiazide diuretic (Ehrlich, Lugibihl, Taylor 
and Jonulia, 196?) #
Tliis normal pliysiologlcal response to sodium deprivation 
and sodium loss in pregnancy was confirmed by Watanabe and his 
group (1963)1 who found that the aldosterone secretion rate in 
3 women in the last trimester increased from a meaii of 1576 ug/day 
to ysfjkj ug/day idien tlie sodium intake was reduced from a mean of 
150 iiiBg/day to 8*0 ii#j/day for 2 weeks. They considered that 
this 5-fold increase in aldosterone secretion in pregnancy was 
greater than would be expected in tîie non-pregnant subject given 
the some degree of sodium deprivation. In one pregnant woman
M,
studied by Bayard aîid co-workers (l970^ , a **lov; sodium diet" 
was associated with a plasma aldosterone concentration of 
29#% ïiTug/lOÜ ml compared with tîie range of 1#7 to 5*0 niug/lOO ml 
in 5 normal pregnant women on an unrestricted diet, hut details 
of the "low sodium diet" were not given#
The effect of sodium logdii^ »-
Watanabe and his colleagues (1965) investigated the effect 
of sodium loading in pregnancy in 4 women in the last trimester, 
hy increasing the sodium intake from a mean of 155 mËkj/day to 
190 mEq/day for 4 weeks. The aldosterone secretion rate rose 
in one of these women from 999 aug/day to 1208 mug/day, hut 
fell in the remaining three, the overall mean showing a 
reduction from 1105 mug/day to 7%7 mug/day. Those results wore 
confirmed by Stork oAid Lehmann-Achilles (1964) who found a
5-fold decrease in aldosterone excretion rate in 11 women in 
late pregnancy given an intravenous infusion of 18 g# sodium 
chloride for 10 days; and hy two other studies which demonstrated 
a drop of at least 50 in aldosterone excretion in 4 pregnant 
women given over 12 g, sodium chloride daily (Mirlèch, Imres, 
httgihihl and Landau, 1962; IM'liclA, Lugihiiil, Laves and 
Janulis, 1966).
Nosîiml pregnant ifomen given on increased intalce of potassium 
(4*0 to 4.5 g/doy) excreted similar quantities of aldosterone
42*
a» prognaat 'xtmnon glvm a normal potaaaittrù dioi o'2 2 g/ûo^
(Baraoa cmd #56)*
Tho offeet o i aldoate&omo ânhibitiosi*
B%rliqh (I9?l) has #o%m #mt haporânoieViaduced &nh&bàt&on 
of aîdestea^ sîo oacration iu  prag*umt wmon ie aaaooia&ed with a 
rise âti aodiam exorotion but Ma ao offect mi ariae pataaoiam#
It is jppparent from tSio S^vogoinu roporta that, although tSio
oxeratioa aàd soes’otica of aldoatoroao in prog&ianoy is eoaa&dordbly 
higher ttoi in nimmpreg^ mat oituationo, thoro appears to ha a 
moiiiml pbysiologioal roapmieo to bo# aaditsu) deprivation mâ 
i’jùêimî loaêimgÿ certainly la the lator Miths of gestation, M  
iœ  es is (mom, tkoro Ueo licea mo report of a study of aldostoroaa 
tmd Qodiua balance h i #e oarlaei? months of prognaaey,
m m m  MmimmmETiGeius,
M;n:y Momy reports Mvo been j^ #liehod m  iueroaooâ
plasma oomcemtvatioa of 17^ 'kyir.oxycerticostoroids, nmiuly 
cortisol, dwiîAg progmaaoy, particularly ia Hm last tvinieo'tci?
(o#g* Clemzoll, 1953l Brome, Eemd and Stoinbock, 1955î
UoMtmm^ I3om#ard, Gmb#, tomor, Sewekot? oad Dllber, #35|
Mortia md Mille, 1#8; Jailor, Olifiety, Wigomi, l/allcico miü 
Gordm, 19591 IMWWmuaseai, Buus, teulwall md Trollo, 1962g
43*
Friedman end Board, 1966; Goldberg, Lewentbal, Gottfried 
and Ben-Aderet, 1966; Neilsen, Binder end Stomp, 1969;
Kopelmen end I*ovita, 1970), This is mainly due to increased 
protein-binding in the plasma (Boe, Fernandez and Seal, 1964; 
de Moor, Steeno, Brosens and Hendrix, 1966; Keane, Pearson 
and Walker, 1969^ ; Hosenthal, Blaunwhite and Sandberg, 1969), 
only Bau^ diaday (1958) failing to show this, A slight rise in 
tnbowid plasma cortisol has also been demonstrated (Doe,
Dickinson, Kinneaian and Seal, 1969; Keane et al, 1969b;
0•Connell and Welsh, 1969; Rosenthal at al, 1969; IMrke and 
Boulet, 1978) and an increased excretion of urinary free cortisol 
has been shown (Jailer et al, 1959| Tliomas and Flynn, 1964; 
Gottfried, liewenthal and Goldberg, 1968; Burke and Boulet, 19?0), 
As the purpose of the present study was to examine 
predominately mineralocorticoid activity in pregnancy, these 
reports on plasma and urinary cortisol levels are not presented 
in any detail here. They are well reviewed elsewhere (Forshom, 
1967; MacNaughton, 1967; %tten and Leitch, 1971)*
Other adrenal hormones with greater mineralocorticoid 
gctiviiy have been loss well reported*
Tobion (1949) measured urinary formaldohydogenic 
corticosteroids as an "index of deoxycorticosterone" and found 
raised levels in 18 normal pregnant women com%)ared wi#% 10 
normal non-pregnant females* Bxley and Nor^ miberski (1964a) 
demonstrated an increased excretion of 17«deoxycorticosteroids 
(metabolites of corticosterone) in ncrmal pregnancy, but no
metabolites of 11-âeosycorticosterone were foimd isi a ftxrtlier 
study (Beley cmd Horysiborski, 1964b). In urine pooled from 
several w<HJien in late pregnancy, Basslor (1969) reported higher 
levels of ll-deoxycortis6ivifian in non-pregnant subjects.
Elasiaa corticosterone concentration (ug/lOO ml) has been
Authors KorsimlNon-pregnant
Bongo*
Normal
Prc#iancy.
Tiiae in 
Gestation#
Morris & Williams 
(1953)
4.0 - 10.5 
a - not given
7.0 - 18.0
a ss 4
Last triitiestei
Stewart et al 
(1961)
0.0 - 2.0 
(mean 0*40)
n « 27
0*0 - 2.0 
(mean O.67)
n - 9
56th week
Martin & Martin 
(1968)
0.0 - 2.5,.
(mean 0.6%. 6 SB)
H SÏ 53
0.0 - 2.86 
(mean 1.5%.7 SB)
a S3 18
late pregnancy
Schweitzer et al 
(1969)
Not stated Mean I.4I1.6 SB Term
Stewart and his colleagues (1961) fomd no sigpaificmst 
increase, but Martin and Martin (#68), using a similar 
fluorimotric method, did demonstrate a significant rise. Both 
of these studies, as well as the earlier one of Morris and Williams 
(1953), showed a considerable overlap with the norsial non-pregnant 
range*
"Sttbmiorogram" levels of plasma ll-deoxycorticosterone wore 
reported in 7 norsual pregnant i«>mon at term ( Schweitzer,
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Branohaud and Giroud, 1969), but no details of normal 
non-pre^ont values were given#
m.
c . cotamts om immATim ihsvïbj.
There la little doubt that pregnancy is associated with 
marked changes in the reain-angiotcnoin system. In spite of 
considerable differences in tecî-inique, plasma renin snhstrate 
lias heon alioim to he elevated in almost all coses studied.
Plasma renin activity end coacentrotion ore raised in many 
women, hut a substantial numhor show levels within the normal 
Boa-pregneAit range. Circulating levels of angiotensin II have 
been less well studied, hut t^ iey appear to he increased in most 
vGiimif al#ough they also may remain in tîie normal non-pregnant 
range,
Many of these other investigations were not designed to 
study the renin-angiotonsin oyatea per se, and report only on 
changes in the individual components of the systems, i*e, on renin, 
renin-suhstrato or angiotensin alone. In few, have tîio plasma 
renin mad ronin-suhstrato concentrations hoea measured together, 
and in none has the major end-product of üie jsystesa, angiotensin II, 
hocn measured concurrently* Comments about the inter-relationships 
of renin mid renin-suhstrate with angiotensin in pregnmicy have 
tlioroforo hoea based mainly on theoretical consldoratiosis*
Many pregnant women show increases in aldosterone secretion, 
excretion and plasma coneentration, Asswaing that the relationships 
ostahlishecl in non-pregnant situations might also hold true in 
pregnanoy, a number of reports have implicated the reain- 
angiotensin systeiî as the stimulus to this increase in aldosterone
procluetion. However, no direct relationship has yet been 
demonstrated by concurrent measurement of the four factors 
involved, i#e, renin, renin-suhstrate, angiotensin II mid 
aldosterone#
The studies to he deacrihed wore therefore set up to 
investigate these questionsi
(1) What changes take place in t!ie plasma concentrations of 
angiotensin II and,.’aldosterone (and also in plasma levels of 
other corticosteroids, e#g*, corticosterone# BOG) during 
pregnancy?
(2) Itot effect has pregnmicy on the relationships batsmen 
plasma renin5 renin-sahstraie, angiotensin and aldosterone when 
these are measured concurrently?
(3) How early in pregnancy do changes taîîe place in the 
circulating levels of these substances, and h w  soon after 
pregncuicy do they revert to tlie normal non-pregnant range?
(4) Wliut stimulates tîi© inerei^ ea in renin, renin-suhstrate, 
osîgiotcnsisî II and. aldosterone in pregaiaacy? Is Üiero a 
relationship to the change© in electrolytes, proteins, haematocrit, 
ïîlaama volume, renal function and progesterone which als© occur?
4$.
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(The results of this study îmve been published previously - 
see Heir ot al, 1970a and X971a)«
The plasma concentrations of electrolytes, renin, haemoglobin 
the proteins, together witîi plasma volume, osmolality, colloid 
osmotic pressure and packed cell volume, were measured 
concurrently and serially throughout pregnmcy in 15 wmien, 
some of the variables measured having been considered to be 
possibly concerned with the control of renin release md plasma 
renin concentration (see Brown ot al, 1966a, 1966c, 1968; Vender, 
1967? Brown, Lover, Bober toon, Hodge, Lowe end Vane, 1967; Heilson 
and Miller, 196O} Hosie, Brown, Harper, Lever, Mac Adam, MacGregor 
and Eobertsott, 1970; Brown, Bevies, Johnson, Lever and Robertson, 
(197®)# Plasma concentrations of aldosterone, corticosterone and 
cortisol were also measured at the same time in 7, 6 and 6 of iîîo 
women respectively#
CLINICAL immmà mm mmms
No abnormality was found in any of the 15 women on initial 
clinical examination# All had blood pressures of 140/80 nBmïlg
4y,
or loa© prior to the 2St!i week ef gestation* All W t  ono 
(ease Q, Table I - Appendis) were primigrovicî. On© (ease 14) 
had a twin pregnancy* TMir. mean age was 26.5 years (range 
21 - 36)5 mean heiglit 162*1 an (rasige 1%5»0 - 167*5); oad 
mean ’^feiglat at the l6th week 60*2 kg (range 51*7 - 73*4)
(see Table I).
The womOB attended as out-patients at the 16th# 28th, 3%th 
and 51%' weeks &t gestation, between 09*00 hem’s gmê 10*00 hours, 
having fasted overnight# but having eaten their aomiml diet to 
that time* At' each visit they were weighed, tlie legs were 
exoîïïiaecl for .oedema# and the wime ws tested for protein by the 
iUbustix Bietîied (Ames Ltd*)*
The women then rested supine for 59 minutes# the blood 
pressure was measm'ed with a clinical sphygkiemmiometer# and a 
saîj^île of peripheral venous blood who Ween*
laboratory and statistical Eîothoâs have hoai outlined -in 
Chapter 5*
mswms ,
.All the women delivered heal'iihy infants* ’ The mean birth 
weight of the singletons was 5*37 kg (range 2*86 - jtsg); 
the twins weighed 2*49 %  and 2*6l %* Detailed results in 
indi'^ riduai %mMm are shown in Table I*
In no case was proteinuria detected at miy stage* In
3 0 .
12 tMKncn MMÂa cWmgo oconpgod ia the syatolio mA  diaotolio 
pmsswes pregQa%@y (F%* 6)# 3h 3 oo80(3 *** 15)
the blood pmu?mm iaorooaod la tho loot 6 week© of progomoy
to ©Koeeü lW/9# RBf|g<j ead easo 14 eXtm devoloped goripherai 
oodom# this yioo la Mood prooow)' would bo BOgg&iMod
by (mm aathoritlea as? hWmmmi ^ data fror) caiacve ■ 15 
H D t I s e l î i i â o â  in # 8  s t a t i s t i c a l  m a l y s i s  mà asù p l o t t e d  
ooparotoly la Hgoroa 6 to 8#
All #e tfoaen sbm/cd a  atoady riao in  weight fgom #e 
l6i% to the 58th %?eok# with eoisoiios^ ibla muriatic# botweém 
(T#lo l)* If the "tDTla it? oescludod,
the average woight gsiii was 9*68 kg (m'sgo 5*9 15*4 bg)#
The 'rninm xdtlH tW%m (easo 14)# w&q dovolopod Biarked ùmHsm 
with Inoiceaiood blood l3i tw laat tayi^ ogjtêa^ , had a
total weight gaim of 1G*% %@
I B m g a a s * .
&a ovmy. coeo the plasma wlma Inoreoaed iteibsg pm#mn0y 
(fablo I# Flgwo 6) the mami value beimg liighoat at 3% woka 
(t « 5#46g 6*001 ^  F < 6*61) oa ompamd %4# 16 vaoka# Two 
of #a 3 00&08 wbooo Mood psoaewo imraeaed bad Mghoi* thm 
civorage wluaa of plama volumo, but the individual roaolta wore 
w&thin tlio range observed M  the other eiibjoots*
Plmüîüa protoln^  %?ietu@t9d &K@$kedly 1% l%adlvl&5t%l 
(%blo &)* a al#lflomt rise in the mmi e^womtmtloA ooowriog
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Îjetîæeaî tlm SStla 38*3% weeks (t ss 5^X4^ 0*01 < p <
Figïisr© 6)#
fl%© isadividual’ ehid mee.% colloid osmotic pressHze va^'iod 
consito’ü M y  no .eléas.' pattei^ i (Salïlo I, J/ignrs 6)*
naemo^ iïXobjm amd haématoc^'it*
la comfomity witli previotiB studios (see Ilyttou aud loiteli^  
1971) throogbout progsTèucy We;mtoc$'it ead Imcmoglobiu 
comcentratiôm -ï'/ospé f^equ#tly lower for noiNnal hoji*
pregagmt fsmales#
Plasma oXootroIytes aail osmolality#
Mo siguifioaat ohmige m m  obsormd as pragaoaicy procooded in 
til© plasma coaieoutrations of sodiumj pjplasslum or cbloride* 
Biiiîiiarlyÿ no significant obange in plasma osmolality
occurred (MsXo 1» Flgiop© 7)#
Plasma TmSsh coacesitration*Wàtw f #*# I w*o T tmmrni
la 10 of tbe 13 womcm, the plasma roaia x'-aliios imre 
above tbe .uaa**prsgaamt rang© in çaeb estimations, Wt'' a marked 
difference was apparent both be'Woen %#mm% rniây in somo casco, 
beWeen different periods of gestation in # e  same woman 
(fd^ îié 1, g'igjurcs 8 and 9)# ^en estimatloaa out of a total 
of ÎI3 in the wiiole series lay ifitMm tliQ imm.al non^pregnont rango* 
#.© fall im the mean plasma reals concentration from I6 to 38 wooks 
was not significant (t s 1.85, p 7 0#lj Figitre 8)* In #0 
3 women '#ose blood pressm?© increased hi late pregnancy the raâg©
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of plasma renin conoentratlon vas not maarkal^ ly different 
froïïi th&rt ie the other 12 (fahle 1# Figaro 8)#
Plasma alclO£tterone eoBoentratioB»
Plasma aldosterone coBoeatratioB vcts measured in 7 of the 
womenp iuclading 2 whose hlood pressure rose latterly# h^o 
results were eoneiderahly higher than the normal non^ pregumit 
rmge h% each of the total of 28 estimations » the Mgîîest mean 
value being seen at .16 weeks (ïahle 1, Hgiwe 8)# i’he individual 
levels in the women whose blood pressure did not increase are 
shorn in Figure 9* âithoufïh the mean aldosterme, concentrations 
for these 5 women decreased from 16 to weeks (Pigitre S), this 
change was not significant hy Student*s t-test (t 2,07#
0>0^  < p < B.l) or hy 'the Wiicoxon test for pair differences 
(ûfcs; 0,1#)» Plasma aldosterone was measured in 2 of the 3 
women whose hlood pressure rose in the last trimester» In <nie$ 
the results were within the range fouu.d in those whose pressures 
did m t increase, The other had rather lower values ^ with very 
little variation hetwem the I» serial estimations, al'though all 
were well above the Bo^ -prognaut ui>per limit (Figure 8)*
Plasma corticosterone concentration,
Apart from elevated values at 23 weeks in 2 cases and at 
iC> weeks in another, the remainder of the 2% estimations in the 
6 women studied, including 2 p,#ieits whoso blood pressure imoreased 
latterly, shwfod plasma corticosterone conceutratioùs -within -fche 
nomal non-pregnant range (Table 1, Figure S), Ho consistent 
pattern?, was noted*
33,
rtisol coneentyatioB»
îïi 4 of the 5 persisiontly momiotcneive women, the plasma 
eortiaoi coBceatration roso frmi 16 to 38 weeks (Table l), 
whereas it fell slightly in ome wmaa, Ho sigaificmt change 
in UiQ moon value betweea 16 gimI 38 weeks ims found (t « 1,29# 
p > #*1) ' (figure 8), All values wéro el.m%re the aoBiial nouM 
pregaaj.it rm.ge at 58 weel^ s, whereas only Q of 18 estimations • 
w#er© .so elevated in eeMioi? xiregaanej* Pl-asam cortisol was 
measured lu only one of the women whoso blood pressure roso ia 
the last 6 weohs and in this ease it rGmaiued above the normal 
uoB-pragiieBt range throughout proguanoy,
So£.\relati ona
All the factors reoordocl in Table 1 (opart frmi those 
ohtaincci in .t3ie 3 women whose blood %)rossure rose la the 
last trimester) .were euhjooted to multiple regression gmalysis, 
both as absolute values and as a percentage ehan.ge from the 
initial value* No statistiealiy sigmficant corrolation 
w;as found heWeen any of the factors measured* In pinr-tieulor, 
the plasma concentrations of renin and aldosterone wore not 
signifiowitly related) as shown iiK Figure 9? wide disparities 
between individual plasiua vmin end-aldostorone cencentvation.s 
ocourred# It is particularly noteworthy that stmiQ of the 
highest plasma aldosterone levels were observed Its a vm m  
in idiom plasma renin concentration remained throughout vjithin
tho MOKmal mugo#
T à o  r o Ê iu î t s  o f  tW .0  o t-u d y  w i l l  b o  d io o n & o o d  t o g o t b o r  w i #
ill©' résulta of tho next 3 studioo hi Oheptor
me m m g  op m m m  iwimHCY on pwsm
cmQmrLmiQm op mmm, Rmm-soBmmTPe mitIotmbbî ii
M B  A M O S m o m  M B  ON THE BîMïOMSilîPS BSBHM THESE 
SÜ1ISTMCPS) meimiNG cismges m  fm^ia hiog-estmwe, 
P&àmà MB  UBINAm œsOTEOLMS, FLA»m OSmMLITI,
BLOOD m m ,  smoM cseatbjihe m b  cimTiNiHE cimpmoB,
GimiGAL tmüwù OF ^om.
A small aimiljer of healthy women studied early im pregnancy 
had been aènitted for torminatioa of prognanoy undor the Abortion 
Act g 1968, Otliendse, all the women had normal full-term 
progaaneies with no complications across delivery or im the 
pBorperium* îlo ease was iacluded where a raised blood pressure 
(i,e, 140/9# or over) was present at any stage of gestation,
A total of 112 women were studied at least oaee during 
pregQaacy or post-partuia* The parity of these women was as 
follows8- para 0-9^5 para 1 - 30; para 2 - 11# para 3 or 
over - 16# Their ages ranged from I7 to 41 years (mean 26,o), 
Two women had twin pregnancies.
In early and mid-pregnancy blood sfsmples were taken mainly 
from women at tending os ©nt-patients, whereas in later pregnancy 
5#^  of the woKien were in-patients at the time of sûHïpling* 
Foat-partnoi sanîplos were taken from in-patients in the first 
two weeks after delivery and from outpatients later in the 
pnerperium. The in-patients remained in bed in tlio morning 
before blood prosauro measurement md venepuncturo, which took 
place between 8,3# Güod 9*3# a.m* The outpatients, who attended
%»
routino asrèaaatal end pos’kiatal clinics, usually in the morning, 
wore rooted anpimo for 30 mianteo before the blood pressera 
was moesureâ and the blood riamplo teiiOB,
With tliG numb era of ifomca Involved, it was eosaiclorod 
i?iq;raotioQblo to ecmtrol olGctrolyto bolonoo proeieoly# All 
tlîo woîBoa tsToro tliorefore allowed to talso mi uarootrioted. diet,
To Gsoludo a poaaiblo major disparity botwooa inpatieat 
smd oatpaticüit ootimatloBg, plamia roaia and mii'm-BubBtiwho 
ceaocatpotiouo were meesurod im 7 women ob 2 oooaaioBB each,
&008 than 8 imeko apart «* as an isipatioat oa ohg oco&s&oa mid 
00 cm outpationt on the other. No oignifioant waa
foimd by the paired t-teatg eitbor for pleoEm reaia ooacoatratiea 
(t £3 0,#8, I? >0,1) or for plaoim roiiin-sahatrato cmioontration 
(t = 0*739, p> 0*l)* îaeaffieieBt data, wore avaiiahlo to make 
the fJafso eomiariGooo for x^ lasma migiotonoin IX mid aldoetorose 
eoaomitratioias, but it waa poaeihlo to etatietioaSly oompero the 
aldoaterosQ results between © nm#or of mipatiente miü a anmher 
of ontpatieato at the 38ti'i week of gootation, Oaeo again, 
im ùignificant differoaoo waa Éomiê (t £- 0*426, ^>0,1, a -lO),
Of the total of 112 women atudiod, ell 4 oen^oaents of the 
TOaia-m'igiotônoâK-aldostôrono oyatei were looosmped eoaourrei-itly in 
IS immea, 3 oompoaoats in 38 womoa, È oompemcmts ia 24 immen and 
elaglo rneasaremeiita wore made in 41) iv*onimi* IXetailo of theoo 
m û  of the mMïore of other faetore meaenroâ are iae'iudod with 
tlio results, la 10 eeaos, ooriol meaeuremeato of at least one
3 / .
es)3îpon©at wero made from the early weeks of pregsiasicy to term 
mid post-pc^ rtiim,
hmiqbs,
Those have beea outlined in Chapter 3*
The concentrations of each substances have been tabulated 
for each of tlie triiaiesters of pre^ancy, and for weeks I to 2 
end 6 to 12 of the puerperium* %#oro more then one result was 
availûhio for each period, the memi of those was taken for 
statistical analysis. Individual results and/or means and 
standard deviations for each trimester and post-partnm period 
ere ahoivn on accompanying graphs, The results for each period 
have hoen compared hy measuring tho t-statisiiccand this, together 
with the statistical significanco, is tabulated for each substance* 
In the case of plasma renin, renia-ouhstrate, angiotensin II 
and aldosterone concentrations, the serial ehsmgea from early 
pregnancy to the post-partum period are illustrated for 6 women* 
This is accompanied hy detailed graphs of the changes in a larger 
number of women in early pregsiancy and serial changes across 
delivery and post-partim,
Where concurrent measurements have hoea made, the corrélation 
coefficient has been tabulated for all the estimations during 
pregnancy as well as for each trimester and post partum period.
Wkovo tîïis îiûs reached statistieal eignificence ^ graphe are 
ehoma ilXustrating the two relevant auhetgaoes platted agaisist 
mo mother, with Üie appropriate regreseioü liae*
Plasma reahi coaoeatratioa#
ïsidividîial resalts mid means for each trimester and 
poGt^ part^ r.i2 period are shown isi Table 2 (Appendix) and 
Figwo 10*
Comparison of the results at those difference stages 
was as folloT/s*#"
Coeporison
I - II
II * III
f ^  III
111 - 0*0 . 
0*2 ■
P*.F*'^  P.P.
0*2
t^ statistio
1.605
0*866
6*&0O 
5*35^
Degrees of 
freedom
Significance
P
■*wJnt^rvT\^n
5% > 0*1
39 > 0,1
67 < 0.01
61 < 0.001
40 < 0.01
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Figure 11* Flaewa ronin concentration in early pregnancy.
59.
every ease Km early prognaney# plaaaa renin 
cmeoEitratieii vas oièvatoâ above tîie uoxmal noa-fprepicmt 
range, #e higjkeot vAlme being 9^ units/i. As sUom in 
Fiam*e 1 1 -^ t^ oae'.^ imcreosde vére apparent as early m  
9 weeks after’ the- last meastmal period, i,e. approximately 
3 weeks after conception^  rjîlie serial readings in 
Figaro :il Show' 'that in th0#e)-e%ly - weeks plasma renisî 
concentration fluctnated consiiiorably within the one 
individnal and there vas alsÇ é marked variation hefe’cen 
individual' vomen. '
Baring pregnancy there was a significant fall in 
plasma renin concentration, althou^ all hut 6 of the 
%f(mcn studied still had values above the normal non** 
pregnant range in the last triiiiestor. This fall was 
loss noticeable in t!io serial study of 6 women during 
pregnancy (Figure 12)#
A marked fall in plasma renia concentration 
occurred after delivery of the foetus and placenta, 
although it was still elevated in some cases at the 
6th day po@t#»partum (Figure 13)# By the 6th week post- 
partustt, plasma rmiin concentration had dropped fur#er,
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Figure 12. Sérial imeaaurememta of plaema renln concentration 
in 6 pregnant women*
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Figure 13. Serial ■eaeuremonte ôf plasma ronin concentration 
across delivery and post-partum*
ail the eases studied havimg îoirols im the lower hali of the 
siormal noa«progsa®at range
Plasma renisiraishstrato coBeentration»
Individual resiults mid means for each trimester and post, 
partum period are shown in Tahlo 3 and Figure 1%*
Comparison of the.results at those different- stages was 
as fellows*-*
-------
Comparison
2*Mi«rfar3WML'Cwa^‘»n(r*«aRT*taaudiLi miwJi_4«m*ii# jjw W«
t-staiistics
.airairaii II.
Degrees of 
freedom
Sigjuifieonce
P
I -  II 6,739 ?a <  0.001
II ^  III 'i.6?5 8& < 0.001
1 -  III 18.8# 84 < 0,001
III -  P,P.
C-2
3.104 76 < 0.03
P*P, -  P.P. . 
0-2 WB' 4,081 4,7 I < 0.001
Plasma Tonin suhstrate emicentration ahoiyed a marked mû 
progressive increase throughout preguaaicy (Figure 1%)# %e 
earliest élévation fomiâ was at 6 weeks* gestation■(Figure Ig)^  
and substrate levels iuereased thereafter» although in a few 
cases they roBiaiued within the normal mon-preguant i\mgo 
during the first IQ %fceks* All were above the nomal non- 
pregnant range in the third trimester» #e highest level reached 
being 6,93 uM,
ÎH1 addition to reflecting the general increase throughout 
prognasîoy» the serial study showed a slight fall in 6 eases in 
the last few weeks of gestatiossi (Figuré
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Fif^ure 15# Plasma ronin-substrate concentration in early 
pregnancy *
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17. üarlal aaasiiro«anta of plaama ronlB-aBbatrmta 
oonoantration moroaa daXlvary and poal-partum*
Uoan piasiaQ s?onia Qu'Erste ooiicemtratioa ehowed a email 
liiit eigaificaat deoreaee ai’ter delivery of the foetus end 
plQoeaitaj hat this was less aotioeahle on serial readings 
(Figs.%re 17)% and in no case had it returned to non-pregnant 
levels hy 2 weeks pos'fc-partuRU Bven at the 6th week in 
the puerpea’iuaij a numhor of women had plasma concentrations 
of renim suhstrato well above the normal mon-pregnont raage#
Women %fho did not Isreaot-feed their infant were given the 
S5?iithôtic oestrogen, stilboestrol, to suppress lactation. As 
oestrogOBS may affect oircitlating levels of reanin substrate 
(see Chapter 12), it was #ought ' that this might explain, at 
least in part, the persistence of hi^ concentrations after 
delivery. Women i&o breast-fed and T/omen were given 
stilboestrol have therefore been denoted by S different symbols 
in Figure -.Blasma renin substrate concentrations in the 
women who breast-fed their-infmits were, in - jgeneral, ' lower in 
the week after delivery mid t;ero within tîi© normal non-pregsiont 
range by the 6th week post-partum, the statistical difference 
between the 2 groups at these times’ being t » 2*494^  p < 0.C2 
and t ss l.?ll, p > 0.1 respectively..
Plasma angiotensin II concentration.
Individual results and means for each trimester and post­
partum period are shomi in Table 4 and "Figure 18.
Comparison of the results at those different stages 
was as follows a-
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Êl&uro_.19, Plaema anglotonain XX concentration in early 
pregnancy#
6g,
Comparison i—stetia'iiios Begreem of freedom
SigirifiemieQ
P
I « II 2^ 983 % < 0.01
II ^  in : S.179 66 < 0.09
I - III / ?.m9 • 62 < 0*001
III # ?#p. ' 3.W. - . 93 < 0.01
p.p. « P.P. ' L r 
0-2 6-12
1.189 . 29 ;> 0*1
plasma-cmgioteasiè XI comoemtratiom showed a progressive 
increaeo diiriàg/pre^mioy, bat in all trimesters a nombor of women 
had XevolG within, the momal noB-pregnasit range. laereeoed 
levels were feimd as etwly as the ütè, week of gostatioii 
(Fignre 19)# Somo woraea slioiTOd very marked increases and 
variatioms throughout pregaaaey tdmreas o#ers showed very flat 
eurves within the nomsl mcm-pregnmit rmige from early pregLnaaoy 
through to the puorperium (Figxire 2§).. . the hipest level 
reoorded was %13 pg/ml.y im the third trimester*
%  the aocoM week after delivery, plasma aagiotmsin II 
coîieeiitratioa had returned to the normal Hion-pregnant range im 
ell hut S wojiion, those two oases showing normal levels ^4 weeks 
labor (Figure 8l)* - .
Plasma aldosterone eouoenti^ atioa.
Individual results and memis for each trimester and 
po8t“partma period are shown in %ble end figure 22* 
Gomparisesi of the results at those different stages
was as fellQwo$"w
I P L A S M A  _
1 A N G IO T E N S IN  U 
' C O N C E N T R A T IO N  
pg /  ml
260-1
1 2 5 -
0
18 3 0 3 6  TER M2 4 66 12L.M.P. 12
G E S T A T IO N  (w e e k s l P O S T - P A R T U M
unve ZO* Serial meaeuromoata of plasma aaglotonsin II 
AoéAt rat Ion in 6 pregnant woma#.
PLASM A  
A N G IO T E N S IN  Ü 
C O N C E N T R A T IO N  
p g /m l
100-1
5 0 -
0-J
2 3DELIVERY 6-2 4 5
P O S T-P A R TU M  (w eeks)
g l » Serial measurements of plasma angiotensin II
concentration across delivery and post-partnm.
PLASMA
ALDOSTERONE CONCENTRATION 
mwg/lOOmI 
180-1
120-
6 0 -
o-J
1 Flmitro 22.
I Plasma aldosterone
1
concentration in noiwa* 
pregnancy and post- 
partum»
$
r 1 r 1 1---- 1 r 1 r
0 - 1 2  1 3 -26  27-TERM 0 - 2  6 - 1 2
GESTATION (weeks) POST-PARTUM (weeks)
PLA S M A  
A LD O S TE R O N E  
C O N C E N T R A T IO N  
m u g /lO O m l
80-1
40-
0_l
84 6 102 12LM.P.
G E S T A T IO N  (w e e k s ]
2 3 m Plasma aldosterone concentration in early pregnancy
Comparison i-statiatie Begree of freedom
Sigpificaneo
p
I -II 1.809 % 39 >  0.1
II « 111 0.909 51 > 0.1
I - III 2.045 . 58 . < 0.05
III - l\l\ 
0-2
1.820 ' 26 •^05^  P'<«Q*1*
P.P. - P.P.':
0-2. , 6-12 .. T '7r\/\
'
— ““
Meern î)ia«ma alitîostai'onG coiiçoîitÂ’atioB showed a 
sigsiificajit,ihcreq-SG.;frota'toarly .tôl'late pregamey# <mly 
2' women having levels id thin the normal Boa-pregnant range 
in the last triaieàter*
Sigh concentratioas wore fomid as early as the 5th week 
of gestatioa* hmt qvgb in these early weeks, there was a 
coïisitlerahlo' variation in levels ? not only hetwooa différent 
T7omon hut also from week to week in the same ifoman (Figure 25)* 
fkose differences were also prososii in the women followed 
serially througliout jsreguancy, plasma aldosterone eoneeatratiou 
rising markedly to 218 mug/lQO ml# at the %kth week of gestation 
in one case, while it remained wi't^ iin or slightly ahove the 
normal wn-pregncmt range in miother case (Figure 24),
Plasma aldoBterone concentration fell in all hut one of 
the cases in which It was measured serially across delivery 
(Figure 25), and most of the results were xvithin tho nomial 
non-preipiant range within 2 weeks post-par turn (Figure 22),
In the one case where plasma aldosterone concentration rose 
from 117 oïug/lOû ml, at the 38th week to 147,2 mug/lOD mi.
PLA SM A
A LD O S TE R O N E
C O N C E N T R A T IO N
mjug/lOOmI
L.
2 5 0 - ,
1 2 5 -
0-J
18 3 0 3 6  TERML.M.P. 6 12 2 4 2 12
G E S T A T IO N  {w eeks) P O S T -P A R T U M
iüoasTiromonte» of plaama aldosterone 
ooncontratlon In 6 pregnant women#
PLASMA  
ALDOSTERONE  
CO N CEN TR A TIO N  
mng/  100 ml
150-1
7 5 -
0-*
52 3 4 6DELIVERY- 2
POST-PARTUM(weeks)
glKure as. Serial meaaurements of plaama a3,doaterono 
eonoentrâtion aeroas delivery and peat* 
partum#
% deyo aftes* no apparont ùoxtno îo%x tirio olsmsgo
i % 0  f o i m d *  ■
..-K
■v-lns’ufficioiii ostiiuations woro m^Xlohlo to ooporate into 
" Serial dheagoe in  9 xmxm ero slimm in  ITigaro g6* 
à progr^ onèlt^  laoroaso oeem^ rod iu ovary emjo \âm^ o it woo 
moDsured Imyead IS voQÎm^ gootatioa#
m d  potaaolma es^oWity,
iBtliviclual resiiltB with metmo and GtimcIaîaC doviations 
oaeh trimoBtor mû  po0t*%}artw% period ere shown in TaMoo 6 
to. B . end figtn?c-27»
Comparison ai! the rooisl'to at iMose difforcmt stages 
— WRS" Î——  -- -
AkwadLam tssatetistio.
Sodimi
:( V 1%
II V III
I V III
SSâS^ Ell^ SISI
III V P#P#
e*8
%\p. V
6-18
I V II
n  V in 
I V mi 
III V P#P*
P#P. V P#P. 
0-8 6-IS
Dogreo o%
ireSi®
0.593 > 0.:
8,093 < 0,05
1,068 > 0,1
< 0.03
0,%6S 0,1
0,364
o , w
0,348'
4.950
? 0.1
> 0,1
> 0,1
< 0.001
4 0,0:
PLASMA
PROGESTERONE
CONCENTRATION
pg/ml
I5n
7-S~
LMP 6 1812 2 4 3 0 3 6 TERM
Fi/.^ iîre 26,
GESTATION (weeks)
Flaama pmgosteroûe concentration In  normal 
pregnancy*
PLASMA SODIUM  
m Eq/l 
142-1
1 37-
132-1
PLASMA POTASSIUM 
m Eq/l 47n
3 9
31
PLASMA OSMOLALITY 
moim/kg 
288-1
2 7 6 -
264-J
NORMAL
N O N -PREG NA N T
RANGE
0 - 1 2  13 -  26 27-Term
Fi'Cpirc 2?
Plasm aodima, 
potaseiiiB anil 
««molality in
no rma 1 pro gnaiicy 
ami post«^partmn
I 1 I 1
0 - 2  6 - 1 2
GESTATION (weeks) POST-PARTUM (weeks)
65.
IvII
II V ni
I V ÏIÎ -
m ; v  i\p*.
" > ■ o*»s
i\p. V i\p# 
u—2 C>"12
1*680
0*58^
8*386
3*9#
1*07^
fioga?ea of 
iVoGeloa
8?
<&7'
36 
53
Sâipâfieaaoo 
P
> 6.E
>  ©.a
< 0.03
< o.ooa
>• O.Î.
jPlôoma sodiwa eonoontration tms feelow iîio  ooRaol sion«*|>s?Gg»a»t
mnge in most %;omen at oaclJt period of goatationp tlio moan 
Qonoontrotloa littio ehango imm early to mi^ '-prognoncyg
hilt a alight drop in lato preg^nmoy* Mtor delivery^ a aiuali 
riüû ooomTodg hut many in^ vo atil.1 holim the normal Mou«"
profi^Bat range botueen tlio/feli and IStb v;eo!s poot^portma*
Moon ploaoû potassâiisi eonaeniratioB remuiaod im the loimr 
ptïi't of the aomial n<m"pro#)imt range with little ^liuetuatioa 
throughout prognenoy* il rieo oeourrod la the first 2 neeks 
after delivery» m t k  a subsequent fail, to pswioue levels by the 
6 #  to I2th w o k  %3oot##pfwtum#
Meoji plasma osmolality woa also la tlîe lowor part of tho 
noraïoi îiîoa«'proÊpj.aiit range in early pregaaaoy* liowGVor» a 
B igail’iecmt ieoroase IukI oocwrod by la te  pregiiasiey anti a fa rth e r  
imm'oase took plaee after delivery* At nono of # o  periods ia 
whioh it t'/ûs measured was it eutnith tsîo aoaTmol ïüon*«pregaaut 
rtaige*
ürisio sodlwm end potaeeima comemrtratlerne
I'liQoo were oa'ieulated from urine eioiloeted over a 8b hour
period#
Xuôividttai results vith moaua aad standard deviations 
for each trimester and post-paritca period are shoim in 
'fables 9 and 10*
Comparison of the results at those different stages 
Vas as f o l l o w s . .
Comparison t4#statistio Degrees of Significonoe
brine 
Sodium . 
Concentration
I vis
II T III
I V III
III V p*p* 
C#2
?#P. V P.P* 
€h-2
brine
Potassium  ^
Concmtration?
I V II
ÎÏ V III
I V III
II v P*P* 
0#8
F*Pé V FiPé
8*836
1.894
0.6l6
1.881
Oi830
0.349
0.970
0.193
0,329
0.830
7
25
84
45
33
6
04
84
45
30
0.03 
0.03 
> 0.1 
> 0.1
> 0.1
^ 0.1 
^ 0.1 
> 0.1 
0.1
hi
Apart from the increase in urine sodina concentration during 
the second trimester# no significant changes in urinary electrolyte 
excretion occurred during pregnancy or after delivery*
Blood urea* serum creatinine and creatinine clearance*
Individual results with means and standard deviations for 
each trimester end post-partum period are sliown in fables 11 to 
13 and Figure 28*
BLOOD UREA 
mg I lOOml 
40-1
10-1
SERUM CREATININE 
mg I 100 ml 
TO-i
0 5
CREATININE CLEARANCE 
ml I min 
200-1
5 0 -*
I 1 I
NORMAL 
N O N -P R E G N A N T  0 
RANGE
1 r
i I
“I r
12 13 26 27  TERM 0  2 6 12
GESTATION (weeks) POST-PARTUM (weeks)
Blood uroa» scrum creatinine and 
oroatinino clearance in n o m a l  pregnancy 
and. p6$t"^partum#
6? .
CompariaoB of ib© rosults at thoao differosit stages wag 
as followsJ-
t-«g tail SticÜosmarxeoa
Blood
Urea
Goacemtratiom
Serum '"■
GreatiiaisiQ
ConoentratioB
Greatimiua
Cl©ar£inQ0
%^a»w^i%Nkizawaaa»*Aï»\*
I V II
II V III 
Î V III 
III V F*F.
0w2 ;
P.F* V .P*F*
I V II _ 
III y: III '
I V  III
m  V p.r* 
0-2
F*F* V F*P. 
0-2 6-12
0*419
0.748
I via
II V III
I V
V  p . p .  
0-2
P.P. V p.p.
0-2 6-12
5.631
5.16b-
: 0 . 4 8 1  L:
0.231'' 
2.358
4.017
3.731
3.992
0.615
Degrees of 
freedom
44 > 0.1
65 > 0.1
63 > 0.1
70 < 0.001
42 < 0.001
86
27
44
Siguificaace
P
84 > 0.1
48 ;> 0.1
46 > 0.1
59 < 0.05
38 < 0.001
< 0.05
> 0.1
< 0.001
< 0,001
0.1
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Blood urea and sorum creatinine concentrations were in 
the lower part of the nornjal non-pregnant range in early 
pregnancy and remained so with little fluctuation to late 
pregnancy* After delivery, both increased signlficmitly to 
the middle area of the non-preginmt r^ nge»
Mean creatinine clearance fell from early to mid-preguancy 
hut this was based on a small 'number of estimations• Â further
fall occurred after delivery 'hut remained %'dthin the normal non- 
pregnant range*
Correlations*
l^ iere concurrent measurements have been made, the 
correlation coefficient lias been tabulated for all the estimations 
during pregnancy'(Table’14)* ' Correlations involving renia, renin 
substrate, angiotensin II end aldosterone have also been calculated 
for each trimester and post-pertuai, and these are shorn in Table 15*
Positive correlations statistically significmit at the 
level where found between*—
renin and angiotensin - post-par turn (Figure 29)*
renin and aldosterone - first trimester (Figure 30)
renin substrate and angiotensin II - first trimester (Figure 31)
renin substrate and aldosterone - all pregocmey samples (Figure gg)
renin substrate and progesterone - all pregnancy samples (Figure 33)
angiotensin II and progesterone - all pregnancy samples (Figure 34)
angiotensin II and osmolality - all pregnancy smiples (Figure 30)
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Figure 30
Plasma renin* 
aldostorono relationship 
In the first trimester i
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Plasma aldos toron© 
sodiw relationship 
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Plasma angiotonsin XX - 
osmolality rolationshii 
in pregnancy*
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135 142128
P L A S M A  S O D IU M  C O N C E N T R A T IO N  ( m Ë q / l
aldostoro3ie and pîasaa ■ eodim third trimester (Eigttre 36) 
aldosterone .ciiid pÎÈ^ ia sodim pregmmoy eampiee (Figure 37)
aldosteraiio artd.^ 'inary .potassiim all pre^aacy sompleo (Figure 38)
plasi-ni eocliw“ "■>ïK? emni'; alitÿ - *# all pre^ paanoy saraples
4 ne'p) ' .Vj coi  ^ atatistioally eignificaiit at tSao 3/j
leift:.l,.\vo.,.> '"S' i . t, ‘.w<'iL5Jii-
,.rcH i j “' Li.atratG mm .'crêsii^inino clearance #» a l l  pregoanicy samples
- 'C-;%yX,/- (Figure 39
>p‘i ' ' 0^odiwa W pa»:t^ iiartuia (Figure
. K a - S S '
IVoitive 'corrélations which almost reached statistical 
significance (i#e, .'those heWeen 3i? and 'tOp levels) werej—
renia substrate * post^ artixp
alclosteroae end plosraa sodium # second trimester
aldosterone and plasma osmolality » all pregnancy saaples
progesterone and plasma M carbonate ## all pregnancy smiples
plasma potassium and osmolality ** all pregnancy emplos
Step-wise regression was calculated where the following 
measurements had been made concurrmtly during i^ regaancyi** 
Plaeaa renin, renin-suhstrate* angiotensin II* aldosterone» 
• sodium and potassium, i*e* variables’ « U to 6»' n’ » 19*
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8 0 -
0-1
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urine potassium 
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pregnancy,
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!Ühis showed a eigaiiicant correlation (3f> level) between 
pleama aldosterone concentration and the plasma concentrations 
of angiatensia II, potéssitM mid renin substrate*
All -the. rooùlt^;■■■iront' .this ' at&dy Mil he discussed later 
in Chapter 6 * ; - '  ^ "
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g*c. ciM«s m  n,.mm ii mmmcomiGosTmom (#c) 
commemTioM m m m  pmmmcY m o  Tim 
piMipmimi.
Clieieal study*#K#r#wmi I iw #11 -m i mMemmtâêmt»
Measurements of plasma DOC coneeati\atioB alone were 
made in S9 womesi at various stages of pregnancy and in 10 
women in the first %ï*eek post«partiya* Parity in the women 
stmiplGd during pregnancy was as follows 8** para 0 *- i4j 
para 1 - Ilf para 2 - 2ÿ para 3 or over « 2* All were 
single pregnancies* Ages ranged from 17 to 33 years, 
mean 24*6 years* Blood pressure was normal in every case 
and there were no other clinical aljnorsaalities*
Blood samples were tdcen at antenatal or post natal 
clinice after the women had lain supine for 30 minutes#
All the women were on an unrestricted diet*
Lahoratory method*
This has been described in Chapter 3i^
leenlts*
Individual results mû means for each trimester and 
post^ portum are shorn in Table l6 mû Figure 41*
Comparison of the results at those different stages 
was 08 follows8«
PLASMA 
DOC CONCENTRATION 
ng /100ml 
40 “I
20-
0-J
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GESTATION (weeks)
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Figure 41 . &0Û oottcentrâtion in normal
prognanoy*
:
Comparison 't^ otûtiatics l)OgS?0OO of freedom
Siipïifieanoo
Î?
I w 13 I.WI Ig >. 0*1
I: V 0*368 81 > 0*1
I V III 1,#0 l6' >  0,1
III V l\P# 8*344. ' '
 ^ ■ ,
80 = < 0*03
Plasma BOO omomitm'hitmj \kw Miomiovo immimQû aurâng 
pregEumey and foil quiekly to.noraaal in the puerper&um# No 
a&gniflotmt clifforoaco apparent boWoon iliiferent stago© 
■of gestation, hut the ouosboro involved wore rather aamil» 
ospeeially’ in early pregaaaoy*
fliOGo résulta will bo diseuooed in more dotail io 
Chapter 6* )
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CliBicai Study gad Methods.
Tfcmea volmitoerod to take a diet containing % imomi 
asaoimt of sodium and potassium over a number of days, and at 
the same time col looted all the urine passed in 24 houi*. 
aliquots for electrolyte estimations* This regime Ta^ s 
carried out on an out-patient basis in both women in early 
and mid»pregnaacy and in one of tSi©- women in laic pregsiancy*
One woman was also tested 12 weeks post-pertum.
Both vomeit wore in good health and blood pressure remained 
aoriHal throughout. • Details are shown in Table 17#
Plasma samples were taken with the women fasting and in 
the supine position for at least 30 minutes# Estimations 
carried out are shown in Table I?. Mcthoda for these 
measurements have been described in Chapter 3*
These are illustrated in Table 17 and Figures 42 to 44# 
Sknall positive sodium balances occurred in early pregnancy 
ill both women and in mid- and lato pregnancy in Case 2$ A 
negative balance was present in Case 1 at the IStîi week post* 
partimî#
Dnall negative potassimi balances were present during 
gestation in both women.
mEq GESTATION 7 th -9^ h  WEEK
Intake 130 mEq/day140-
1 2 0 -
8 0 -
4 0 -
0-
GESTATION -  24 th WEEK 
Intake 138 mEq/doy
mEq 
120-1
80 —
4 0 -
0-
-4 0 -* i
POST-PARTUM-12 th WEEK 
intake 128 mEq/doy
m
30 îjaX atio o
Case 1. SODIUM BALANCE
mEq 
80 n
4 0 -
0-
-4 0 -
GESTATION 7 th -9 th  WEEK 
Intake 7 0 mEq/doy
m.
7SLBZ2 ; 7m
gift-tiro 43.
Oa&e 1#
Potassium balance*
GESTATION- 24 th WEEK POST -  PARTUM-12 th WEEK 
mEq Intake 49m Eq/day Intake 61 mEq/day
6 0 -  
3 0 -
- 3 0 -
Case 1. POTASSIUM BALANCE
SODIUM
INTAKE 128mEq/dqy ]48mEq/day
150n
100 -
50-
0-
30-
0-
30-
ll^h WEEK
^ ......
141mEq/day
—50 -*
POTASSIUM
INTAKE 47mEq/day 53mEq/day 49mEq/day
60
m
25 WEEK 38th WEEK
Case2 : SODIUM and POTASSIUM BALANCE
Oaso 8* Socliwm and potassium baXanco#
7lu
Baorisig in mind tîiat faoces were not incindod in tîio 
esmiysia and #at, apart from t-M early etndy in Case 1# tbo 
diet was controlled for only 3 daye, too much ahould not he 
read into tkoee results* Howewri they do suggest that further 
longer studies would he worthwhile* 0)1 s may he difficult to 
achieve p as those two Tmnien had considerahle trouble in adhering 
to their fijsed diet (o#g* early j>regnaney study in Gas© 2)* 
a problem which was aggravated by nausea and other syinptmDs 
especially in early pregnancy*
Plasma electrolyte eoncentratious in Case 2 were 
unremarkable# but a low sodium concentration was present 
in early pregnancy in Case 1, This was associated mth 
increased eoncentration of plasma renin# renin substrate# 
aBgiotenoin II end aldosterone*
ïhese results %mll be discussed in more detail in Chapter 63,*
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CMPfËE 6 
DISCUSSION
Firat Qf ali# tlie changea in each subatmce deacribod in 
Chapter 5 will be evaluated with reference to i^ie résulta 
previously puMiahod by other workers# %e effect of i>roguBncy 
oil the rolotionahipa between renin# renin aubstrato# angiotensin II 
and aldosterone will then be discussed and compared to the 
relationships found in moiMpregnant situations. lastly will be 
sections dealing with possible stiamli to tlio reported changes in 
tîie renin'^ aaigiotensin-aldosterone systeai end the role of tliose 
ohanges in the maternal physiological adaptation idiich occurs 
in pregnancy.
6.A# CMNGE3 m  t m m w m > . ppimmmr
d m
Plasma renin concentration.
The fall in plasma renin concentration hetwemi early and 
late pregnancy is in agreeaient with #e results reported by 
^i&mer and Ms colleagues (1972)» who also found very high 
levels in the early weeks of gestation. Their results» hoT^ evor» 
were higher th*m those found in the present series particularly 
in early pre^micy. This difference in the degree of increase 
could possibly he due to differences in posture» s^inner*s 
patients being seated et the time of sampling id&ereas üie women 
in the present series hml been recunhent for at least 30 minutes.
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As reported before (Brown et al# 1966b)p plasma renin 
eoBCQBtretion took a number of days to return to mormEtl after 
delivery of the foetus and placenta# while all the ostimatioBS 
were in the lower part of the normal noB-progiiasit range by tlie 
6th imek post-psîrtiœi, The implieatioas of those results will 
1)0 diseussod later*
Plasma roulm substrate .coneontratiOB*
The progressive rise in plasma reniai substrate eoBoentreitiosi 
was very striking, although a small mm#or of %mmea showed only 
slight increases above the nomml aoa-pregamit range* These 
raised oiroulatimg levels of substrate are similar to the levels 
described in previous reports, which wore discussed in Ohapter 
4*A*
Preliminary results of the present study had suggested that 
plasma renin substrate ccmcentration might remain fairly 
consistent in individual women from about the 20th week onwards 
(Weir et ai, 19?0a). This has not been home out by suhso^ ueat 
results (see llgure l6).
The delayed fall after delivery of the foetus and placenta 
may he due to the effect of the synthetic oestrogen, stilhoestrel, 
given to suppress lactation, %  the 6th week pos't-partuÿ, all 
the women who had not boon given stilboostrol had levels within 
the nomual non-pregnant range, whereas high concentrations wore 
still present in some of the other women. This effect of 
OGstrogens will he discussed in more detail in Chapter 12*
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FlciSîiu oMdotOBSia 21 cpaocatraiiono.
Sîike s*eaia-6ttbsts?ato» ploema osigiotonsla II ooaoeatmtioa 
showed a progroooivo isioroose from ooriy to lato preguaBcy*
I» a nmbor of 00000# bmmvw# voluoe romnined within tlio 
Bomiml sion-pragnamt range throo^ioat# in eontraot to atriking 
inos'OQSoa to very high lovola in othora (Plguroo 18 and 20).
Tho overall raege ia the third trivsester wao î?icIor thon that 
reported By Maasani omd her eolieaguoo (I96?) and tlio moan was 
lower* âs montiosied ia Chapter 4,A, it is likely that Haooani^ o 
method over^aotimatod tiio level of oiroulatlog ongiotesiaia 21.
Tho ohongos after delivery of tljo foetus and plaoonta x-mx^ o 
oimilor to tlioao of ronia, in that after one week moot, and oftor 
6 wooli’o ci'ilÿ tito roauito wcra w ith in tho nor?nal sion-pregnant 
rcmge#
Plaemo aldostoroH© ommomtratlon«>1 «itWPi'OWOrmi
In tlio proliminary study (Chapter 3#â) no eigoifiec^t eliaugo 
im mean plastsa ciltlooteroBo oeioentratloa ooourrod from l6 to 38 
wooTm* gestation# In the oubaccfaont larger study (Chapter g.B), 
howavor# a oignifioaat rise in mean eoBoentmtion ©eeurrod hotimon 
early cmd lato prognmioy (Figure 22). This inoreaeo during 
pregneoey is in agmoeaent with tho reoulto of the seorotion md 
oKeretioa rote studios ômùmmQâ in Chapter 4.B#
laa tlie earlier imoBtigatmu (Chapter 3*â) plaema aldooterono 
oonGQutznttoïi vms eooaidorably higher than tlio normal aoa^-p^^egnaBt 
rtmgo in every 0000 in whioh it vmB monauyed# mû many of the
78*
reoults were above 100 amg/lOO ml* (Figure 9). Ib contrast# 
over the same period of gestation a number of the results in 
the subsequent larger study (Chapter 3*B) remained within the 
normal non-pregnant range (Figaros 89 and 24) and in only 3 
cases did the levels rise above 100 mug/lOO ml. One difference 
between the 2 groups was that the woaîiea studied in the earlier 
series were resident in London whereas those of tho later 
series were from Glasgow, Dietary habits, and in particular 
the sodium intalm, might possibly explain the differences 
between the 2 groups*
The increases in plasma aldosterone found by Bayard et 
al (l97Ca) were distinctly less than in either of the series 
we have studied; furthermore the secretion rates they reported 
were also much lower than in the studies by Jones et al (1939) 
and Watanabe et ©1 (I963), Bayard and hia colleagues tentatively 
ascribed this difference to the 10 hours recumbency ©ssumed by 
their patients before tho measurements were made# However, a 
recent study in our laboratory lias shorn a mean of 10*82 mug/100 ml, 
(S.B, - 2,9B) in 13 normal non-pregueut mm m  after 12 hours • 
recuHîbGacy, this rouge being very similar to that for all 
noriiial non-preguaat subjects (sec Chapter 3)*
The degree of élévation of plasma aldosterone above the 
nomnal non-pregnant range in the present series was of a similar 
order to the increases in aldosterone secretion rate found in 
pregnancy by Jones et ©1 (1939) and V/atanabe et al (1963)*
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The results described in Chapter 3*B.woa’e also isi accord with
those reported by both those groups of workers \^io had fouad 
a proportion of results in or close to tho normal aon-preguont 
reage. Coacordaace hetv?oea the magaitude of iacreoso ia 
aldosterone secretion rate and plasma aldosterone concentration 
is mot naezspectedg since there is general agreement that, the 
overall setaholi© clearance rate of aldostemie is not greatly 
altered in pregnancy (Jones et al# 19S9| Watæiahe et al, 1963; 
Tait et al, I9605 Bayard et al, 1970^ -^)* Also# there is mo 
evidence of significant proteim-himling of aldosterone in 
pre^ piant women (Meyer, Layao# Tait and Pincus, 1961 )*•.
Plasma cortisol concentration,
TEio present results (Table 1# Figure 8) have shown 
smaller increases in total plasma cortisol than those 
previously. reported (Stewart#et al# 1961; Brc-IWsmussen 
et ai, 1962g Friedman and Beard# 1966; O^ Üomioil m& Welsh, 
1969; Bnrke and Boulot, 1970). Tliis may he due# at least 
in part# to differences in specificity. With the exception 
of those of BrWMssmusscn ot al (1962) # for which no evaluation 
of specificity is available# end of Burke end Boulet (1970) who 
used a competitive protein himding method, those previouQ results 
were obtained by fluorimotry# wWch has been shorn to give higher 
values than the double isotope derivative teolmique (James# 
te®send end Fraser# 1967),
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Plasm© QorticosteroBQ coacGatration.
With few esoeptions# plasma corticosterone concentrations 
remaimed witMsi aorsaal mom-pre^omt limits (Table 1, î?igmro 8)» 
tliG range in pregmomcy boimg similar to those of earlier 
re p o r ts  (S te w a rt e t  a ’i#  I.96 I5  M a rtin  and M a rtin #  I9 6 0 ) *
The results found by Morris emd Williaias (1933) wore laiglior# 
but their siomal moa-pregkimit conceititratioms wore also above 
those of this and the other 2 studios raemtioaed*
(wo) comcemtratiom.
ÈB far as is kao;m, only one study of plasma DOG 
eomceatratiom in pregisomcy has been published (Schweitses? ot ©1» 
1969)* The authors merely memtioE that suhmicrograai levels 
woro found in  7 normal pregnant woaom mû. did not iive details 
of their results or of their iiosmal Bon-pregnont values#
The data from the present study (Figure &l) have shown a 
pattern during pregjaaney which is siudlar to that found for 
plasma cortisol concentration. Moan levels rose from early 
to late pregnunoy at TJhioh stag© 7 out of tho 12 cases had 
concentrations above tho nomal non-pregnant rasige.
Plasiim progesterone concentration,
The progressive increase in plasma progesterone concentration 
from early pregnancy to term (Figure 86) is in accord with the 
results of other studies (Eton end J^ iort# I960; Greig# Coyle# 
Cooper and Walker, 1962; Wioat# 19675 Yamione, McCurdy and 
dQidfioB, 1968).
Plaim© eieotroXytos mü ossiolality.
l'IîG redncGd plasma sodimi etmeoutrations in early and 
raid-pregasmoy (Figure 27) have eonfiraied the results of temam ’ 
(1937)9 lîerhiBger and Wiehsiami (1967) mid 2'WBonald miû Good 
(1971)* Unlilse those earlier reports and our mm- earlier 
study (Figure 7)9 the larger number of estimations illustrated 
ill Figure 27 showed a further small but statistically 
siguifieant fall in the third trimester, a findimg which had 
been noted hy Brandstetter and Sohuiler (1939).
Plasma potassium coiicentratiosi showed loss fluctuation 
thmi socliuïa during pregnancy, although in general the results 
wore in the lo'c^er %)art of the normal non-pregnant r&mge 
(Figure S7). TMs small decrease in pregnancy is in accord 
with previous reports (Nommn# 1937» Herhinger and Wichmcmn, 
1967» MacDonald miû Good, 1971)* although Branclatetter and 
Schmiler (1939) had found no change*
MaeBonald and Good (I97l) reported a fall in plasma 
osmolality 2 to 4 weeks after ovulation and Eohortson (I968) 
demonstrated a fall in plasma osmolality in the first 8 weeks of 
pregaamoy, mth no further change to tesTii. Tho nonmai non- 
pregnant range associated with the teclmique used isi the present 
study was eonsidorahly lower tliasi that quoted hy l^ ohertsoii, hut 
tho low levels found in early pregnancy (Figure 27) are in 
accord with the previous reports* The earlier study (Figure 7} 
did not show such low levels at mid-pregnancy, hut this way have 
heeii due to the esialler umAer of estimations carried out*
Ualikô the results of our preliminary study and #Ke previously 
reported series# *m ineroas© iu moan plasms osmolality 1b th© 
third trimester was found in the larger study (Figure 27),
The changes in plasma osmolality during preguaaoy showed 
a small hut statistically sigsiificant correlation with the 
changes in plasma sodium# less so with plasma potasslwi 
eoueentratioB (Table 14), MacDonald and Good (l97i) have 
coïîimeiated that plasma osmolality correlated less well with 
plasam sodiuva and potassium im pregaaut than in Boa-pregnaBt 
womea* They suggested that some plasma electrolytes may he 
osffiotically inactive due to protein hiudiug and that this 
becomes loss as the plasma protein pattern chojiges during 
pregnmey,
No attempt has been made in the present study to compare 
the results of primigravid with multigravicl women* MacDonald 
and Good (1972)# however# foimâ greater changes in plasma 
sodium in multigravidue and suggested that this might be due 
to the greater oxijmsion of plasma volume which occurs in 
these women.
Blood urea# serum om atinine and creatinine oleai*aaic©,
Creatiaino clearance is a ineasm'e of glemorular filt-ration# 
although less accurate then iaulin clearance* The results of 
this study (Figure 28) have confirmed those of previous reports 
that creatinine clearance is increased during pre^^mey, 
particularly in the early months and that it returns quickly 
to normal levels after delivery (see %tten and Leitch# 1971)#
The lowered serum levels of creatinine (Figure 28) ere 
© reflection of tho increased clearance mû are :1m accord 
with those reported hy Sims and ICrantsj (193®) emd loss 
variable thmi those described by Ifehlhack and WicHiolm (1966).
The reduced blood urea levels (Figure 28) are a roflectiom 
of the Increased urea clearance fomid in progaaacy (see Hytten 
and heitchj 1971 ) and have also hocn described by Sims sad 
Eramta (193®).*
Haeiaogloljins haematocrit, plassaa volmie* plasma proteins end 
colloid osmotic pressure.piKteiH— # r M w\I m :wi tmmamms»
The changes im haemoglobin# haematocrit, plaama volume 
asid total plasma proteins (Table i# Figure 6) were generally 
©.imilar to those ^ Aioh have hem reported earlier (see Hyttcm 
and Laitoh, 197l)&
Mean colloid osmotic pressure (Figure 6) was slightly 
lower and showed a less consistent fall hotwaem the l6th end 
3Sth week than that reported by Ilohertsom (1968). I%rbtm md 
Leitch (1971) have illustrated a close relationship heWeen 
serum albumin oonoentratioa m d  colloid osmotie pressure in 
pregnancy. This relationship is likely to he the reason for 
the divergence he tween colloid osmotic i>rôssure and total 
plasma proteins foimd in the %)resent study between the 28th 
and 38th weeks', the increase in total proteins at this time 
being duo to rising alpha and beta globulins which have little 
eInfect on colloid osmotic pressure (see Hytten end Leitch# 1971).
6.B. Emm# moioTmsm m o  Aixmarmom
BELàTIONSHIPS IN PBmNmCY.
Although the preciee role of renin and esigiotensisi in 
relation to the etimulatioa of aldosterone eoeretion in man 
remains a matter of controversy# there is no doubt that# 
using the methods of the present study# positively correlated 
changes in concurrent plasma renin/angiotensin II and aldosterone 
cone entrât ioBo have been demonstrated in a variety of situations 
(see Chapter 2 and Figures 4 a^nd 3)# These include sodiuiij 
depletion induced by diuretics or dietary sodium restriction# 
renal hypertension and chronic renal failure (Fraser et el# I963# 
1966 and 19691 BroT® et al# 1971b). By contrast# a sigmifieaat 
inverse relationship has been shown between the high plasma 
aldosterone end low plasma renin concentrations of '^ primary^  ^
hyperaldosteronism (Brown# Chinn# Biisterdieck# Fraser# Gieadle, 
Lever# Sobertson and Tree# 1969©; Ferrios, Brom# frasor# Kay# 
iiovor# Neville# O^ î-fuircheartaigh# Bobertson and %mington# 1970)#
Before discussing the possibility that# in pregnancy# the 
roBin-angiotensin system might be a regulator of aldosterone 
secretion# it is important to clarify the relationships betweon 
plasma renin# rosiin substrate and angiotensin XI concentrations 
in this situation*
Tho relationships between renin, renin-substrate and angiotensin II*
liie incregises in plasma renin substrate occurring in 
pregnancy are within a range which theoretically could influence
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the amount ®f ongioteasin formed %  a given conceatration of 
the QumymQ renin# and U\o clepeadeaeos of reaction rate on the 
prevailing substrate concentration has been demonstrated for 
all substrate levels eaeomtoreâ in pregnancy (llelmer and 
JudeoBp 19671 Skisiaer ot al# 1972)* It Is not surprising# 
therefore# that no correlation has beem found in prepinEiiioy 
between the plasma eoncentrationa of renim alone and of 
angiotensin II@ although they have a normal relationship post- 
partmn (Figure
In view of this# it seemed possible that in pregnancy 
angiotensin II miglit be related either to the product o f renin k 
renin-substrate or to the level o f renin-substrato alone. The 
present results# howwer# have shomi no correlation between the 
product of plasma renin % renin-substrato and plasma asiglotensin II 
at any stage of aestation,ÉtiwiÉMiiii *ni#iMim* . 1 ihéiiIi i A
Gould, then# the amount of angiotensin II generated bo 
governed alone by the increased amounts of substrate available 
in pregnancy? No evidence for this was found v;îien all the 
estimations made in pregnancy were amalysod. However, on 
separating the data into trimesters# a positivo relationehii) was 
dosionstrated betifcosi tho plasma concentrations of renin substrate
w*T - ^ i* W im i i W i i i« i . j i i’ inu iin i *iH m #cn»ii ii mm 4m i # w i i  i# *m n ####& ! * , ' JMM1 0 1 # 1* 1
and angiotensin II in early premanoy (Table 13» Figure 5l)* Both 
substances increased progressively throughout gestation and why 
this direct relationship was not apparent in later pregnancy is 
not clear. Following delivery# there oppeored to be a possible 
relationship, although this did not reach statistical significance
at tho level (Table 13).
If# tlien# it is.tSio substrate %Aich is eontrollias tlio 
generation of mgiotomsim II in early pre^moy# why tiro tSjo 
very high placnaa coneeatratioBs of rcmia not also iaflueneiag tho 
réaction at this stage? A clue may be fomid in the paper by 
ImAors (l9?l). She fouad that most# but not all# of tlio reain 
in cjiimiotie fluid is iuaetivo at pM 7.3 and is only activated 
by acid treatment below pH 4.0* The method for estimating 
plasma renin eoncesitration Ui the present study (Bromi et ai#
1964a) and the method used by dinner {I967) both involve eucîî 
m  acidification*
It is possible# therefore# that tSieso methods#, in addition 
to measuring üie active ongyme renim# also Djeosure a renia- 
like euRymo t;hich is inactive at the jdï found in physiological 
situations# sadnner and Ms colleagues (I9?S) have suggested 
that this inactive cmponcnt may bo derived from foetal chorion 
(see later in #is chapter). If the high concentrations of **renin*® 
moBSured by #eso methods in pcegnaacy plasma are clue# at least 
in part# to tisis inactive eagyme# this might explain the lads 
of apporent effect on angiotensin II production*
Isioreased circulating angiotensin II levels may# in amie 
ciroums'tonces # exert a direct inhibiting effect on renin 
secretion (Genost ot al, 1963; Voador and Geelhoed# 1963; 
ïtiûus mü ïïoiamaan# 1967). This feedback meclianiea could be one 
ea^lmmtion for the fall in plasma reaisi concentration in the face 
of inereasisig plasma concentrations of substrate mid msgioteeein II
from early to late prognanoy* It is possible also that the 
iaoreaseel aagiotomoia II coaceatratiojiG may have a stimulating 
offeet on the production of renin substrat©, but at present this 
remains speculativ©*
Throughout pregnoncy in this study, plasma angiotensin II 
concentration was within normal non-pregnant limits in a greater 
proportion of women thai plasma renin or renin-substrate 
concentrations. The presence of on inactive component in 
the renin concentration being; measured could be tho explanation 
for this* On ‘fchs other hand, it could mean that angiotensin II 
production is blocked or that tho clearance of asigiotensin II 
is increased during progsiancy. To date there is no available 
evidence to ouj>port or refute those possibilities.
The relationship between the renin-angioteusin system and aldosterone<
In contradistinction to other situations discussed earlier 
(Gliapter 2), no relationship has been found between concurrent 
plasma roain and aldosterone concentrations in mid and late 
pregnancy* This is true boidi of the present stud)'- gmd also of 
the eiaeller study previously reported (Weir ot al, 1970a).
Moreover, a marled disparity existed between the concurrent 
renin 6md aldosterone levels in individual women at tliose periods 
(Figure 9).
In early pregnancy, however, there was a significant 
correlation betweei plasma renin and aldosterone concentrations
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(Figure 3QJ, Zm view o t the lack of relationship) betwem 
plasma renin and angiotensia ÏI levels at this stage, the 
possible reasons for which have been discussed ia the pirevious 
section, it would seem ualikely that in early gestation realm 
is stiemlatiag aldosterone solely via angiotenain II. . The 
possibility therefore exists that in  pregaaney reaisi might also 
he effecting aldosterone secretion hy a pathway distinct from 
augietensin II. This raises the question as -to whether the 
postulated renin-like ©Bsyae of pregnancy îuentionecl earlier 
might perhaps he inactive in the generation of the octapeptide 
angiotensin II# hut active in the stimulation of aldosterone 
secretion toy some other iutomodiate product* Although it is 
pgi^ tly measured in the assay of asigiotonsin II# such a product 
might toe 2-B heptapeptide# Tjhieh has toeen shmm to stimulate 
aldosterone secretion by Blair-Host and his associates (1971).
In our preliminary report (Weir et al# 1970a)# a 
significant positive correlation was found whom the aldosterone 
coiicontratiosi was plotted against tho product of the concurrent 
renin and renin-su3)strate eoncentrcttiona. However# subsequent 
study of a larger number of women at all stages of pregnancy has 
aoîJ aiioî® .fte..plasiaB rgim sabsteate
product ^gnd plasma aldosterone concentration.
It was shot® in the previous section that changes in plasma 
renin-antostrate coneentratica occurring in pregnancy might bo 
important in detertfiining the effective plasm# concentration of 
angiotensin* It seemed possible therefore that renin-subsirate
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might also be related to eldosteroao in pregnancy* M  the 
preliminary report of this study (Heir et al# 1970a), mo 
Guch reiationahip was demonstrable in tho second half of 
pregnancy, and measnrements from the enlarged study ?iavo 
confirtaed this for each stage of gestation* However# when 
all the estimations thronghomt pre&gnmicy were analysed together, 
a significant rolationship emerged (Figaro 3)2) • fMo positivo 
corrélation hetwe.en plasma renin substrate and aldosterone 
concentrations daring lacegnencya taken ifith the positive 
correlation hotvfeeii plasma renin sahstrate end angiotensin II 
ocsicentratione certainly in early pro^ency (Figaro would 
he In accord with Ûxo liypothesia that circulating angiotensin II 
may he affecting aldosterone secretion# at least in part* The 
parallel changes in mean plasma concentrations of ongiotensin II 
end aldosterone during preg^ aancy and the imerporiura (llgures 18 
cad 22) are also suggestive, albeit indirectly# that a relationship 
might exist hetweon them# and this is supported to some extent 
hy the fact that both showed a correlation with plasms osmolality 
(Table 14# Figure 35)»
Surprisingly, however, on statistically analysing; the 
paired data from individUEil womeji, no sipnificent correlation 
between plasma angiotensin II and aldosterone concentrations 
has hoen found at any stage of gestation (Tables 14 mû 13)•
Unlike some other clinical situations, thoa, in pregsisnoy the 
amount of angiotensin circulating in the blood does not appear 
to be the major factor controlling aldosterone secretion*
Otlies? Gctiiag; sepeirately or together# perhaps
I'jith aagioteiiQia# have heea implicated isi tîie control of 
aldosterone secretion in states (see Eraser et
al# 19691 Brown et aX# i97^ h)# îhe effect of these factors 
in progiiosicy will therefore he discuoaed in tlio next section*
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âitlîongh the relatioBsMj:» hetweea circulating renin# 
rosiin suhotrato# asigioteBsiB II and aldcoteroao are less 
el ear-cut in preguauoy th^m im other situations# marlsed 
elim^ ges take place in all four oomponenta during geatatlou 
wid tliG  puerpertea. A numhor of fa c to r©  are Imoim to influence 
the plasma concentration© of these component© im the saoa-pregnant 
©tote# It i© therefore pertinent to discuss the effect of theee 
factor© osi the reaixi-tmgiotoBQin-aldosterone system in i)re^aucy# 
as well as their possible modifying influence om the inter­
relationship© within the aystem*
EACfoRs B m m m  m  AiBoggmom s m i m i m »
1. The renin-mijgiotcnsim system*
la the previous ©ectiom it was shorn that plasma 
aldosterone concentration did mot appear to be related to 
plasma oagiotemsim II eonoomtratioB# whereas it was positively 
correlated with plasma remim substrate eomceatratiom over the 
whole of pregnancy amtl with plasma renin concentration im the 
first trimester,
As the overall metabolic clearance rate of aldosterone 
im pregnancy appears mot to be sigaificamtly different from that 
im moa-pregaamt subjects (see Chaptor 4*B*)# it is likely that 
the secretion rates of the liomosie in précisât women are reflected
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by its ccmeeatretloB im the plasma. It follmm that 
clngelatiiag cmgiotensim II oitlior has ao influence <m 
aldosterone secretioa in pregoEmcy or that its effect is hoiag 
modified by other factors yet to be discussed*
2, Pituitary^ AOTI*
%G evidemoQ in favour of plîysiological stimulation of 
I^dostorono secretion by ACfH is conflicting (see Eraser ot 
alg 1969 amd Browa et al# 197%). It is also uncertain whether 
ACfH output is increased im normal pregiionoy (see For sham# 1967s 
IlytteB and Ijeiteh>i97l)* The marked dissociation found in 
this study between xslasma aldosterone and cortisol concentrations 
when measured concurrently (see Chapter 5*A.) indicate that the 
increased aldosterone secretion is unlikely to be the result of 
stimulation by AC’M*
3* Hntiian placental lactogen (lIFiig . hm%m chorionic somatomainmo^ rophin) 
ïîîiô peptide of placental origan# resembles pituitary growth 
hormone im its action# and its plasma concentration appears to 
increase steadily throughout pregiioney (see Uyttcn and &eitoh, 197%)#
A preliminary stucty by Melby and his colleagues (1966) showed that 
■fihe intravenous aëiainistration of llPb stimulated aldosterone 
secretion in normal non-pregnant females and in males* No 
confirïuatiosî of this report has yet been obtained# and a 
relationship between the increased plasma concentration of HP& 
end aldosterone iai propsency remains to be investigated.
la aoa-pr©gaaat subjects aldostoroae secretion is increased 
by sodium depletion end also by potassium loading, These changes 
could be mediated by #e renia-aagiotonsia system (see Chapter 2), 
Alternatively # they could be brought about by a direct effect of 
changes in plgsiaa cossceatratioa on the adrenal cortes. In support 
of this is the rise of plasma aldosterone associated with 
hypomatraemla induced by severe sodium depletion (Eraser et al, 
1966); Mowover# it is also well established that aldosterone 
secretion is affected by electrolyte status before any change 
occurs in plasma electrolyte concentration (Broim et ai, 1978b).
It therefore seems more likely that alterations in electrolyte 
balÊiïico msy stimulate aldosterone production indirectly,
Hiysiftlogieal quantities of ACTÏ have been shown to have 
little effect on plasma aldosterone concentration in normal 
oubjecta,ta!îing an unrestricted diet. However, when tSi© 
subjemt is sodium depleted, ACfll causes a marked rise in 
aldosterone secretion (Jemea, landon and Eraser, 1967), 
âltertvtiosiB in electrolyte balance may therefore be important 
in modifying the response of aldosterone to other trophic factors, 
(a) Alterations in sodium balance.
If an increase in circulating aldosterone cornstitutes a 
Borsaal response to sodiuia deprivation or depletion, its 
©ccurrenoQ in pregnasioy suggests a similar basis.
Plasma scdimi concentration has been aho^ i to foe low 
throughout pregnancy (fable 6, Figaro 27), A correlation 
with plasma aldosterone concentration has also been demonstrated
9%,
(Table 1%, Figure 37), Surprisingly, however, this correlation 
was positive rather than negative as found in other hyponatraemie 
states* Although statistically significant, there was a very 
wide scatter on plotting the plasma concontrations of eodJ.ma 
against aldosterone•during pregnancy, suggesting t&iat this 
might bo a s%mrious result (I'igure However, on dividing
the data into trimesters, a more strongly positive correlation 
was obtained in late pregnancy (Table 13, Figure 36’), while in 
mid-pregnancy a loss marked, hut still positive, correlation 
was fomid which was significant at the 10§ Imt not at the 3^  
level (Table Ig)*
Plasma aldosterone concentration, therefore, appears to he 
positively correlated to plasma sodium concentration in prognmncy 
apart from the early months of gestation* Further support 
fimnthis ehaervation was^  ohtaisied hy finding that liotli plasma 
sodium concentration end plasma aldosterone concentration 
correlated in a positive direction with plasma osmolality, the 
correlation with sodiuas being significant at the 8^  level and 
with aldosterone being less significant at the lG/5 level 
(Table 14)*
Why should the relationship between the plasma concentrations 
of aldosterone and sodium at theee stages in pregnancy be opposite 
to that of other hyponatraemic stages? Could it be due to a 
difference in overall balanee^  ^ In non-pregnant situations a 
Im*; plasma concentration of sodiwi is usually a reflection of 
severe bodily sodiums depletion \7ith the eaieeption of antidiuretie
hemmne o^ roass* Studias' im later pregLionay# hawGVer, have 
eliot^n mo aviclemca of matarmal aodiim claplatiom* Oa tiza 
contrary, retention of sodimn haa bean toionstrated, the 
quantities retained being approximately similar to those 
reqiiired by the foetus and placenta aad by the imeroascd 
ostraeeiimlar fluid (MacGillivray end Bucbanosz, Plemtl
and #ray, 1959; MacCillivray, IgSl),
The balance studies reported earlier (Chapter 3.B) were 
curtailed for practical reasons, especially beoauso of nausea 
and other symptoms in early pro^ancy* The results of these 
studios ore therefore of limited value* However, they lend 
support to the data observed by the above workers, in that 
there was no evidence, even in early pregnancy, for nmtomal 
sodium depletion, rniû that, if anything, there appeared to be 
a sllf^ tly positive sodium balance (Table 17, Figures 4S to 44)* 
The foregoing data suggest that tîie increase in aldosterone 
secretion in pregnancy is not stimulated by sodim depletion 
or hyponatraeaia* IW&er, it sgck^ q more likely that, like 
primary hyporaldosteroaism, the raised plasma aldosteromo is 
the initial event, vdiich results in sodiusn retention and a 
positive correlation with plasma sodium concentration, albeit 
at lower levels them those found in noa-progmant subjects*
This effect of aldosterone on sodium balance mil be discussed 
in more detail later (Chapter 6*E), when the overall role of tSi© 
renim-aiigiotonoiE-aldosterome system in pregnancy will bo examined*
(îî) Alterations im potassitia balmieo*
Total exehcsigeablQ potassium is inoroasGd im normal 
pregaaacy although tho mount of potasslmi per kg* body welglit 
Is less than la non-pregnasit females (MacGiliiw^* mid Baohanmi, 
19585 MacCrillivray# 1961)# ' Tlie present study has shoim m  
evidence of hypsrkslaemia - in feet, '^ 0 plama potassiusa 
eoBoentration cluriag pregaaBoy was mainly la. the lower part 
of the normal BOBrpregsiant range, a possible result of 
haeaodiiutioB# However, whosi the changes in' plasma po-fcassina 
wore taken in conjunction with #hcmges in plasma renin substrate 
and angiotensin II coBcentrations, a positive correlation tjitk 
plasaia aldosterone merged (chapter' 3*B). The amount of 
circulating potassium may therefore be influencing 'tlie action 
of angiotensin II on aldosterone secretion in pregnancy#
The corrélation beWcen the urinary excretion of potassium 
£52id plasma aldosterone concentration is likoly to be a reflection 
of the potassium oxcrotiry effect of aldosterone on the renal 
tubules, and is therefore an indication that the increased 
circulating aldosterone in pregnancy is in on active form*
moTOBs mro:;vHD m  i m m  sœœioN.
The association bettmen the plasma concentrations of 
renin and sodima in non-pregszant subjects has been discussed 
in Chapter 8, renin secretion being stimulated ?iy sodium 
depletion and inhibited by sodium loading# This roiationsMp
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aia© ©GGsas to osdsi in the pmerperimt# lAore an inverse 
eorreistioB has been found between the failing renin and 
rising sodimi levels (Table 13)-(Figure 40).
îMring gestation, a relationship beWoen the ^ ayponatraemia 
and the increased circulating renin might have been expected. 
lîQwever, no such correlation has been obtained at any stage.
The reasons advanced for the failure of the hyponatraemia to 
stimulate aldosterone sooretion could bo put fon/Rrd im the 
ease ©f renim secretion. It also seems possible that other 
factors may be playing a part in renin release during pregnaEoy.
Like plasma sodimi concentration, plasma esmolalily is 
reduced, especially early im pregnancy (Figure S7), and failure 
to correlate with plasma renin concentration could be due to 
similar factors.
It has also been suggested that changes in blood volume 
or hacmatocrit may affect renin release and hence circulating 
renin levels (Brown et ai, 1966c; Nielson and M^ l^lor, 1968), 
but no relationship was found in this study between plasma renin 
and plasma volume or haematocrit (Chapter 3.A). Similarly, 
changes in plasma protein concentration mid colloid osmotic 
pressure have been shown to have no correlation mth plasma 
renin concentration (Clisptor 3»A).
Stimulation of resiin secretion secondary to arterio-venous 
ohmting of blood in the placenta (Mulrow, 1964b) or pressure on
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the renal arteries by the gravid uterus (Forohom 196?) have 
also beea postulated# hut seem imlikely to he operative as 
early os the fifth week of pregucmoy, whesi a marked iueroaee 
in TQuiu has already heeu noted (Figure 11).
The failure of cireuiatiiig renin to correlate with any of 
the otiEiuli estahliehed in other situations might he clue to 
the interaction of a numher of these factors during pregnancy.
Ob the othes? hand it pould he taken as evidence that the plasma 
renin concentratioa being measured contains a proportion of 
inactive renin derived possibly from chorion (Chapter 6.B).
The possible role of non-renal sources of renin in human pregnancy 
will bo discussed in Chapter 6.2)^
FACTORS mroLvii) m  èrobuction.
Increases in plasma renia-substrat© concentration similar 
to those found in pregnancy have been found in wonmm talcing 
combined oestrogon-progGstogen oral contraceptives^  (see Chapter 12, 
Figure 38 ). As the secretion of oestrogensand progesterone 
increases steadily from early gestation (see Hy&ten and laitch,
1971)9 one or other, or both, of these hormones could be the 
cause of these increases in plasma levels of renin-subotrate.
Melaer aaid Griffith (1932) found that rat plasma renin- 
substrate was increased by oestrogen a#inistration and this 
has binôê been confiamed in man (îîelmer and Judson, 1967s 
Mowton, Sealey, Lediiigham and Laragïi, I968)* Progesiogesz alone
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had no effect on rat substrate (ïïelmer miü Griffith# 1932), Tmt 
the progestogen nerethymodrel, which also has some oestrogenic 
properties, produced a small rise in hueaa plasma substrate 
ooBCentratioB (Mewtoa et al, 1968)*
III au experiment to be described later (Ghapter ÎS), woraea 
given OM ©estrogen (mestramol) showed aai'ked increases ia plasma 
rouiu-substrate coaocsoitratioB, whereas those givmi a progestogen 
(ethysiodiol diacetate) showed no response (Figure 63 )*
It seems likely, therefore, that it is the increased 
oestrogen secretion isi pregumioy which stimulates the rise in 
plasma reuim-substrate ooBcentratioB*
Oestrogeus and combined oestrogeu-progestogeu oral 
contraceptives hmre been shoim to produce ssi increase in 
cortisol-biEdiiâg globxilin (Sazdbarg and Slaauwhite, 19391 Layne, 
Moyer, ITaishwanar and Finous, 19625 Hoe, Mellinger, and
Seal, 19675 Keaae et al, 1969<&)# thyroxinWilnding gloTmlin 
(Doe et al, 1967, Keane, Fogg and Johnson, 1969b) and in 
©lpha-2 macroglobulin end transferrin (Horne, Howie, Weir and 
©audio, 1976). As reiiin-substrate is in the alpha-S globulin 
fraction, it seeam possible that the raised concentration in 
pregnancy is associated with increased hepatic globulin synthesis 
stimulated by heightened oestrogenic activity#
MCTOBs m v o m m  m  immmmBm pboiuctïon.
'111© ©ctspeptide angiotensin II ia generated via the
1#,
deeapôptide aaglotonsin I by the ©etion of the enayme reaia 
©a its protein substrate im the plasma. Factors xAloh affect 
circzilatlBg levels of romim and remin-substrate would therefore 
he expected to iirlluoiaoe %e amomit of amgiotemsia II presemt 
im the plasma. Such factors have alreac^  boem diseussocl,
The presence or absence of Wmhitors or activators of 
the realm - renim-suhstrate reaction might also imfluGmee the 
amoimts of amgiotemaim I and II gemerated, as might alterations 
133 the emaymes Imvolved im the conversion of angioteaslu I to 
mzgioteKsin II, Little is kaoxm about these factors in human 
pregnancy,
Variations in "angiotensinase activity might affect the 
survi.val, aud hence the concentration, of angiotensin. II in 
blood* As has been described earlier (Ghapter 4*A), amgiotenoinasG 
activity is generally increased in pregnancy# hut Its iiiflueBce 
on the circulating levels of angiotensin II in. this situation 
h^ s not been clearly assessed. Also, an alteration im metabolic 
clearance of angioteiasiu II has not yet boon Bhmm. im pregnancy.
6*ï) m a  spMîFiciPCSî. of i m m  m  m  m m w s  ,mn 
Fôïîîû-FMCMrMs m m  mm of mmsrmmiË m  ma 
' ' ' jmÉms.
ia iMo Siuaioa# liigSi cmcoBtrationa ùt renin, oj? ©a eaepao 
closily reseiMiag ii, have tioea found ia csmiotio fluid (Broi-m, 
BiïViôs# Boak, Lovor, Boliertson aad Tree# 1964b# â^ iiaaer et al# 
19685 liamîîorg, 1971 ) (Figure %3) cmd iu dhorioa# amuiou# 
decidua, placenta osid myometrium (Skixmor et al# 1968). Fenia 
liQS ûlso been detected ia tîie humea foetal kidney (Ljuagcjyist 
end Wûgarmerk, 1966).
Uterine renin increases during pregnancy (Oeelhoed# Vender 
end Cerlaon# 1970) but conaitloraîily lees ronia is detectable 
in hummi uterine muscle tSxea seme to be present in that of 
certain otixer mammals# such es the rabbit (Skinner et el# 1963# 
Ferris, Oorden mà Mulrow# 1967; %em# 1970). As a result of 
tissue culture studies %aonds# Stanley and Skinner (1968) 
concluded tîxat in man tills iatra*-utôrine renin was mainly of 
chorionic origin from where there was ready access to mmiotic 
fluid.
Brotm and his colleagues (1964b) found generally elightly 
liiglier coneexitratioas of renin in umbilical vein plasma tlxan in 
materaiil peripheral venous plasma at tema whereas in two similar 
studies c^inner et el (I96S5 1972) found no consistent differences 
between the plasma renin concentrations at tlxose two sites*
Although not certain, it seems likely that in late pregnancy 
the higla levels of renm in tike maternal blood cxre derived from tlie
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(from Brown et al 1964b)*
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izàdneya them :Sgom iho litos'aa its comtcmts#
d^amos* ot ol (196s) |)0fjt^ 4lat©d that it be difficult fog
tÎ20 hikiitm ohogimi to eoBtrihuto to ths maternai oiroulatioa 
tlîgoiîgh thù thicSs tlcoidml layer. GoafirtisatioB of time haa 
beoB ©btûiBâd by tim rocoBt BtxiëiQO \iiich domoastratotl loifor 
roHiisa aotlvlty omU coBüefâtratiosi M oompared to porlphorel
veaow plasma ia wcsioa at tern {îiolmt aad WcAski* 19?2s 
et qIj 1972). Wwooveg# otmsxtaû levels of roam nmy persist im 
tho matomal poripheml blood for several clays aftor dolivory 
(I'lgare 13)9 wheroas the haif'-lifo of oodogonoBa renin, at any 
rate iu  the tmophrie. auhjoot, io of the order of ISO miimtos 
(Brot’Mp CJnrtis^  Lover, EohortsoBp do Wardcaor and Wing, 1969b)* 
SliGoe avgamoata, Iiowovor, do not aoocosarily apply to 
the QQgly wedsQ of prognoaoy, at vMoU time msaoorcsaosit of 
atorimo wiiquo roaia eoBoeats-ation hae aot yet boon reported, 
d in n e r  and h is  associâ tes (1972) have ohoim th a t moaens’einGiit 
of plQ&ma reaie omiooatration in pregnenoy «light incteio a 
pliysic^ logioaily inootive z'min-^likQ onayaîo with oharaotoristioo 
airailar to those of ohorionic and mialetie flnid renia (Wnbors, 
I97&)* lliey have also pointed ont that ehovioaiG goBadotropbia 
Gcm pass into tlio maternal ciroalatioa daring tho phase of cyto« 
tmphobleetie proliferation (Jgbqs, Bel fa end Stresi, 1944) end 
have GBggeatod that oborionio leeaia might do lilmeiso# As 
disenBSQd in Ghapter 6.M, this might explain tîse very high 
pifisme ronim oonooBtretioaa in o&rly prognnaoy ami the ppparont
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lack correlatimi betwoaa eircnlating levels of renin 
and angiotensin II im this situation*
%e fimotioH of intramterine renin remains smoertain; 
possibly it may bo ooncomed w'itli the regulation of sodium 
mid fluid transfer to the foetus* 3Xie rudimentary comter- 
eurrent vaseular systein of the human placenta resembles, in 
some respects, the mmre elaborate arrangements in the kidney 
as described by ISris and t-evor. (1969)? it is at least possible 
OB present evidence that in both situations renin, via 
angiotensin, controls the velocity of blood flow, and hence 
the efficiency of fluid and electrolyte ©nchonge* Another 
possibility is that the ronin-amgiotemsin system may have a 
role to play in parturition, as angiotensin II has been slioim 
to have an oaytocic effect (Paiva and Pei va, 1969)* Some 
support for this is suggested by the finding that 2 wm^cn with 
histories of poor uterine contractions had lowr uterine renin 
eoncGsitratioBD than other women (Oeolhoed oi al, 1970)*
Plasma reain«substrat© concentration has been found to be 
lower in foetal than maternal plasma (Skinner ot al, 1972) but 
to date no reports of angiotenein concentration in foetal blood 
have been published*
fhe human foetal adrenal is capable of coverting corticosterone 
to aldosterone in vitro by the l6th week of gestation (Bufau and 
Villee, 1969)* At term, significant cmoimts of circulating 
aldosterone in the foetus appear to be secreted by the foetal 
adrenal while only a small proportion seems to cross the placenta
I#,
from the mother (Bayard et al, 1970a)# ïhe levels In foetal 
plaiSîïia are generally higher than ia maternal plaam, bat 
respond ia a similar fashion to changes ia maternai sodium 
iatalse (Beitias, Bayard, Levitsky, Aices, lowarski mid Migeoa,
1972)# Wiether this disparity ia aldosterone coaceatratioa 
between mother and foetus is associated with placeatal trasisfer 
of sodiuni remains to he iavostigated#
6.% ™  WMm m  rm sïsïm
m  pimmmoY#*wfmp# n#wmM3 mumimaWMM##*##**' ' i m* w.iwmii .«iji#i:#i r#-x
the résulté of those mû previously reported studies, 
it is new well established that profound changes occur in the 
circulating levels of renin, reula-substrate, aagietsBsin II 
and aldosterone during normal pregnancy. At the same tliae, 
the mother is adapting to the demands of the enlarging uterus, 
placenta and foetus by marked alterations in homiional, fluid 
mii electrolyte halance# VJhat, then, is the pîiysiological 
role, if any, of the renia«anglotensin*-aldosterone syateüi in 
preserving maternal homeostasis during this time?
It has been shorn that, rather than soditm^  depletion 
acting as a stimulus to aldosterone secretion as in many 
aon-prognmit situations, in pregnancy the increase in aldosterone 
production appears to be the prime mover in the control of sodium 
balance, That is, the increase in plasma aldosterone 
concentration may occur prophylactically in the early weeks to 
prevent the development of r^ atemai sodima depletion as gestation 
advances,
A number of potential sources of maternai sodima depletion 
have been identified, Token singly they might not have a 
dramatic effect on sodium balance, but their cumulativo effect 
a-s pregnancy proceeds could result im a marked sodima deficit 
unless compensated by a powerful sodiuij!i*-retainiHg agent such 
as aldosterone.
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1. It is Imrnm the glomerular filtration rate is 
mmâmêXj iacreased as early m  the 12tli week (sima end 
ICronts;# 1958$ %ttea oad Witch, 1971)* This 'î-jould lead 
to increased sodium excretion unless compensated by increased 
tubular ©odtoi reabsorption, promoted possibly by increased 
circulating aldosterone# Watanabo ot al (19Ô5) were unable 
to demonstrate a correlation between glomerular filtration and 
aldosterone secretion rates in later pregnancy, but by that 
stage other events to be described could have obscured a 
simple relationship#
2* teôîig pregnancy., the increases in plasma oestrogens and 
progesterone parallel those of plasma renm-substrate, angiotensin II 
end aldosterone concentrations (see IJ^ tten and Witch, 1971$ and 
also Chapter 5#^ , Figures 14, IB, 22, 26, 35 and 34).
Progesterone inliibits the action of aldoatorono on the 
renal tubule (làndau and IsiglbiM, 1958, 1961 ), and increases 
the urinary excretion of sodiuîü lAen given to non##pregnmt 
tmmem im doses com^rable to the rate of secretion in nomal 
pregnancy j|Widau, Borgenstal, togibihl and Kascht, 1955$ 
imidm, ÎAigibihl, Bergonstal and Bimick, 1957)# In momal 
pregnant wonien tlie administration of progesterone has been 
shown to stimulate aldosterone secretion (Laidlaw, Fuse and 
Bommll, 1962) and a correlation between urinory pregnonodiol 
excretion and aldosterone secretion lias been found (Jones et 
al, 1959)# A translmit natriuresis and an increase in 
aldosterone secretion rate have also been demonstrated during
*t!ie administration of oestriol and ©estradiol to aoswpregaont 
Qub^ octs (l%tg and S£ai>pas, 1967)$
Eowovor, in attampting to relate these events to ehangos
,
ia renia mâ aldosterone it should be borne in mind that 
progesterone (Figure 26) and ©estrogens have boon shown to 
increase slowly in early pregnancy, with a progmesaive rise 
to term (Short and Eton, 1959$ Greig et al, 1962$ Ymmone 
ot al| 19681 Brown, 1956$ Klopper and Billewiez, 1963$
Smaan, Bradbury and Goplerud, I969) and they would therefore 
be expected to have a greater effect on sodium balance, rmin 
and magiotonsin in late rather thwi early pregnancy#
3m During pregnancy, there is an added requiremjent for 
ôpproxiEîatoly 950 m %  of sodiim, of which about 530 m %  
are needed for the growing uterus, foetus and placenta 
(%ttosi and Leitch# 1971)# Although it is unlikely that 
diversion of sodium to the footo-placental unit \70uld bo 
sufficient t© deplete the laotlier in the first weeks of gestation, 
a cumulated deficit could occur ia later progsjancy unless 
counterbalanced by an increased dietary salt intalm or by 
increased renal tubular reabsorption of sodiwa#
If a rise in circulating aldosterone is required to 
prevent the onset of maternal sodium depletion due to those 
factors, what is the initial stimulus to the al#@»terone 
secretion? A speculative sequence of events is shown in 
Figure 46#
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Speculative role of renln-an^iotenain^aldosterono eystem in 
pregnancy.
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(Hie raised pracluctioa of oootrogemo froa tlso early 
veoïsa of gestation m%ay stimulate inereasod liver syBthGBis 
of reain«*su|jatrate* At the same time a rise in rmia 
secretion occnrSp possihly maisily from the chorion, ïhe 
increased renin-*aubstrate results in elevated'levels of 
oirenlatiBg engiotenein II,
Modifying infinmcos, especially plasîiia potassium 
eoncentratic-a* may explain the lack of direct correlation 
hettzeem the plasma levels of angiotenain II and eldesterono. 
Nevertheless# in view of the strong correlations in otîier 
situations# the ohaence of sneh a direct relatienship in 
pregnancy is remarkahle. It may mean that in preg&xancy, in 
addition to its effect on the adrenal eor-tox# angiotoasia II 
itiay also have a major influence on fluid balance by stimulating 
the secretion of mtidinrotie hormone (Bonjour and Melvin#
197#) or by itself everting m  intrarenai ontidiuretie effect 
(Brotza et al# i97Sa). To date# antidiaretic hormone levels 
have met been measured in pregnaEcy*
The direct relationship hatîzeea ronim and aldosterone im 
the absence of a relationship between renin and angioteaain II 
has led to the earlier epoenlation that circulating *^ choriomie 
reain*^  may act m  snhstmte to foim# for ossasnple# 2 ^ 8  hepta* 
peptide which has l?eem stated to stimulate aidcstoroBo secretion 
(Blair«4i?est# et al# 1971)# This# of coirae# reclaims hypothetical.
109#
The eombimed effects of water reteiition (mediated by 
oagiotensia II with or without asitidluretic hormone) end 
sodium retoiitioB (mediated by aldosterone) would 3;@eult 
in increased plasma volume# whicia has been shorn to be 
necesoary for adequate development of the foetus (llytten 
and Lei tola# 1971 )♦ Increased renal blood flow and glomerular 
fii'to/fcion rate would be a eonsequeaice of this, Greater 
retention of water than sodii«m would cause increased plamia 
water content (Paaby# 19995 Hytten and Leitch# 1971 ) and 
a lowering of plasma eleetrolyte concentration sncl osmolality.
miin-cuigiotensin-aldostex'one systeia appears to bo 
ffictionally active in normal pregnancy and there is evidence# 
albeit mainly circumstantial, that it may have eR important 
rolo in the maintenance of maternal electrolyte and fluid 
balance*
ïïowever# a pussiing situation arises when women with 
little or no adreno-cortieal function heeomo prognont* There 
is no evidence for significant piaeent.al secretion of aldosterone 
(Baulieu# de Vigmi# Bricaire and Jayle# 19975 Laidlaw# Cohen 
and Crornall# 199B§ Christy and Jailor, 1999? Iriager# 
febriiove and Coffer# 19ôû)# and those immen therefore have 
negligihlo circulating levels of the hormone* Ifeiless they 
increased their dietaxy sodtoi considerably', such vzoraea might 
he cK;pect0d to require increased amounts of exogenous
lie.
mineralocorticoid to maintain sodium balance during Mieir 
propiauey* That this is net so has been suggested by a 
study of women following bilateral total adszenaleetomy 
(Barber# Grsber mà O^ Bourke# 1966). These wmaea had 
quite normal proguaucies without requix'iug an increase isi 
their replaeemont doses of gluooeox'tieoid o%" .mi'heralocortieold* 
They were talslug salt in their diet ad lib*
In 2 'ïfomea t/ith adrenocortical insufficiency studied 
ia late prcgnasjcy# serum olactrolytos izere t/ithln the noimml 
pregnant rajiige m x à  aldosterone secretions were very low or 
uîidotectable (Drucker, Hendrix, Lara#i# Chi'isty and Van do 
Wiele# 1963)# When given a nomal sodiisa intake of 
91 m% daily, one of the ^ zomen had a negative sodium halanco 
while the other had a positive balance when given an increased 
intake of 23? 53%  sodium daily* Meglihlc effects mi electrolyte 
excretion were observed wlion large quantities of aldosterone 
were administered intravenously to those women before delivos^ # 
tdioreas post^ partum the normal sodium retaining effect of 
aldosterone was restored* The insensitivity to aldosterone 
in pregnancy was thought to he due to the antagonistic effect 
of progesterone*
In the absence of aldosterone# progesterone does not 
appear to cause a natriureais (Landau et al# 1999* Landau 
and Lugilîiïîi, 1993? I961). The tendency to sodium depletion 
may# therefore# he loss isi pregnant women with adro3iocortlcal
in :.
isBuffieieaey tîiaa ia normal progaaat women# aad they may 
be able to oope more easily with the requlremeats for 
additional sodtei by imereasiag their diot&iry salt intake,
CoBcarreat uieasuremeats of plasma roida# reaia-suhEJtrate# 
aagioteiisin II mid aldosterone ooaoeatratioa aacl of electrolyte 
and fluid balance during gestation isi woiuea wi'lii adrenocortical 
isisiïfficiensy might help to elucidate further the fascinating 
problem of the role of tlio resiisi-aBgioteiisia"-aldooterono system 
in normal human pregnmiey.
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MeCanee (l93ô) gavo a detailed aceomrô of tlm oymptamo 
oxporimood by normal oabjeeto Awing aovoro osfpei'imontai 
sodium itoplotioB, Prominent featuroo inolnieâg nausea# 
abeszrotiosio o f taste# a peculiar metallic tase sometimos 
mistaken for thirst but mot relieved by driuMBg water# 
maeealor erampo# md mmvhûl ami yliysioal lassitude# Tm 
Cliaptor 2 it was oeeo that oocliuA depletion io aeeooiated 
with increased plasma coneontratioao of renin# angiotcsiein amd 
aldoateroBO# It ia mieortaln to what onteat the oy^ ptoms of 
sodium obloride defieienoy are ilttQ to eodiura chloride lack as 
BO oh# or altornativoly to the aaaociatod hoBAonal ehcmges#
For example# augieteaBim has hùm% shown to cause polydipsia in 
rata (Fitsaimona end. Simozm # 19b9) and the aaaooiatod riao in 
circulating augioteuain has been suggested as a possible cause 
of the iiîtesîse thirst which sometimes noeomponlGo aevoro renal 
failure in mmi (Bmm ot al# 1969b).
As has Won eoeu# pregnanoy ia a situation ^ Aero there 
are adequate eausoo for ii merkod temdenoy to aedinait depletion 
(see Chapter 6#B)* Moreover# severe;! biochemlonl .featiiroe 
associated with bqûIwm depletion may W  present frw early 
progimiey# mmely# inoreaoos in the plasma eencontrationD of 
renin#(Figure 11)# angioionsin IS (Figum 19) and aMostemiiQ
23) *  mamy o f  t li©  Gy&nptoma o f  s g w ^ g
aoââiim depletion (naiieea» abeiM^ ations of taste* a metallic 
aenoatioB in the moh# wirelieved by driiihing* thirst; 
cramp, mental and physical tiredaess)* are so gosîmob in 
pre@agmcy, especially in the early xfeeks * as to be dismiascd 
often mthout o<xme&it* These similarities of biochemical 
featBros and symptoms seemed to be safficieHtly striking 
to merit farther escaaiisiation*
Gliaical methods*
28 no3snal pregnant women were investigated before the 12# 
week of gestation* 81% of these vomem had been admitted for 
termimation of pregnancy imder the âboriion Act (19SS)* and 
blood samples were taîsen from them botweeB 8,30 and 9» SO a,m*
The remainder of the women had blood samples takem at rnomimg 
or afteriiooa visits to the anteBatal clinic or Ward* All the 
women were on mi amrestricted diet end had been reeeabeat for 
at least 30 miiiutes before the smnples were taken*
All the x-^suea were given a qiuestiosiiaaire to complete 
regarding their symptoms at the time of sampling. This is 
illustrated in Figure k? * The spsptoms wore them arbitrarily 
scored* <me point being given for each symptom présent * as shoim* 
Where the patient indicated a marked severity of a sy sip tom,
2 points were allocated, The èotal score was entered in -Mae 
protocol before the results of the biochemical tests '\7ero M owb,
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Biochemical and statistical methods#
These %fere as described in Chapter 3#
The correlations between aymptouiQ end biochemical changes 
%fere as follows#-
Plasma a r Significanco
P
gymÿtoms Heain 07 0,062 >  0*1
symptoms Substrate 88 0.010 >  0*1
symptoms Angiotensin II 22 0,883 >  0,1
Symptoms Aldosterone 20 0*068 > 0,1
%iuptoms Sadism 27 0,870 >  0,1
Symptoms Potassium 87 "0,530 <. 0,01
%aptoms Osmolality 1 3 0*3# >  0*1
Mo relationship was found between the overall symptoms 
of early pregnancy and changes in plasma concentrations of 
renin; renin-sabstrate, angiotensin 12 and aldosterone g 
neither wore pleema sodiusi mû osmolality related to the 
indideaco of syeiptemB#
A sigi^ ificancè negative correlation, however, was obtained 
between the severity of symptoms and plasma potassiisja 
concentration (Figure 48)#
Further analysis of the results showed no evidence that 
plasma angiotensin II concentration was greater in women tdio 
complained of thirst alone than in women wïio did not admit to 
this sytiiptom#
PLASMA
POTASSIUM
CONCENTRATION
mEq/l
42-1
3 6 —
3’0~
• *
#
r = - 0  53
p  < 0  0 2
I r
3 6
SYMPTOM SCORE
48. E^tlationBhlp between plaema potassium 
ooncoaitratlon and ayiuptoma in early
pre^^ancy#
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Biaoüïsaioa,
Boau4iig Im wiind tlso pogGlblo &n5oon&\«0ào8 in tho m e t h o d
of meorimgg aemo o f the c m i p o a e R t e  of the x'onfewangioteasiii** 
G&doetesrono ciyoteni cm?rolütoü ai{paii!ion.ntly vdtk the mmi^ hor 
X)f 8 © W Â " i t y  e f  e y a i p t o m s ) *  I m  pnrticnler^ p la m m a  eagiotes^ ein 1 %
çî^ Boeî^ teitlcs^  û iû  no t appeai? to ho zmieteê t o  the preaeaao o r  
de^oe of
fho feet that piasüîa müivm oom ontixitiou @howd ao 
o o r r e l o t i o n  t - ^ i t h  a g r ^ i i p t e j o  d o o o  m o t  m o c o o o ^ t m i i y  t h a t
ooiim depletion %mo siot presemt* It lo$ 3^ oTfove&?@ in heopirsg 
with the rOBBlta filoserihsil iu  ©liapter %3) (Plgumoo &8 end 44) 
i l l whloh there was no ovidemoe of a môgativô sojîim halaaoe 
Im early gootatiom#
Momo o f  the women s t i H l i o â  o o m p l e i m e d  o f  vcmitimg o r  
diamlioea# It is  müikely$ thorogoro» that the hypokaleemia 
v&B ûim te these compiiootiomo* On the other htmil$ at le a s t 
some o'S the amid he attrih'atod to the lowered
plasma poteoaimin eoneeiâtratioa#
‘m pregaemey* a relationship OKiotp hetwoem tirimary potasslBa 
oxorotiom and a'idosteroae ee^ ieemtertioa C-Hgiure 8^)«
Althtm^ a no diroet corrélation has homi pisowa hotwoen plasms 
lewis of âlûQBtBmmQ miû petassiuis (fabio 14) or botwen plasma
aldost
oympto
one emil oymptoma, it seems poosiblo that ss-me of the 
3 o;? pwgnenoy any be duo to iwekoleemia imdnoed by the
iBCvwesod oiiOTlating lowlo of aldoatorow#
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DI8EA8B OF WMmmC^ (^W^WÎàWSIA)
Bofiaitiosis ©f wliat is eailod variously ”pre«eclampsia'* 
"toxaemia of pregaaaoy”, "spocifie hyporteiisivo disease ©f 
pregaemcy", "%)regBamoy hy%* or teas ion" ^ differ widely froia on© 
centre to asiotlior* VJhovQ different coapoaeats of the resiia- 
QEgioteasia-aldosteroao system have heea estimated > ©degaate 
oomtrol ©abjects have been studied In parallel im only o few of 
the reported sei’ios. The methods for measuring these various 
oomponemts have also differed cmd satisfactory comparisoas are 
therefore sometimes difficult to make (see Chapter 3)*
pmem imm
Îlîia has heoa variously reported to be iaeroaseâ» uachaageâ 
ùT decreased in women with Ijypei’tensive disease of pregnancy, 
la 1944 Uextor and Mayaoo reported renia l^iko material in the 
blood of 3 women with hypertension of sudden onset in late 
pregnancy j but found no evidence of this substance in 3 pregnant 
women with a gradual onset of raised blood preoeure* Their 
results I however I were not compared with normal pregnancy where 
an increase M  plasma renin activity and concentration frequently 
occurs (see Chapter 4.A; 3.A and Bj Figures 8, 10, and 12).
lia
Pressor laatorial isi blood from pgtieats with px’e-oolampsia was 
also claimed hy lamter mid Howard (1961) and Tatum and Uulo' 
{1962) hut in aoither study was this definitely related to 
renin or angiotensin activity* Haebashi mid his colleagues 
(1964) found increased plasma renin activity in px'o-QClampsia 
as compared with noSBui pregnancy, hut this finding is difficult 
to evaluate as the same workers found no difference ia renin 
activity between pregnant and non-progaant normal women 
(see Chapter 4*A)* In a prospective study, Gordon and co-
workors (I969) claimed that mean plasma renin activity between 
the 13th and 27th week of gestation was higher in 10 woiaen %Ao 
later developed toxaemia of ^ egnmicy thasi in 48 women where 
pre^enoy was muevontfui* This difference, however, was mt 
statistically significant,
Winer, in a brief abstract (1963)* mentioned 3 patients 
witli toxaemia of pregnancy where plasma renin activity waoM© 
higher than in norn^ al pregîiancy hut no further details were 
given, SiBJilctr levels of renin activity in normotensive and 
îsypertensivô pregnant women wore also reported isi a more recent 
study i^  lAiioh no correlation was found between blood pressure 
end plasma renin activity (SclMaidt and Hoseathai, 1971),
Im contrast to the foregoing reports, Helmer miû Judsca 
(1967) reported the mean plasma reain-activity in preguent 
women witlx "elevated blood pressure" to be lower than in norsBal 
pregnant womoB in spite of the use of thia^ aides in most of the 
hypertensive cases.
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wm m  cqncmfatioh,
The difference between the measarGment of plasïiia renin 
activity ami plasm© reain eonceatration has beem discussed 
iu  Chapter 3* Fewer ©tudici of plasma renia coacoatratioa 
i l l byperteasive disease of preg^ Jtimcy have homi reported#
III a cemparisoQi be two mi 32 wommi vrlth liypertansiwa 
during -feho third trimester of pregaaacy mid 60 woracs! at a 
comparable stage of normal pregaaacy (Broim, Davies, Doaîs,
Lover, Hobertsoa aad Trust, 1963; 1966^ ), mo sigaifioaat
difforesieo ia plasma remim comeemtratioa was foimé ia those 
with raised blood pressure alomo# Eoifover, the plasma remiss 
coîicemtratioa was signifiemitly lower isi the womea with vexy 
hi^ blood pressure plus ^ sroteimuria# This lower plasma renia 
coiieeatratioii ia the more severe eases of pre-eclaBnpsia. was 
also noted in 9 Amerieaa negro women T^ hen compared with the 
levels ia ? mo%%ml pregnant controls (Bonar, Brown, Davies, 
Langford, Lever miû Bobertsoa, 1966)#
ÎB contrast, Brovm and his associates (1966(3) found that 
ia 7 tfomea in hypertension was u coBîplication of rhesus 
iso*«insamiisatioa or hydotidiform mole the mean plasma renia 
coaceatratioa was considerably MgSier than the value for mortal 
prcgaaaoy*
FM&m mmmwmsTBATB' coHomTmTim#
âs far as is known, only erne adequate study has been reported
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to date in plasma renin^ -substrate concentration hao been
measured in pregnant women with raised blood pressure in the 
last trimester (îlelmer and Judson, 1967). In 9 such vwien 
the circulating levels of ronin#substrate did not differ from 
thme fousid in norisal pro^ pmncy, the means being 1872 ng/ral, 
and 1736 ng/iül respectively* This was in keeping with on 
earlier finding isi one case of hypertension in pregnancy of 
a plasma renin*«sttbstrato level within the normal pregmait 
I'ango (Gould et al, 1966)*
BLOOD moioTmsm cmcmTmTi#.
The paper by Massoni and her colleagues (1967) appears 
to be the only report of blood angiotensin concentration in 
hypertensive prognmit wcmeu* In 3 patients with raised blood 
pressure in late pregnancy they found a mean angiotensin ' 
concentration of 230 ng/l (S.B. i 29), which was not significantly 
different from the mean of 9 normotensive pregnant controls 
(soa ng/i, S.B. i  aa).
Blood m^iotensinases#
Beports of •ongiotensinase* activity in peripheral blood 
in pre^ eclampsia have shown conflicting results. Gompored 
mth aonmal pregnancy at the same stage of gestation, 
angioteasinese activity in pr^ weclampsia has beem reported as 
Imer (Page, 1947| Talledo, 1968), higher (Lasides^ aan et al, 1963; 
Berger and tesghans, W&7) or Vmlable (îiEckler et al, 1963).
It is possible that these variations represent tecîmical 
aberrations as much as gonuisie in vivo physiological differences.
12X#‘
It him olrotuÿ boon shorn that ilio peossw ipqaponoo to
ongiotopoln iofugdon Im vQümoâ in nomol prog^ amaoy (ace 
Chapter ,%*&)* Uimh cmJ his aasooiatoo (1936) found that 
pra**aclaiïptl© vmm. hod greaios? pyooaor rospoaeeo. t&xm 
Eiormetoasiv© progom^ t women (.mû #is was subsoquoatly 
muii&vaoû by other (Chooloy, 1966a; faîloîlo ot ai,
1.966; Taîletlo, Ohùsloy mû topm, 1968), the raspm^ ao ta 
angiotensin infusion boiag similar te m%mil 
SUbjGfâtS#
AMmsTFimm. mGPmi# jmsigmgioM,
3n 1946 Voimimg ouggostod that su hioroamâ o^ ioretiom 
o î minemloGortlooids ooourrod in toi^ aornia of pro#&%moy*
TMo appoared to bo confiraîod when the presonso of a 
"sodimt^etaining faator" in urine from ^ rosuea with pregosm^ 
toxaemia was roportod '^ Eploy m d  Gordon, 1931 g Vooning
ot el, 1994)# Bowvoy, altboogh' Demos mid Quilll%#i (1996) 
desîoaotrateil aldosteroaq exorotion rates ia woaiaa xrlih pra«* 
eela%5Sia to bo greater tliaa iUi aomal pro^oat womoa, they 
sarprioiagly fomid that tko iivimwy aldootoroBo lovolo were 
Mgiior m  tho mildor pro-ooEamptie patients rather them ia the 
eemjror
ÎM ooatraot to tho earlier reports, Martin g#d Mills 
(1996) did not shm; emy iaoroaeo in  aldaetoroao eacretioB ia 
prooclampsia eompareê with aossuotcusive pregrmaey emtl sevoral
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other workers suhsequexitly fouaci ttriKory ©Idoe toroae values 
to bo loT;er in tho prG-^ ociarûptie patients (iCbcaerek ot al,
1937; Bimslor and Bighy, 1937; Venning et al, I937; Kmas? 
et àl, 1959)#
Aldosterone seeretioa rates were meaeured in 2 womea 
tJith toxaemia of prognanoy by vmi de Weile ot qI (i960), asKl, 
in spite of a low soli diet, both showed lower values (320 and 
710 ug/day) than 3 normal pregnant women on mures trio tod diets 
(lOfeO « 2230 ug/day), Thomas and Flyan (1964) also found lower 
aldosterone secretion rates in 9 women with ^ ire^ eolauipsia, 
although the moan values (niild PJST 232 ug/dey, severe FM?
247 ug/day) were net significantly different from noimotensive 
preguaaoy (332 ug/day).
Both of these reports were confirmed by another study 
(Watanahe, Meeker, Gray, &im& and Solomon, 1963) which shw?ed 
aldosterone secretion rates in 3 womea with severe pre«.e0lampsia 
to be 100, .160 mà 3# ug/day in contrast to a previously 
reported nomal range for the same period of gestation of 390 
to 2640 ug/day (tWanabe ©t ai, I963). six women Tfith wild 
pre-eclawpeia had values within the normotensive pregnant rang©, 
labile tim had secretion rates of 330 and ' 380 ug/day* All the 
wmen in this study were taking a fixed sodium intake of 2G/clay.
In general, then, aldosterone secretion appears to be lower 
in women %dth hypertensive disease of pregnancy compared to 
normal pregnant women, the earlier reports of hi#ier urinary 
excretion most likely being due to the inadequate techniques 
then available#
FM,W MDOSrmONB GONOmmTION,
from OBO very level in eolespsia mentionod in 
a brief paper by Stark (1967)1 as far as is kaown, 'fcliere has 
bem BO other' report to date of changes in plas^m aldosterone 
eoneentration in women witJi raised blood pressure in preg^ aancy*
QTimi îmmMêGoimaoiBB*
In vie\f of the raised plamia concentrations of 17-hydrosy** 
eorticosftéroids in nomal pregnancy (see Chapter 4*B) a nuîiîbor 
of workers have studied ^ mmen with pre^ eolampsia to deteiviine 
if '&his condition mi^vt be associated with even hi^er levels 
of these hormones, especially of unbound cortisol# Howevex’, 
apart from qhq report (Wataaabo, 1961) none of those studies 
has sliotfii gx^ eater plasma cone entrât ions of total 17*-hyclro2j£yc©rtico-* 
steroids in hypertensive pregnant women (Aaaali, Oarst and Voskion, 
1933; Martin and Mills, 1938; Meyer, 1963; Frieitaan mid Beard, 
1966; Graves and Agorsborg, 1966; Eopelmon and Levltg, 1970) 
mà one showed loifor concentrations (Thomas and Flymi, 1964), 
coaîpared with nojKual pregnancy*
deduced cox'tisol binding was claiiiied by de Moor ot al 
{1966) and this appeared to confirm the report by Moyer (1963) 
xAo had found less cortisol binding and greater "free" unbound 
cortisol in 13 pre-aclamptic women compared with 3 nomial pregnant 
women ia the last trimester# Ttm other studies, however, showed
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no differoBoe batwoea end hyportenoivo prognaaoios
(fliemao and Flytm, 19641 Kapalmcia md Larits, 1970)#
Tobiom (19%9) fomd greater wiaa&y levels of
fùvmalûoJ^^éùgoniù cortieostorolde (these ioaluia matabalita© 
af dee^ jyeorMcosteromo) iu  imimu with marked aadema mad lEtk 
hypmrhonuiQm la prognmey tlmm is mmiwl jmagmmt eit'bjaets#
V'amÉBg, îEïsgar miâ Simpson (1934) eonfim^oâ th is  lu  milder 
fomia of pragûojüoy toxaemia but i i i aovaro praK^ alcsuxjels they 
foimd ImmiT velmoa* Aorotrcaid (193B) eiaimaCI no cliffaroneo 
iB cleo:^ yeortiao3toraBO exerotlen bottmon moBBotcmaivo miû 
hypartoBaiva pregaaut waman, Imt Q'SimûmvJjimi oi' h is datu ate?© 
lower urim^ ry lovela of this kosmoao im #iio hyportaaoiva graap*
ÂB far ao ia Immm, no moaauroüio:ota of %)laana deoxyoarticostoroao 
ïmvo bom made in wamm with bypertoasivo dieoaao of pragnoBoy*
Gpmmg#
âpart from plasma ranisMotivity, wliiola has produood
ooafliatMg results, te; iisaasureiHOBts of plasma 
eoBOantratioao of ranin, raaia substrata mià mgiotonsin II 
Iîlwo been reported ia women witU ig/ijerteasivo disease of 
progAaaey* In partimlar, there ia a doo.r&h of iaforiuatiGn 
about plaeii!© al&Qst>m?QRO ooneontraMcn ia this oonûition^ âlsoÿ 
xfho'£Q tlieso different eompoaents hmo been cotimatod ia 
hyportoasivo progaaat women g eompariaea with a eoatrol group 
of Bomnot#ieive prego-ont vmmii 1ms not always bom ^ satisfactory#
i
Therefore, having estahiistiGcl, at least ia part, the 
physiological changes %Aich 'take plg%>'e in tho reBin-angiotsBsia- 
aldesteroae systora during normal pregnmiey (ace Gheptors 3 end 6), 
the nest step was to osaJîîine the possible pathological role of 
tho syetem in liypertensiw tliseoso of pregnancy.
1S6.
ea«’î5ü 9
A smss m  WASîA nmm» amm-masamB* ANommsni sx
mm A&BamamB eosesam'eicas, aî© bïssïbïiB ksm'S'ïsîî
E # m w
For #ù purpoAGo of, t h i s  study® hyportonsive disoas© of 
proipiCîSîcy weo dsfinad as a rise of Mood pressura to 140/9© 
or over ÔM at least 2 aepara'fae oeeaeions after t W  24th week 
of gestatiosa ia a v lim o  h lo o û prossm’o hod hem coBoiotoBtly
3.068 them th m  heforo tho 24i!,i weak ef prognmey# fSioso Mood 
presBuro moaGuromeats %mro tetea after a 3© miimte period of 
rooiKiboBoy#
A moasaro of tho severity ©f Isyporteasivo û îsq q sq of 
pregaanoy wao tho devolopiaoBt of aigaificaat alhixiiiaiiria £b the 
lost trlmoatox" in the obooaoo of tirlnory tract iafocstioii or 
proviouB hloto&y of ronoï tract disease, Sigpifiomt eltedanria 
t?as defined as a oomcontratiom of albumin in the 'orino of at looet 
l^Q^/litvo when measured by Ssbaoh’s olbixaiwrneter or of at leeat 
©*!lg/litro wliea Kqoamrod by a tnrbldomotrio method#
I'ority and the prosenoe or obsonoe of oedeaa wore not inoladod 
in the definition#
A total of ÈI vm iùa met tho requirements of this definition 
of hyportonsiw éiùoaso of progaaucy xrith Cfestotrie
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cmà cllnieel detail© were as
Case Parity Seat? B.P, Oeteia
Mhiiîsia
J#B, 35 2+9 38 200/il0 0
M,C# 28 O'*-® 33 184/116 0
M.G# 23 o^-« % 164/120 'K' 8,0
0*0, 20 0+" 35 190/100 0#3
L.0, 17 O*-® 35 170/110 *- 8,0
S’*K 38 „+0 ss 180/120 ■f 6,0
G,L, 19 o'*-® 37 170/100 *f'5* 4,0
S.ll, 20 J.!0 39 190/106 6,0
H,S* 28 88 170/94 •H- 1,2
A.W* 33 0'*-3 28 194/110 + 2,0
A*M, 36 J+O 160/110 0 1,0
29 @'>5 34 190/120 0,4
e.B, 26 o'*-® 37 140/95 1.0
J,0* 18 o'*-® 36 140/95 't* 0.3
Iî,H. 20 0'*® 33 180/110 •H* 0,33
M.tl, 23 1-*-® '33 170/110 -î* 1*7
B,K# 26 o'*-® 39 140/100 1.8
A, Me A, 27 a'*® 38 130/90 ‘S'+ 0.33
37 0'*'® 33 170/130 0.9
23 a'*-» 33 0 0,38
E#F, 26 o'*-® 33 160/90 0,33
All wore in-patient© at the time of Mood saaplisg, being 
tre a te d  b y  Is e d -re s t w ith  o r  ir lth o u t  s ia y ta l © e d a tio n . Hone w ere
E'’e e e iv iB g  hypo tcE s ivo  te ig s  o r  d iu ro tic s *  â l l  were tà î-iing  m  
unrestricted diet* Blood samples xieve talsoa bo'Weem 8.3© end 
9*3@ a*m* after at least 30 minutes reombeucy*
From the women idtli normal blood pressure in pregiïonoy 
who have been described in Chapter 3*B, eases were taken 
retrospectively to match cm near as possible tho women ia tho 
hypertensive group* As it was not abeehuicaliy possible to 
melîG all the ostiaiatious under study in each woman, mWbers 
were found to bo too small for a comp^ mison of 2 complete 
groups where ©11 tho ostimatious had been perfoxmed in evory 
case, Thea^ efore, a matched control group was selected for 
each substance investigated, the maim aim being to have as 
close matching as possible for ago, parity and time of gestation* 
Closenoss of matching was tested by %e paired 't-test mid isi no 
instance was the difference between the 2 groups of a statistical 
sipiifictmce less thmi the level. To prevent bias, tho 
results of the estimations imder study were not ïmouu at the 
time of matching,
ComparisoB hoi^mon the 2 groups for each substance measured 
was by the paired t-teat and the Wiiooson test for pair 
differences, An attempt was also made to see vÂiothe^ the 
correlations found in norsEal pregnancy were also present in 
hypertensive disease of pre^ aaney and whether any other aignificasit 
correlations were present in this condition.
MBOgâlPM MM6BS>
Theao MVQ Wen deaei'ilsed in Gkaptea? 3#
Tkese as'e illustrated miû desea’iked for eacli sulistane© 
or group of substanoea separately, and ore followed by m  
analysis of the statistical eorre'iatioiis between suhstaaoos 
which haire heea measured eoiieurreiitly*
Plasma ^rosnit concentration#
'file Individual results for each matched pair of women are 
BhGim im fable 18, xuth data of ago, parity csic'l gestation*
Memis mid standard deviations of both groups are illustrated im 
Figure 49*
Statistical ec;i%iarison of the results from the SO matched 
pairs Was' as-foi lows s-
(/o m p ariso u F a i r e d  t * t e s t S ig u if io m io o
P
âgé 0 *0 8 0 ;> 0 ,1
ïy e s ta tiO B 1 ,9 9 7 > 0*03
Mmin - 3 ,0 5 3 < 0 *0 1
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"Blama renin ceneentration ms sigaificaaily lower in 
the women with hypertensive disease oi? pregnancy than in tho 
matched control group of nor,:#tensive pregnant womon, both by 
the pairefl t-test''(above') and tho l'/ilco3ron test for pair 
differences (3> <'|î,ül/,.■•. , However| all hut 4 of the results 
were above tb.e normal : non-p.regnant range*
}71amm rGBin-suhstrat-e - concentration*« o* s .\*ffvWi
ïliG individual results for oadi matched pair of wcmen ere 
shotm in I'aMe IB» with data of t%ge$ parity mü gestation*
Means miü standard deviations of both groups are illustrated in 
Figure 5Û*
Statistical comparison of the results from 18 matched pairs 
was as follows?-
Comparison ' Paired t-test Significûîicc
P
iige 1*857 > 0*1
Gestation ' . - . 0.145 . . > 0*1
Iïenin-Sdbst5?ate " 8*556 0*02
A significantly lower plasma renin substrate concentration 
was found 'hi the hyperteissive coiuparsd to the norsîoteasive 
px’egüsKt Tmmen, both by the paired t-test above and by the 
Wilcoxon test for pair differences (p < 0,01)* In all except 
2 womcs^ s howeverj the plasma substrate levels \mre above those 
for normal sion-pregnsnt women.
13:,
Plasma ejagiotQBOin II concentration#
It t/ao poasiblQ to satisfactorily match=only B pairs of 
women ia whom plamm aagiotoaisia II concGatratioa was moasurad.
1?he individual results for each matched pair are shown ia 
Table 2©^  with data of ago, parity aïiâ gestation* Moans and 
standard deviations of the two groups are illustrated in Figure 51, 
Statistical comparison of the results from the 3 matched 
pairs was as follows#-
Comparison t-statistic Significance
P
âge 1*698 > ©*1
Gestation 0*579 > ©*1
ângiotenoiïi II -2*598 < 0.05
3m the women T/i#: hypertemaivo disease of pregEmicy, 
plasma asigiotoBsisi II oomcemtratioms were within the normal 
mom-progaoat range ia ovary casa studied, and wore sigaificemtly 
lower than the levels found ia normal progaosat woman, both by 
tho paired 't-test (above) asid by the Hilcoson tost - for pair 
difforeaees (p < ©.(
Plasma aldosteroae coacoatratioB»
The individual results for each matched pair are shown 
ia Table 21, with data for age, parity and gostatioa* Meoas 
and standard deviations of both groups éiro illustrated in Figure 52 0
PLASMA 
ANGIOTENSIN I I  
CONCENTRATION 
pg/ml 
225
150-
75-
0-J NORMAL HYPERTENSION
+
ALBUMINURIA
Plasma angiotosisla Xï conoeîi fcration 
±n hypertsjEisiv© disease of pregimney,
PLASMA
ALDOSTERONE CONCENTRATION 
mwg/lOOmI
225
150-
7 5 -
0-"
T 
I
l
NORMAL HYPERTENSION
+
ALBUMINURIA
Plasma aidpatarons concentration 
In hyî>ortonsivo disease o t  pregnancy#
Statistical comparismi of tho results faraia the 12 matched 
pairs was as follows#-
Comparison Paired t-test ■' Significasico 
P
Ago 2*105 > 0*05
Gestation 1*887 > 0*05
Aldosterone -1*667 > 0*1
Those womea were loss satisfactorily matched for ego end 
gestation than for tlâo other estimations, but tSiese wore tho 
best matches posaihlG among the cases whore plasma eldeotorosie 
cosacontration had been measured* Although tîie paired 't-teat 
X'/as mot significant at the XBp level, the Hilèoson tost for 
pair differences was significant at the 5/^ level (p < 0*05)# 
Seven of the %-jmmi wi# hypertensive disease of progmmcy 
had plasma coBeentratioBB of aldosterone above the noi^ nal 
sion-pregsiaat muge, hut the mean ^ ms considerahly loimr than 
that of the normal pregnant immoa*
Plaaaa aoostycorfcicogiiegTOeJjMLAom^iteatig.
To date only one estimation of plasma doo:%ycorticosterone 
concentration has been made in a woman with hypertensive 
disease of pregnancy, This result was within the normal 
pregnasit range for the last trimester (l6,0 ng/loo ml).
P&aema aoclii^  miâ potasaim cono©Etgatâoiia aa^  osmolality#
B ie  i M l v i d i i a l  i? asB lts  f o r  oec li m a to M d  p a i r  o f  %romea a ro  
8hmm ia 'faliloa S3 to 3%, t;ith data of G^ o, parity aad gestation, 
Mqcmb and standard deviatioaa of both groups asi’G illustrated im 
Mgure 55»
Statistical comperisous of the résulta Tfore as follows3™ 
Flassoa sodium ooaoeutratioB {u s 14)
Gomparisou Paired t~test SigmifiooacQ
P
1*395 z 0.1
©GStatioB 0.354 > 0*1
SO®™ +0*954 ^ 0.1
Plasma potassium ooucoBtratioa (m w 15)
CompariBoa Paired t-teot Siguifieauoc
F
1.417 > 0*1
Gestation 0*163 >  0.1
Fomss™ +1*906 0*05<p<0*l
Plasm a o s a ïo la l i t y  (sa «  9 )
■ Comparison Paired t#"test SignifieaucG
P
% G 9.135 > 0*03
Gestation 1.000 > 0.1
ommM&ETi +9.918 < 0.09
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Plaoais. Goiiîîiii mm met B&gmif&cm&tly
different in #e liyperteseivo eompared to t&e siessaoteaei'^ re 
greap) either by paired t-toGt (aWve) or by the W&loonoa 
test for pair difforeaees I&et of the results
were in the aoraal pregaoat rmgep that is# lower then values 
fo'tmd 1e normal moa*«pre^mnt weaem,
Mae of the 15 hypertensive woaea Bhm'mü plasaa
potassium eeaeontrctio iiG  tliasi the  aormotemsivo vm oii and the 
mean was hi#erg W t  t h i s ' difference did not raaek statistical 
8&g#ifieaaoG a t the 5^ le v e l$ e ith e r by the  p a ire d  i- t e s t  m  
by the Mle©3roB to s t fo r  p a ir  d iffe re n ce s* Moat o f # e  re s u lts  
were in  the  Bosieal noii«-pregssgmt rasigo*
Plasma osmolality $ however, did show a statistical difference 
between the 9 groups by paired "t»to8t (above). fhie was 
oonfimaed.by the ¥ileezea test for pair difforomoos (p< 0#Ol)*. 
All 9 wenioB with hypertensive disease of pregBaney showed higher 
plasma osmolality thorn the morisal pregnant women ^ W t  their 
levels were still \mll Wthim the nesmal s^ oa^ preipiant range.
Blood iiVQQ, gild Boru^)} oreatimime omapemtratioms aaaci ogeatinine 
eloaraace.
'Ihe individual results for each matched pair of t-;os.m are 
shei'ss in tables 85 to S’fo with data of age, parity and gestation* 
Moana and standard deviations are illustrated im Figaro fS#
GGmpor&Goao of tba roBü&to woro as followug™ 
&& # &&)
Pair# Wtost Si£^ iiS:iefttioe
Ago 8.018 ©,6S
Gestation 0.0G8 > 0,a
m m '20,69? < e.ssj.
(s. S3 B)
€(%5pariGsa Paa6’«6! W'leat Bifiniiiom 'mQ
..... i>
% o i,C-^B (%,(%?
Goototicm 0,313 ^ O.i
■us,rm < e*#5
Cemparisosi IWred W x m t %%#ifieau8e
..p. ...
% 0 >  G.l
©oBtatiem 1*580 .......
G2%3üÜg, oa,aA32, ;> 3t,&
Mood ixpoQr (mi o%?ootWlao ooaomiWAt&om tfoz%3
signif&omtly w&th byportomivo dimaoo of
gwo^amoy tbm isa aomoi% tfoswxa# SS%&8 tms œnfimod
b%r 3&ao (f&&€K&%%wa ibocyt <&&3f &%%&%? (k&f%&3&%sB#G0 (and
rovspeotivolyl* Ml Mi& rooultsg lio'wovoa*® worn i/:ltë:m ttm mmal
mOrGstiniiiQ clecÆmco allowed m  sigsiifieant differonce 
by either teetg s wido mmge of vaiuoB being fomiû# m  m  the 
Moraicl pregraeBt
ürmo Godium# potasaimm m d  oeatripl e%cretiom#
III© individual ro m itB  for eaoh matched pair of %-maou are 
Bh&m in fables 88 te 3B# with data of age^  parity mid goatatiOB* 
Statistleai omiparlGme of the roenlta were as follows:##
feüie sodium smdpptaseimi ezierotimi ' (m ks 8)
OoHaparioom Faired t^ test Bigmifioamee
P
âge 1*705 > 0.1
Gestatiom 1.580 > 0.1
m m a  s m m i +0.69B <> 0#1
m m E  FOfMsmi +0.545 > 0.1
Urisio oestrioi eatoretion (a « 7|
Ornuperisom Faired 't-teet Si^iificamco
1?
Age 1.306 • > 0.1
Gestation ■i*o6e > 0,1 •
OESfEm +0.009 > 0.1
fhe urinaiy es:crotioa, of sodiim, potaseimï and ©Gsiriol 
8ho%mê me sic^ifiemt iiffereace isi iiypertemsiw oemparod to 
mermetemsive pregmamt woiaem, whether by üio paired *l>-te8t or 
t/ileosmi test for pair differemoes#-
13?,
fable 51 illustrates the correletien eoofficients be‘tt7een 
substances measured coaeurreatly in wemem mth hypertmisive 
disease m2 pregasmey*
Positive correlationst statistieally significant at the 3f  ^
levels were foimd beWeem:"*
plasma renin snhstrate mü as'sgiotensiB II (Pi^^ wo 55)
and at the 10jS level botween;*#
l>laÊTiiîa renin substrate and aldosterone 
plasma ronim and plasma sodium
A negative correlation statistically si^ifleant; at the 
^  level was found betweens#*
plasma renin suhstmte and soraiiï creatinine (Figure 56)
and at the 10^ level botweoEi-###
plasma aldosterone and creatinine clearomce*
PLASMA 
ANGIOTENSIN il 
CONCENTRATION 
pg/ ml
r = +0 76
p< 0 02
15-
0 20 4*0
fonin eubatrato 
- angiotensin X I  
rolatioriship in 
hypor tensive disease 
of pregnancy*
PLASMA RENIN-SUBSTRATE CONCENTRATION ( uM}
PLASMA
RENIN-SUBSTRATE
CONCENTRATION
Mm
5 0
X^Xasma ronin«rsubotrate
sezrnia croatlnino
relationship in 
hypertensive disease 
of pregnancy#
3 0 -
1*0 -
r= 0  71
p < 0 0 1
0-5 1-0 1-5
SERUM CREATININE CONCENTRATION
(mg/lOOmI )
3a tîsis ©heptes-h the oheagee in  each sahstauce descj^ ihed 
:1b Ohaptor 9 will be evaluated idtli rofemice te the results 
previously p^ ablishocl for hypertensive disease of pregaieney 
smd will be compared witli those found in normal pregamt tmmm# 
The sigàiifioancô of the différences found betimea Bormoteasivo 
a M  hypertensive prognmey t^ ill then bo dieenssedj mth a 
critical assessment of the postulated role of the renin*- 
^iegiotensin-aldosteroae syst®! in the pathogenesis of 
hypertensive disease of pregnancy*
io*A.
BISaSB OP PEKiîWCÏ,fwc»=*&#c'3a}*ïTm%#!iWwi;*:.ïmcK:L#6oRv,air;
Plasma renim eoncentratioB,mwta&ig:r*a# a >—ft»» i*-Mjr èi¥ t r n i i i i #*##' i»i s\
The significant réduction ia 3>lasma renin coneeatratioa in  
women with late j^rogasjiey hypertension and albuminuria compared 
to normal pregmmt vfomon (Figure 4'9) is in agreement with the 
results pro#ously roported using a similar method (see Chapter 8) 
There was* however* a Gonsiderablo overlap beWerni the two groups* 
The range im the SO normal pregnant women appeared to be 
representative of that foimd iu 3? uomal woTaen. analysed in the 
last trimester in the larger study of normal preguoBcy (Figure 
the memm being 33*4 uuits/l (S*B* - 12. o) and 43*8 units/i 
(S*B* « 17*3) respectively*
139*
Bmmi mid îiis eolîeagiîes (I966d) dGîaoBstotod very high plasiaa 
concentrations of m d n  in eases of rhesus isoiïMuniaatioïa 
of hycletidiform moie complicated by hypertension# No such 
case îiecÊffiiâ evailahlo for analysis during the time of the 
present study# E&nfevor* im one caso of hydatidifortu mole 
mû one of choriocarcinmm* both i=mmen being normotensive* 
plasma renin concentmtions were 21.1 units/l and 23.4 miits/l 
respectively* Also# 12 aormotensive women with rhesus 
isoiKïiîuniaation had circulating renin levels in the last trimester 
ranging from 13.6 to 32.9 units/l (mean is 38.1# t ll.l)* These 
results are very sWlar to those found in noxmal pregnancy 
(Figure lo).
Plasma renia->*attbstratG cmccmtratioa.
The plasma concentrations of reaia--substratG in wmen with 
hyporteasioa in pregnancy have been shown in previous reports 
to be siîîîilar to those of norsüal proguont women (see Chapter 8).
The presence or absence of proteinuria was not mentioned in thoae 
cases, but it is interesting that# of 2 cases with ocla^ npsie# 
one had plasma renin substrate levels much lower than the normal 
pregnant rangé (llelmer mû Judson# 196?) * In the present study, 
significantly Iwer plasma, renin substrate concentrations were 
found in the hypertensive compared to the nomotensive pregaont 
women (Figure 3û)* The distinction between these results and 
those previously reported may be due to the fa©t that albuminuria 
was present in all the liypertonsive studied here# As with
plasma renin concentration# there was a mde overlap t/ith the 
nomml pregaant subjects, had values similm* to those in the
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larger normal third trimester group tleserihed earlier (Figure 14)# 
the meaie of these 2 moimal groups being 3.73 «51 (s.B. - 1.32) 
m d  3*98 tîM (S.lî. ^ 1,07) j respectively.
Plasma aa|giotensiu II coBceBtratiou*
All 3 hypertensive pregnant women reported hj Hassaud 
Î2IÎCI her colleagues (I967) had hlood angiotensin' levels witîsin 
the range found in 9 normal pregnant women at the same stage of 
gestation. of the hypertensive oases had proteinuria
greater than a trace. As mentioned in Chapter 4.A, those 
results may have been influenced hy teolsiioal factors in the 
method employed.
Isî thé present study of 8 cases of hypertensiom with 
allîuî5iim.uria in late pregrianoy* a wide disparity was present 
when the plasma angiotensin II legols were compared to tliose 
iQimd in 8 normal pregnant women in the last trimester. In 
every hypertensive woman except one, circulating levels of 
aiigiotenain fl were lower th&M in #e mmal women, and all were 
within normal non-pregnaîit limits (Figure 31 ). The 8 normal 
progumit controls had values within the range found for 33 normal 
women in the last trimester (Figure 18) the means being 78.2 pg/ml 
(S.lï. ^ 67.4) and 88.2 pg/ml (S.l># « 8^ 7*1) respectively.
Plasma aldosterone coBcentration.■wiiir I .n 1 !■ 1. ■ I ,  --- — ----1-'-"-"—^ 1—r irrmmm II
Compared to the other components of the renin-migiotensiE** 
aldosterone system which have been measured, plasma aldosterone 
concentration has stem adoss marked distinction between 
hypertensive and noraiCftensive pregnant wooim. Although the
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moms for the hypertensive greup was eoBsiderahly lower thm for 
the mortal pregKwnt group, the latter conld be influeaoed by 
me very high result (Figure 32), eaci this result apart, many 
of iiiQ values overlapped one another* However, this oao high 
reading in the normal group oould also he affeoting the t-test, 
and when the matched pair imclading this result was withilraivn 
from the statistical analysis, the paired t«test became 
aigiûlicmit at the 3^  level (t a 2.331)* That plasma aldosterone 
eoiieeratration is lower in the hypertensive women is also suggested 
hy the slgaificont cUffereuce obtained for ’all the pairs by the 
Wilcozon test for pair differences. The mean for the normal 
group was very similar tu that for the rather larger number of normal 
women in the third trimester reported earlier (Figure 22), hut a 
very wide scatter of results was present in both (mems 30*9 
mg/lOO sal, S.B, - S4.7 an& 31,7 mtig/lOO ml, S.B. - kO.3 
I'sspsc-ti-irely).
Apart from one very high value im eclampsia mentioned in 
a brief paper by Stark (l@67), as far as is Immm, there has horn 
no ether previous report of pla#3ia aldosterone concentration in 
hypertoBBive disease of pregnancy. However, the lower 
circulating levels found in the hypertensive women in the present 
study are in agreement with the seoretion rate studies previously 
dosorihed (see Chapter O).
Plasma 11
milj one women T;ith hypertensive disease of pregnancy has 
80 far been studied in our laboratory, and as far as is kaoim, 
no other reports of plasma ll-^ dooziyGortioostorone concentration
have heon published* This one case had levels within the 
normal pregnant range for the last trimester*
Plasma sediimi and potassium concentration and osaiololity.
Three previous reports (Diec&maim mid Pottingor, 19S6§
Johnson g Me^ aughey and Thornton, 1961; luster, 1962) 
deraonstratecl no difference in serum or plasma sodinm concentrations 
between women with normal and women with raised blood pressure 
in the last trimester* The results of the present study have 
confirmed this (Figm’ê 53), the plasma sodium levels in both 
groups being lower than the no ratal 5ion**pregnant raaige*
MacS-lllivray {1967)- reported a mean serum sodiiiu of 136*3 m%/l 
i l l pre-*ecla«iptic patients hnt did not give figures for normal 
pregnon.ey*
Plasma potassium concentration was generally higher in 
the hypertensive compared to the normatensive t/omen, mid most 
of the results were in the nomial non-pregnant range (Figure 53)* 
Although this difference was only significant at the level# 
the hitler plasma tjotassiiBii concentrations are in agreement with 
the findings of Lister (1962) 1A0 had carried out metabolic studies 
in Cl small number of women*
As far as is Mmmi, measurements of plasma osmolality have 
not previously been reported in hypertensive disease of pregnancy# 
The results of the- present study have showi a significantly higher 
mean plasma osmolality iu  this condition when compared to noa'mal 
pregnant women (Figure 3 3)* However# the values In both groups 
■to'ere id.thin the noFiKal xion-pregEont range*
i43.
Blood œ ’Qa and sexnau croatiniao ooaoeati’atioa and cfeatinineW3BtBàm9Mm\ mt4 m ^
clearance
As diseiissccl ia Chapter 6.A, the increasG in clearance by 
tlie kidney during normal pregnancy is associated with reduced 
circulating levels of nwea and creatinine (Figure 2S).
Glomerular filtration rate is inereaaod to a lessor oKtGiit 
in women with hypertension in pregnancy (G hesiay m id Baffns#
19?i) and the correspondingly smaller increase in urea and 
creatinine olecranoe would be ojqieeted to result in higher 
blood levels of those sahstances than in normal pregnancy.
The higher blood levels have been confirmed by the results 
of the present study (Figure 3!4), but the difference in 
creatinine clearance between nomotejisiva and hypertensive 
women was not significant, this being in accord with Klopper’s 
failure to find a difference in croatinino excretion (1964).
All the cases of hypertensive disease of pregaanoy had blood 
urea and serum creatinine concentrations idthin the iiOBnsl 
non-pregnaiiit ivmge.
Urinary sodium and potassium excretion*
In the present study, no difference in sodivBU or potassium 
excretion was found in the Siypertsnsive compgired to the normoteneive 
pregnant vm m  (Tables 28 and 29). As the electrolytes were 
measured in. urine collected for 24 hours, a distinction between 
the 2 groups may have been affected by differences in posture, the 
hypertensive women being subjected to more bed rest than their more 
ambulant normal cowiterparts. Klopper (1964) found that sodium 
exoreticn was less in hypertensive than in normotensive pregnant 
women when in the semi-recumbent position, but obtained no difference 
T/hon the women wore lying on their sides*
1 # .
Thé data presented here are inadequate te detosrmiue wliothes? 
sodlma retention does or does not occur to a greater estent in 
hypertensive disease of pregueacy than in uonaal pregnancy*
Studios of total exchaugeahie sodim are more likely to give 
cm answer, hut there is a considerable conflict of evidence 
from these# ClliGsley ( 1966b) in particular favouring increased 
sodium retention, while lîacGiilivray (1961 and 1967) considers 
that the severe pre-eelastptio patient lâthout oedesaa has a similar 
of sodium as a non^ ml pregnant woiîïaa*
excretion#
The urinary excretion of oestriol is widely used as an 
index ©f adequate foeto-placeatal function, althou^ i its 
interpretation iïmst he treated with some caution (so© Hytten 
and Witch, 1971)* In the present study, women mth hyportensiom 
and elhumiauria in late preguEmcy had urinary oeatriol levels 
similar to nomial pregnant wromen at the same stag© of gestation# 
This is in accord with the results desorihed fey Samaon and 
his colleagues (1969), hut at variance with those of another 
study (Sfeye, Scott, Oakey and Stitch, 1969) which showed a 
correlation between subnormal levels of urinary oestriol and 
the degree of albimiiimria In pre-eclanptic wcmon*
lo.B. Emm# Emm-smsTmTB# mGiormsm ii m) ALDoarmom
HSIATX0M8ÏIÏPS m  MipmemsiVE bismsk of pmmmGi*
The only positive correlation to emerge wiilcli was sigaifiaant 
at tlîo 30 level was the relatiems3aip between the plasms 
eoBoentratioBs of renxa-suhstrate aad of angiotensin II* M  
the study of nermal px'egaaaey# a similar relationship had been 
observed ia the first trimester (Figure 3l)# but# for uaoxplaimod 
reasons, not subsequently* â less significant corx'elation at 
the 100 level# was however present post-partu« in those aor»aal 
oases* As discussed in Chapter 6*B, this association between 
'tïie circulating levels of renin-substrate and angiotensin II is 
in agreement with the theoretical aspects of the renin #. renin- 
substrate rcaction#
Like normal pregnmioy# the plasma levels of renin did not 
coî*rel.ate with the circulating levels of angiotensin II* Thus 
the patters^  established in normal pregnant women seems to be seen 
also in women with hypertension lu pregumoy* That is# it seems 
likely that the plasma concentrations of migiotensin II are being 
gonerated by -^ e aBouut of available substrate rather than by 
the coiseentratlon of the enayue renin*
The possibility has been disciisaed earlier (see Chapter 
6*B) that the renin being measured in the plasaa-of noTüiaï 
pregnant woraesï might contain a proportion of physiologically 
inactive '^chorionic renin”, and that this might explaiai the 
lack of relationship witli plasma axîgiotensin II concentration.
This may also apply to women with pregnasicy h^ pex’tensioa. As
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for as is mo laeiisuromeais of renim in chorion or Gnaiion
have been reported in oases of hypertensive disease of pregnancy* 
Although the correlation between the plasma coneentration 
of renin-substi’ate and aldosterone was positive only at the 100 
sigsiifici-mee level in thé Iq^ pertensivo cases# this is in accord 
with the more signifieosrt relationship) deraonsti*atecl in normal 
pregnancy (Figure 3^ )* Once again, this give© rise to the 
pnssle &B to why renin substrate is related to both angiotensin T, 
Qiîcl aldosterone in the plasma, yet these two substances have not 
shown a correlation# A speculative esp)laaatloB for this has 
been given in Chapter 6*B and this comld also be applicable 
to pregnomoy hypertension,
The plasma conceatratioBs of renin and aldosterone 
correlated only in the first trimester of nomai pregnancy 
(Figure 3ô) but not subsequently* It is not surprising, 
therefore j, that no relationship has been found in women with 
hype.rt0nsioa in late pregnancy*
In view of the low level of significance, it is tempting 
to consider the possible association between plasma renin and 
plasma sodium conoontration in hypertensive disease of 
pregnancy as spurious# It is imteresting to note, however, 
that this was a positive relationship, lAich is uuoxpeeted isi 
view of es|>3riencô in non-pregnant situations (see Ghapter 8), 
This might be regarded as a further indication, albeit rather 
tenuous, that the remln-migiotensin-aldosterone system is\ the
prime mover in the control of sodium balance, rather than that 
sodlmi depletion is the initial stimulus to aldosterone secretion,
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fact that tiio eirculaiisg levels of the oomponeata of 
the ©ystem are all lower than in normal pregnancy# could 
then indirectly suggest that sodium retention may he less in 
*6130 l3ypertensi*ve women than in normal tmmoai, thus aggravating 
even further the existing controversy about sodium balance in 
pre—eclaîiipsia*
Mo adequate exjüasîatioîx is available as to why the 
îïypQrtensivo cases did not show *lihe relationships between the 
plasma concentrations of aldosterone and ©odium and botween 
plasma angiotensin II conoentration mid osmolality found in 
normal pregnancy (Figures 36, 37 and 35).
The negative correlation between the plasma renin 
substrate and serum creatinine concentrations raises tlie 
possibility that the kidney may be affecting the amount of 
circulating substrate* Bilateral neplirectomy say lead to 
eh increase of circulating renin-substrate in some situations 
and a decrease in other© (see Broim et al, I97&X This 
variable effect of changes in renal function may also be 
seen in prepiancy* VJhilo an increase in creatimne clearance 
was associated with a iox^ ered serum cAatinine and a decrease 
in plasma renisi-substrato concentration in normal pregnmit 
women, a lowered soruat creatinine was accompanied by an increase 
;m plasma x*eain-substrate levels in hypertensive pregnancy*
The explanation for these opposite effects is not knom*
m10* c m m  PosBimng of tiïb
sysrm m  m  PATHoomssis of mpiamsiVE m s m m a  
  . OF pmmmcy*
la view of the abrupt onset of marked hypertension in some 
women in late pregmmcy end the dramatio foil to noaiml levels 
after delivery of tlie plocento, tlie possible secretion of a 
l>otcnt circulating pressor agent bas been postulated on many 
occasions*
Perhaps the coanoaesi and most longstmidiag tlieory to 
explain the changes in toxaemia of pregsiancy has been that of 
utertee and placental ischacjsiia (Young, 1914g Bober, 1929;
Page# 1939; von Bowwdijkj Bastiaaase, 1934)* ISeduced uterine 
blood flow has been demonstrated by Assail miû Morris (1964) 
and reduction in botia chorio<*deciduai and myométrial blood 
flow by Dixon# Browne end Davoy (1963)* These functional 
ehaiigos are consistmt with tiie pathological changes of infarcts, 
haematomas# proliferative endarteritis and degeneration %-Mch 
are found more frequently in hypertensive than in normotensive 
pregntmcics (Dixon and Dobortsoa# 1938; Brosens, 1964;
%lvatore, 1968)*
Several reports have shorn that interference witîî the 
placental circulation in animals can result in on elevation of 
blood pressure which doe# not appear to be dependent upon intact 
kidîîeys (Ogden, Bildobraad and Page, 1940; C^ ongydssy and 
Kelentey, 1938; Kumar, 1962; Borgor and Gavanogh, 1963; 
lodori, 1969)* Sophian (1953) and Franklin and Winston® (1933)
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îievc elaSaîied that stretcliiîig of the uterine mmcto could result 
in a "utero-renal reflex** with renal cortical ischaemia and 
suhsequeBt release of renin* Joffcoate (1966) however, 
considered this üieory to he unlikely and pointed out tliat 
simple hydramnios was not usually associated with hypertension.
More aceoptahle is tlie theory of pressor release following 
placental ischaemia. In rabbits a circulating pressor 
substance has been demonstrated following reduction of tîie 
placental circulation (Berger and Boucek, 1964)* In women 
with pro-GClauipsia Hunter and Howard (196I) found e'fpressor 
material in amniotic fluid while Ttxivm and (1962) showed 
a slight rise in blood pressure on re^ infusing after delivery 
blood drawn from womesi with hypertension in late pregiiancy* 
Neither of those studies# however# showed adequate comparison 
mth noimal pregnancy* Nevertheless it did seeia possible tîiat 
the renin-like substance found in the foeto-plucental unit in 
norsiîal pregnancy (see Chapter 6*B) might be present in greater 
quantities in the circulation of women with hypertmsivo disease 
of pre#iancy*
An increase in the circulating levels of migiotensin or 
of another pressor material is therefore an attractive iiypothesis# 
whether due to placental or renal ischaemia or to other factors*
It has been shorn conclusively by the present study# hwever# 
that j>lasma angiotensin II concentrations are not increased in 
hypertensive disease of pregnancy* On the contrary# all tJio 
hypertensive cases studied had levels within the normal non- 
pî?ogî3ant range# xdioreas most nomal pregnant women had
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considerably elevated levels (Figure gi). Plasma eoucoutrations 
of renie# ronin-subsirate end aldosterone have also been shown to 
be significantly lower in hypertensive disease of pregnancy than 
ill normal pregnancy (Figures 49 y 30 and 32)#
The lower pla#ia angiotensin II concentration in pregnancy 
îiyperteneion does not necessarily ic^ ly tîiat it is incapable 
of affecting blood pressure* In states of sodtoi excess the 
pressor effect of angiotensin II is eidnmced (see Broiai et al, 
1971a). If, then, ïiypcrtensive disease of pregnancy is a 
condition in which excessive sodium retention occurs, the lower 
circulating levels of angiotensin II might he having a greater 
effect OB blood pressure than the higher levels found in normal 
pregnancy* As has been discussed earlier in this chapter, 
however, the existence of greater aodim retesition in hypertensive 
progncuit -mnen is a matter of controversy* Also, in the present 
study no direct relationship was found between the changes in 
plasma angiotensin II concentration and the changes in blood 
pressure (Table 31)*
As pressor miinoB have likewise been shown not to be 
increased in hypertensive disease of pregnancy (Dickering,
1963), the long-postulated existence of a circulatlîig humoral 
pressor agent reimins as elusive as ever#
Ob the basis of tine raised pressure, oedema end possible 
sodium retention in pre-eclasiipsia, a number of reports have 
speculated on the role of the mineraloeorticoid aldosterone in 
this condition. Bseretion and secretion data, however, have 
demonstrated lower rates in hypertensive than in normal pregE&ont 
women (see Chapter 3)* In spite of the secretion rate results,
m .
it seemed possible that pregnancy hypertension might be asoooiated 
TTith impaired metabolic clearance of aldosterone with alterations 
in the circulating levels of the hormone# ' No abnormality of 
metabolic clearance has been fomid in normal pregnant ^ mmon 
(Tait et el# 1962) but# as far as is known# cleereaco studies 
ia hypertenaive disease of pregnancy have not been reported.
The present study has now showi that the plasma concentrations 
of aldosterone arc not hi#i©r in hypertensive than in 
norm©tensive pregnant wmaen (Figure 32). In fact# like the 
other exponents of the reiiia-angiotensin system# the levels 
in the hypertensive patients were lower than in novmal prejpiaucy# 
altliough this was less loorked in the case of aldosterone#
Sims (1963) was unable to demonstrate any change ia 
adrenaline intkiced contractility of rabbit aorta s#hen aldosterone 
ia physiological concentration was added to the media* He tlius 
failed to confirai the theory that women with pre4#eolampsia had 
an increased sensitivity to pressor agents due to the action of 
aldosterone on tSxo arterial wall#
If the circulating levels of aldosterone are not greater in 
hypertensive disease of pregnancy# could there bo an oncess of 
other mineralocortiooids? Tills bad been shorn previously 
not to be the cose for pluama cortisol concentration (see 
Cîiapter 8) and the present results have shown no evidence of 
greater plasma concentrations of corticostoroao in t^jo wcmicn 
or of ll-deo:^ €orticastcroao in one women with this condition#
, Sorrobin and Lloyd (1970) have suggested that progesterone 
could cause all the facets of pre-eclmipsia* 3h general# however# 
progosterosïQ secretion has been found to be normal or Im;
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in prepumcy hypertension (Etom and Short# i960} JlaoNaa^ toa#
1967? Elopper# 3.969)* Oestrogen secretion also is usually 
BOBiiai or low ia this condition (Hoy# ïlarîmesa sad Kerr# I9635 
5!aoHaugbton# lp67; Haoktigoll# Bassett# Bogsaader and Levits#
1968; mopper# 19%).
Decreased production of oestrogen %ad progesteroa© may 
possibly be a reflection of impaired placental function ia women 
ifith liypertsaeive disease of pregneacy. The fact that the 
plasma concentrations of renin# renin^ suhstrate# angiotensin II 
mâ aldosterone are also reduced is suggestive that they too may he 
influenced by placental function* On the other hand# it is also 
possible that they are being suppressed by m  excess of 
circulating mineraloeorticoid tdiich has yet to be identified*
Oa tlm basis of this study# the renin^igiotansin-aldosterone 
system does not appear to be a major factor in the pathogenesis 
of this still Mysterious and sometimes lethal affliction*
133.
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The difference between the toxms renin«»actiirity end roain 
concentration Siovo been diecnseod in Chapter 3# 'Wiere the 
advantage of 'measuring the coneentrationeef renin in the 
plasma was emphasised#
Plamm renia-activity ie raised in tîie majority of women 
taking oeatregea-progestogen oral contraceptive© (Netrfcoa et 
al, 19661 Crone end lîarris# 1969# Weinberger, Collins# DoWy,
Mokes end Lcutscher# 1969| Somta, Saado and Kaplan, 1970|
Croao, Harris end Wineor, 1971$ Cain, Walters and Catt, 1971)#
In contrast, Skinner and his colleogaes (1969) found the plasma 
renin concentration to be reduced in 6 and unchanged in 2 vmim 
during the first oontli of oestrogon-progestogen therapy* This 
disparity between renia activity mid coaeentratioB was aabsequently 
confirmed ia 2 other studies, no sigaificaat change in plasma renisa 
concentration having occurred in 31 women t/Iio had talvca oestrogen- 
progestogen oral contraceptives for up to 30 weeks (goruta et al, 
197c) I Tdiile a mean fall to 320 of the control value ooeurred 
during treatment in 13 women studied by Cedii and Ms assooiateo 
(1971).
The women in those studies rmoincd nomotensivo tlirou^ iout, 
but Saruta and his colleagues reported in the scsdg paper a further
11 00808 ia a arise ia blood preesare occurred wMlo taliiug 
m  oral coniracoptive* %  those twmm, plasim roain coucoutratiou 
increased from a momi of 6.8 uuits/^ 1 to 9*1 uuite/rsd after 14 
veoks* the difference between the nomotmsivo and ÎjyperteBsive 
group being statistically significant at this tiiaOj although 
it was not significant after 18 to 30 weeks*
Plasma reuin^ -substrate conoentratlou#
■ A  number ‘of reports have shown that plasmm renin substrate 
concentration is consistently raised' in women taking oestrogen- 
progestogen oral contraceptives a-
Authors ' - Horiiial range '
On Oral 
Omutraceptives
Duration of Oral 
Contraceptives
Helmer and dudson 
, , , (1967) 
{ng/ml)
Mean »■ 423 742 # 2240 
mean I6l7 . 
(n « 7)
Not given
Skinner et ol 0.9 ~ 8,0 2.3 ^  % 3
(n sa B} '
4 days- 3 %'%eks
■Saruta ot a l .
, , , (1970)
. (ng/ml) , ,
Moon « 1048 
S*B* t 263
, Mean. « 2539 
8.D* i  416 
Mean = 2886 ‘ ' 
S*D* t 390 ■ 
(% -  91)
,, 2 weeks 
13 -  30 weeks
Cain et al ' ' ■ 
(1971)
(ug/ml )' '- ' '
■ 1*0 -  3*0 
(approximate -  
' read from graph)
2*5 V 11*0 
(approximate -  
road from graph) 
(n « 3.3)
3 •* 12 weeks
ÏÎ1Ç results quoted by Helmer and Judson are lower than the 
others for both users and nosiHisors of oral contraceptives, but
JL57,
UiQ degree of inoreaBo ia siiailar in all 4 series* Sieinuer 
md Ms colleagues fomd tlie maximum effect to be fs*om 4 days 
to 2 weeks after starting the oral contraceptives* d^iile normal 
results were obtained 2 to 4 weeks after stopping troatnîent*
M  the larger and longer study by Seruta and his coworkers*
5 of the 91 women had initially high blood pressures miieh wore 
not affected by the oral contraceptives*
Three other reports (Mewtoa et al* 1968; Veinberger ot 
al* 1969; Orane et al* 1971) also showed marked increases in 
plasma renin substrate concentration but can be criticised on 
the grounds that all the sneasuremontB were made on hypertensive 
wmen with no noxtaoiensive controls. I&^ wever, 11 women tdio 
developed a raised blood pressure while talcing oral contraceptives 
(Saruta et al* 1970) showed greater increases in plasma renin 
substrate concentration (îSSeon s» 2850 ng/sil* 8,D# - 521 j at 
2 'moks and 5590 ng/ml* 8#D* $ 6l6 between IS and 50 weeks) 
compared to the 51 normotensive women already described* âB 
with the plasma renin concentration * there was a statistically 
significant difference in the early weeks after starting oral 
contraceptives* but not beyond 14 weeks*
Blood angiotensin concentration
Im a study of blood angiotensin II concentrations in nomml 
and hypertensive subjeets (Catt* 2:Wmet* Cain, Cr^ m, Best and 
Coghlan, 1971) the angiotensin II levels in nomnoteasive women 
receiving oral contraceptives were found to be elevated to 5 esid 4 
times tlio normal value* This was subsequently confirmed in a more 
detailed study (Cain et al* 1971) in which the plasma angiotensin II
%58.
concentrations in 3 wmien rose from between 3*5 end 4.3 n g /im  ml 
before, to e mean of 12.5 ng/il30 mi (8*D, i 2*7) 3 doys after 
starting treatment* Ten days after the oral contraceptive 
was witlidram, the levels had returned to tlie normal range#
During more prolonged treatment in 10 %#mm, tlie some autîîors 
found a mean concentration of 8.3 ng/lOO ml (S.D* t 2.9) at 
the end of the first end second cycles compared to a pre#treaimcnt 
moan of 2*7 ng/l90 ml (S.D* ^ l.O), the blood angiotensin II levels 
falling to normal within one moatli of stopping tlie oral 
contraceptive* Kfo difference was demonstrated between the 
effects of Ovnlen (eil^odiol diacoiato 1*0 mg; cthinyloestradiol 
O.CS mg) and lyadiol (lynestrenol 2*3 mg; Mbatranol 0*073 uig).
In contrast, a preliminary report from our laboratory showed 
a variable roSi«mse in 2 immm giv^ oral contraceptives, one 
showing a rise mà one a fall in angiotensin II
concentration (Weir ot al, 1971b). This apparent discrepancy 
will be discussed in more detail in Chapter 12*
Increased angiotensiaaso activity induced by combined 
oestrogcn-progestogen and sequential oral contraceptives has 
bofôi described (hubash ot ai, 1969) but lias not yet been 
confirmed#
Mteterone excretion and secretion and plasma concentration.
Ïïi 1962, Layao and his associates reported an increase in 
aldosterone excretion in 7 noraotensive women treated witîi 
EJaovid (Norcthjrnoclrel 3.Ô mg îlestronol 0*023 mg) for 20 days, 
compared with 9 normal women on m  treatment* Aldosterone
159.
secretion was also iaoresiood (mean 203 ug/day s#E. Î 31.7) 
compared with the control group (mean 76 ug/day S.ÎÏÎ* - 9.2).
TIig authors did not comeut oB diet or posture.
Less coBslstent results ■mvo obtaiaed by Noirbon ot el 
(196s) %&o found elevated aldosterone excretion isi 4 out of 8 
hypertensive patients talcing oral contraceptives, urinary
aldosterone returning to normal in 3 of these women after 
stopping the trea'Went#
In another stuc^  (Oraae and Harris, I969) 2 out of 13 
immen on an unrestricted diet showed a reduced aldosterone 
excretion rate but the memi value for the group was increased 
significantly compared with normal controls* Dietary sodium 
restriction for 3 days produced a normal increase in urinary 
aldosterone bo# during and after the oral contraceptive 
treatment* The sme workers later demonstrated a significant 
degrease in measi aldosterone excretion several months after 
stopping oral contraceptives (Craao et al, 1971)*
Sisteea women studied by Weinberger et al (1969) showed 
increased mo^ levels of urinary aldosterone, although only 5 
had higher levels while taking oral contraceptives compared to 
3 months after stopping tlie drug* Those wmen had a norsal 
response to a low sodium intolse and to the adaitnistration of 
a thiaside diuretic while taking the cmbined prcpar*atioa.
Ap far as is know, apart from.our own studies (Weir et al, 
1970b, 1971b) to be discussed in Chapter 12, «0 reports of plasiiia 
aldosterone concentration in women talîisîg oral contraceptives have
lëû.
so far been described*
Other cQrtioostoroids*
A consistent increase in plasma cortisol, induced by oral 
contraceptives has. been reported by many workers (Leyne et 
al, 19685 Metcalf and Beaven, 1963; Wallacli, Garcia, ICistner 
and Fineus, 1963; Dodek, Segre and Klaiber.-, 1965; Stump# 
Sole and Buus, 19663 Nielsen et al# 1969-5 0*Comioll end 
Welsh# 1969)* Most of those authors attributed the raised 
plasma cortisol levels to increased protein^ biading and tMs 
has been confirmed by other ^ fos?kers (beyne mid Meyer# 1965; 
do Moor ot el# 1966; Keane et al# 19699)» However# Burke 
(1969) lies also reported a small rise in non-protoin-bound 
cortisol during oral contraceptive therapy#
As far 08 is knmm# plasma concentrations of other more 
potent mlneralocorticoids such as ll-KÎeos^ corticoatorone have 
not been reported in vomen taking contraceptive steroids#
IbZ*'
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These have been deacrihod in Chapter 3*
CLÎNÎCAh mmiODS.
A group of normal women were studied before end between 
2 and 6 weeks after starting oestrogen-progestogen oral 
contracoptivos* Diet v m  unrestricted and blood aasaples wore 
taken in the sitting position at morning or evening clinics # 
at the sane time in the menstrual cycle lAen possible*
The plasma concentrations of renin were measaro in 2Û, 
rcmin substrate in 22* migiotonsin II in 18 and aldosterone in 
12 women* No significant changes in blood pressure, wêègîit or 
plasma electrolyte concentrations occurred during the short 
period of the study*
MCTbTS.
Plama renin concentration*
As shown in Figure 57# mean %)lasma renin concentration fell 
Srorn 18.7 uoito/l (8.D. Ï 6.?) to 8.6 nnits/l (S,B. ~ 6.5).
This decrease was not statistically significant (paired 
t ts -1*538, pp^ O.l)* The reason for the iisicreaaed levels iîx
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3 vmom Ijcfor© tipeatfiiont wa im^ leor* Tîioâe womea were 
apparentlsr aermal tmd were eaiupled in tîie eorlier part of 
the menstrual cycle hihmi plasma renin concentration is slightly 
lower than in the luteal phase (Brown* Davies* Lever and 
ïlohertson* 196&c; Shinaer ot al# 19#)# Mso# the normal 
range quoted for this metlüod in our Ishoratorj^  includes values 
from women at every stage in the monstraal cycle# When the 
results fr<m those 3 women .were excluded from the analysis# 
the small decrease in plasma renin concentration induced by 
oral contraceptives became oven less significant#
la. 3 womesi in whom plasma renin concentration was measured 
up to 9 months after starting treatment the mean showed an 
insignificant chau^ e^ of 0.8 units/l# compered witli tlio value 
after one montîi.
Plasma renin-substrate concentration#
H'iis increased to above the nomal range in every woman 
taking oral contraceptives (Figure 38)# the mean rising from 
0.78 uM (s,B. i 0.17) to 2.69 «ÎI (s.B. - 0,68). ïïjis difforonco 
was Siighly eigaii’icoat (paiPed t = 11.686, p<O.Ol)l),
bnlike "plasma renin levels# those of plasma reain’-substrate 
continued to increase up to 9 months after starting treatment 
(Figure 99)#
Plasma angiotensin II concentration.
The response of plasma angiotensin. II concentration was 
VQvy variable (Figure 69)# fhe mem level showed a slight 
increase from 13*1 pg/ail (S.D# t 8#8) before to 13#8 pg/ml
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(S*B* S after starting oral coatraeeptives* 5*ljis 
difference was not statistioalXy significant (paired t =
p>0*l)* None of Üie wosaen showed increases above the aorbial 
range* ■ ■ '
Of two women followed while tW^ ing oral contraceptives 
for up to 6 Rmnths^  Oi%e showed a rise of 8 pg/ml and another 
a fall of 6 pg/ml in circulating angiotensin II levels*
Plasma aldosterone concentration.
Like angiotensin IX* plasma aldosterone concentrations 
showed no significant change (paired t « 1*004| p > 0,1) 
after oral contraoeptivès had been started (ligure 6l). The 
means heforo mid after starting treatiient were 7*7 mug/lOO ml 
(L*B* w* ^ *8) and 8*6 Hiug/lOO ml (S*B* ^ 3*2i) respectively, 
l£i no case did the plasma levels rise above the normal range,
Isi 4 women followed for up to 9 months* plasma aldosterone 
concentration rose to 20 raug/lOO ml in one* fell to 4 rnug/im ml 
in another and remained unciianged in 2 women,
Corrolationa,
Tîic foregoing eatimations were measured concurrently in 
a mumher of vjomen ta^ dsag oral contraceptives* The correlation 
coefficients for those concurrent measurements are shorn in 
Table 82,
Bearing, in mind the small nmihers involved* there was no 
evidence of any statistically significant relationship between 
tlio individual compon^ts Of the renin»<iugiotensin4»aldosterone 
system in women taking oral Contraceptives,
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Tiio increase in ploesia yenitt-subairato conceatratiQa 
fomd isi tSiis study are similar to those described in other 
reports (see ChapterU)*
The lack of aigaifioaat change in plasma renin concentratioti 
has confirmed the findings of Saruta and his colleagues (l!>7d) 
but tïiG fall in circulating levels of renin, reported by others 
(^nnor et al# 19%; Cain et al# 1971) was not seen in the 
present, study# in wMch a similar laboratory method was used*
This discrepancy might have been due to sampling at different 
phases of the menstrual cycle# plasma renin concentration 
being increased during the luteal phase in normal women (Brown 
et ai# 1964c; Skinner et al# 1969). îïowevor# the present 
study did not show a significant difference in aeon levels 
between the follicular and luteal phases in women either before 
or after starting oral contraceptives (t ««0.044, p>0*l and 
t 83 1,019# |> 7 0*1 respectively#
The results for angiotensin IX denionstrated in this study 
(Figure 60) oi’o at considerable variance with those reported 
from mother laboratory using a broadly similar radio»# 
imunoassay method (Catt at al# 1971; Gain ot al# 1971)» 
reason for this difference is not clear* Although siost 
of the immen in the present study were sampled at the sew 
stage of their menstrual cycle before and after starting oral 
contraceptives# a small number were seen at different stages.
In this laboratory# a study of one woman# who was not taking
lü%
oral contraceptives # showed a very marked rise in plasma 
angiotensin II eoacentratioa daring the luteal phase 
(Figure 62)# mid this appeared to confirm the report hy 
Bundsf jord and Aaloraag (l97û). However# tlie present study 
did not show any significant difference in mean levels hetwecn 
idle follicular and luteal phases in wommi oi'Mier before or 
after starting oral contraceptives (t « 0 .4 8 0 #  p > 0 ,1  and 
t “0.87|lf p? 0#l respectively)• This latter fiiMing is in 
accord with #e results of Cain and his colleagues (1971)# 
who found a small butt insignificant rise in the luteal phase.
It SGc^ is unlikely# therefore# that variations in  time of 
sampling during the menetrual. cycle could influence the 
present results significantly,
. Variations between morning and evening saisies are also 
unlikely to have affected the results# as it has been shotju 
that circulating levels of angiotensin II did not differ 
hetxmem 11,00 a,m, and 4,00 p,m, (Gain et al# 1971)* Feature 
has a significant effect# recumbent x«nmen having significantly 
loizor levels than ambulant whether taking oral contraceptives 
or not (Gain et al# 1971)# This postural effect might ho 
expected to give hif^ ior results in the present study in Wiich 
the women were sitting when the samples were taken# in comparison 
with the 2 hour recmnbency used by the other group, Tiio opposite 
results have been obtained# however# and the diocropancy cannot 
therefore be explained on this basis.
Most of the studies of aldosterone sécrétion and excretion 
Slave involved \m m n with raised blood pressure while taking oral
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Bi one otnêÿ' ï>f nomotensive immea (Layae 
ot alt 1958)* aldoatorone oec^ otioa ani oxcrotioa were 
elevated daring oral contraceptive adsisaistration* The 
miehmgod plaonm coacentratiosaa found ia tlie preeeat otndy 
are at variaaee with this report. Changes in aot-abolic 
eleoramce may espîüîE this difforoace» hut this has so for 
not been investigated in womem taking oral contraceptives. 
fho increase in aldosterone binding protein iacluced by 
OGatrogon-progestogen oral contraceptives (Moyer at al» 1961; 
ïioyae ot al» 1962) would not 02Q)lain the low plastua levels 
in the face of apparently increased secretion and excretion*
Benin* reniti-suhatrate» angiotoaQin and aldosterone relationships 
in women t#in^ oral contracoptivos.
The incroaaes of plasam renin-^ suhstrate concentration 
induced by oral contraceptives wore similar to tîiose which 
occmTod in prepioat women (Figtw?es 9B and 1&), In pregnancy» 
a significant relationship has been demonstrated hetweeu the 
plasma concentrations of renin-suhstrate and m^ giotensin II in 
the first trimester (Figure ^ l) end hot%mm reain-suhstrate 
and aldosterone in overall pregnancy (Figure 52)* Neither 
of 'tîiose relstionsïiips has been found in women toJslag oral 
contraceptives* A significant correlation has also been shorn 
hetifocn tîie plasma concentrations of renin and aldosterone Su 
early ^ wegnancy (Figure 50) * hut not in vmon given oral 
contraceptives *
m *
Ab montioîiocl in Chapter 6*B» raised eirenlating levels 
of oîEigiotGBsin II inliihit renin sécrétion* This may he 
one explanation for the fell in plasma renin coneentration 
from the first to the third trBneator (Figaro lO). It has 
alee been suggested as a reason for the decrease in plasma 
renin concentration in some xiomen ^ liile taking oral contraceptives 
(S2dmer et al» 1969)♦ %is postulate» however» is dependent 
on tïie confirmation of raised afîgiotoasin II blood levels 
being fomel in women given these preparations* As has been 
discussed in the previous section» the effect of oral contraceptives 
on plasma angiotensin II concentration is controversial» and 
the results of tine preoeixt study do not lend support to tliis 
theory#
The reason for the apparent failure of the increased 
substrate levels to influence angiotensin II generation and 
possibly aldosterone secretion in i^ is situation must await 
further investigation*
Cause of rise in plossma rooin-suhstrate concentration*
The main effect of the coaihined oestrogen-^ 'progestogen 
oral contraceptive on the renin-^ oiagiotensin'-aldosterono system 
appears to ho the increase in plasma renin^ subetrate concentration 
(Mgiwe 38). ^
Halaier aaâ Griffith (1952) îouaâ that rat plosuts reaisx- 
substrate was increased by oestrogen administration and this 
has since been confiraied in mm (Helsicr and Judson» 196?;
Newton at al, 1968)* Progestogen alone had no effect mi rat
168,
p lasm a  (H e lm e r  and G r i f f i t h »  1 9 5 8 )  hut t l io
progeatogcB aorethysoclrel produced a sîîiaiî a'ise in hmaam 
plasma 3,'onim^ substrate eoaceatratioB (Newton et al» 1968)»
lleooatiy a samll study was oarried out iu our laboratories 
to determine the effect on plasma reuiu^  reain-‘Substrato mû 
aldosterone ooacentratious wlien the oestrogen and progestogen 
cmpomeuts of the oral ooBtraceptivo (hml.en were adîaiaistered 
separately (Weir et al» 1971b), Two groups» each of.éis. 
îiealtlâj^ women tedîiug a normal diet» t/ero given orally oitlier 
99 ug mestranol (oestrogen) or 1 ing othyiodiol diacetsto 
(x>roge,stogen) daily for 21. days. Samples ifere taken in t!xo 
Enorning from the gmteouhital vein tMlo sitting;, I week before»
3 weeks .af.ter starting mxd 3 weeks after stopping tîxorapy,
Tho plasma was analysed for renin, renin-sabstrate and aldosterone 
eoneentratioms# Flaaaa renin-substrato concentration increased 
markedly in all 6 %m.ion taking siestranol» in contrast to the 
group taking ethynodiol diaoetato in idiich there was no 
significant change (Figaro 63)* Tîie 6 women taking mestronol 
showed no change in mean plasma renin concentration» hut a mean 
rise did occur in those taking ot%nodiol diacotate (t sa 2,86»
0,92 <p <0,93» Figure 63}* The significance of this rise is 
difficult to interpret» as the mean plasma renin concentration 
before treatment woe lower in #is group comîiared to t£xo mestranol 
group. In no case did the plasma renin concentration exceed 
the upxmr limit of the normal range. Plasma aldosterone
PLASMA RENIN SUB.STRATF 
Mols>«10'‘ (Normal <1.2)
4 0
2 0 -
QL 
Plasma Renin 
Units/I (Normal 4“2 0 )  
20r
iO
OL
Plasma Aldosterone 
m jjg/K^m l (Normal<18)
10
OL
Before During Affer
Mestranol — f —  Meon± I.S.E.(6  Subjects)
Ethynodiol Diacetate— { —  Meant 1 S.E. (6  Subjects)
63 Changea plasma renisi, trate
a n c î  a l d o m t e r o a e  i e  i m m e n  g i v o n  i m s t r a n o l  
or ethynodiol tlia.eetoto.
m *
<5oneoBt3?atioH ©îso ■ ^esataetî x^ tîiin tlie aoasnal range la evotf 
ease mà signiÆIcmit eliange occurred in either gx’oup 
(Figure 63)*
Thie- exp^ ririioat has otm^ irmed the marîged lucreaee ia 
plasma x’ehSiWGuhçLr; ie oouce^ KtratiW, Im gi-vm. au
oestrogim (mcsir;ïïiol)' al.one, vith ao cHsmge la the woeaeu 
talciîîg a progcütügi'i (^ tïiynorlloi diacetate) alcue. It seeeiB 
liheXy^  thereinve, thaï 'it le the oestrogen compoîieut of the 
cemhiuéd proper at .loe w.dch etiuiuîates the rise ia plasnia x'eaia- 
auhstrate ceuccDlral.lcn, and the. ^ ight Inercase induced by 
uoretfaynodrei (Kc#e 1 ct a i 196,8) may hare been due to the 
oestrogeui'c properties of this compouud*
The possibility has beau discussed earlier (see Chapter 6*C) 
that elevated cirGuia#%^%e.uWjt%te might he due to increased 
hepatie globulin synthesis stii'wxiàted. by oestrogen#
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PiaSSSOEF M  WOBM TAOTG OESTEOOm^mOOESTOOm OEAÎ,
 - ■ commoEpmms.
Siîall iticrcoso0 in systolic and diastolic I>lbod prosourcs 
bave been reported in women taking combined oestrogesi^ progostogen 
oral contraceptives (Walters and 1970; CaWchael, Tqylor 
and <Ayers, 1970; Weir, Briggs, Brmming, %ck, iJoismith,
Taylox’ and Wilson, 1971d; %ellacy and Birk, 1978; Weir,
Tree mû McBlwee, 1972) (Figures 6% and 63) • It is also now 
well established that combined oestrogen-progestogen oral 
contrace%)tives may smietimos induce or aggravate hypertension 
(see Weil' ot al, 19710 and 1972; Crane et al, 1971; Wallace, 
1971} SpellQcy and Birk, 1972) (Fi*^e 66).
Similar chemgos in plasma renin and renin^ substrate 
concentrations end in aldosterone secretion and excrétio&i have 
been described in normotmsivo and hypertensive women xdiile 
taking oral contraceptives (horagh, Scaley, Ledinghm) and 
NoTxton, 1967; Weinberger et al, 1969; Crone ot al, 1971),
Saruta and his colleagues (1970), however, reported greater 
concentrations of plasma renin and renin-substrate in women 
vxith a rise of blood pressure while taking oral contraceptives, 
com%)ared to wo*iîeïà whose blood pressure rmmined unchanged#
The present study was designed to assess #e possible 
x*elevtioaship of changes in the reain'-oagiotensin^ -aldostei'ono
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Figure 66 Hypertension associated with oestrogen*
progestogen oral contraceptivoe (o#c.)#
I7h
system to ehoagcs in blood preasuro iu vomeu taking oesirogea* 
progoatogea oral coatraceptivea,
hxmmsiQW
#be8G bavo beeu deeoribod iu Gîiapter 3#
cbmiGAL imnoDs.
fwolve wraeu wre studied iu yîicKa persistent hyperteusiou 
(i*e# B#P, l40/f0 or over) had developed vMlo taîîiug combined 
oeatrogeu-progestogeu oral contraeeptives, the mean pressure 
of the group being 164/1# (systolic S,i>. * 11*0 diastolic
S*B* i 3*^  ma%)* . In each cos© blood pressure foil beloi/
140/90 %dthin 1 to 3 mouths after stopping the pill# The 
brands of oral coatracoptives being taiîcu \jhm l^ i^erteusion 
first discovered were #nilym (3 cases)# Gynovlar# Bliuovlor 
and OrthoBoviu 1/30 (2 ceases each) mid Volidou (l case). These 
had been taken for periods varyiuf^  from 3 montîis to 10 years 
(mem 29*1 mouths). Mem ago was 28.4 .years (S#B# * .7*0)*
Bï© measm'oments from this liyperteusivo group wore compared 
with those from S2 normotensive women taking oral coutraceptivos. 
The results from these aormotensivo women wore reported iu 
Chapter 12# The mom blood pressure of this group was 113/68 
systolic S*J)* Î 13*3 diastolic Æ 8#8 mm%). Mem
age was 24*9 years (s.D. * 3.4)* Oral contraceptives had been 
token for one month in all but one case (6 months) and the brands 
used at tîiô tiiae of smipliîig were Ovulen-ltIO (7 cases)# Minovlor
(s casoe)# Noriuyl*! (4 cosos) # ■ Miailya (3 casoa)#. OrtUonovin 
1/5# (S cases) anil Gynovlor (I caae). In both groups diet 
was mirestrictod. Blood aainplos wore taken from t3i© 
mit&mhitül vein while the woraeu were sitting. Time of 
sampling iu the menstrual cycle was not stwidaidised# as no 
significant difference had been found between the follicular 
md luteal phases in the nomnotensive wmea (see Compter 12).
As shown in Table 35 mid Figures 67 and 68# there was 
no significant difference in mean pl#sma concentrations of 
renin or renia-substrate between the hypertensive and 
noimotensive groups* Mean plasma angiotensin II concentration# 
however# was higher in the iQ^ ertensive if omen# althouf^ i the 
difference did not reach statistical significance at the 50 
level* of these women showed increases of plasma
angiotensin II concentration to above the upper limit ,of the 
noKBal range (Fi^ çure 69). Plasma aldosterone was not measured#
mscussi#.
Mechonlw of the dianges in blood pressure*
wcmen taking oestrogen^ progestogon oral contraceptives 
#0 Rioçhquisiü of .the increase in blood pressure is not clear* 
Increased sodium end fluid retention# possibly due. to excess 
circulating aldosterone# has been postulated# but no relationship
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has Îîeosi daiaonstratad between change in blood preesnro and 
change im tæi^t ia those mmmi (Woir et al, 1971b)* Also, 
total ©xMîaaigoablo aodiim and potaasima, total body water, 
and plasma aldoatetoae coaceatratioa did aot change sigaificaatly 
in one hypertensive woman xàioBO blood pressure fell si^ pifioaatly 
after withdrawal of the oral contraceptive (Weir ot al, 1971b) 
(Figu\*e 70), This, however, does not exclude a role for sodium 
and water retention in producing the initial increase of Mood 
pressure in those cases (see hsdiaghoia and Cobea, I96^ g Coleman 
and Guyton# 1969)#
Mrsi, &iW)ers, Walters and laSielan (1970) demonstrated an 
increase in systolic blood pressure during intravenous infusion 
of oestrogen and suggested that it may be the eestrcgen component 
which causes the raised blood pressure in women taking oral 
contraceptives, by inducing a rise in plasma votee, cardiac 
output and stroke volume ( Walters and Mm, 1970)# In support 
of this a raised blood pressure during oral oestrogen treatment 
hm been reported (Crane at al, 1971? Spellacy and Birk, 1972), 
aitkougli Gmf and MaeGillivray (l97l) using smaller doses 
demonstrated no change» Howwor, no evidence has so far been 
found that oral contraceptives i-dth a higher dose of oestrogen, 
have a greater effect on blood pressure than those with a lower 
dose (Weir ot al, I97ld| 1972)#
Morrobin mid Lloyd (1970) demonstrated that progesterone could 
cause small increases in systolic blood pressure in rabbits.
We have confirmed this in a small pilot study of 3 rabbits 
given 90 mg intmmscular progesterone compared to 2 controls
giveai intramuscular ethyloleate (unpuTjiiBhed data)* Howovor, 
a reoaut report (Winter et al, 1972) ImB failed to d^ ioaatrat© 
this effect* Ho Im^eaoe in Mood pro,genre liae bceîn fouad 
in Immeme given a progootogen either intraameoulairy (Maeley# 
Mîoo and Adam, 1971) or orally (spellacy and Birk, 1972) aid 
there is no evidaiee so far that the progestogénie potency 
of oral oontraeaptiveo is related to the ohimges in blood 
pressure (Weir et al, 1972)*
lalationsliip. of plasma rmin* ..reain^ subatrato and miglotemsim II 
concentrations to changes in
Ab the changes in the rOBin-angiotensis'i systesi %mro at 
first demonstrated la women with hypertension lAile taking oral 
Gontraeeptivea, it was thought that these chasiges might induce 
the rise ia hlooel pressure (ÏAsregh et al, 1967)* However, it 
Ims since been shown that the changes in plasma renin, renin- 
substrate and angiotensin eonceatration occur irrespective 
of the iihmigeB in pressure (see Chapters 11 and 12)*
In Chapter 12, the possibility of a feed-back mechcmism 
was discussed as am ezplanatiom of the nomal or reduced plasma 
renia concentration in the face of raised plasma renin substrate 
coBcesitratioB and possible augmented angiotensin II levels in 
xmmen taking oral contraceptives* An impairmoat of this 
suppression of renin has been postulated as a cause of the 
raised blood pressure in some cases (haragh et ol, 1967?
SkiBuer et al, 1969$ Saruta et al, I97C)#
W m n  compared to a momotensive group, Scruta and his 
colleagues (l97û) reported 'timt hypertensive women had greater
#plamm coaccBtratioaB of renin at 1# and 14 ifeeks end of renia- 
eabstrato at 2 and 6 weeks after starting oral contraceptives, 
but act thereafter* M  spite of the fact that plasma renin- 
activity not sigaificmtly different between the 2 groups, 
the authors suggested that their results lent support to the 
hypothesis of impaired feed-h*ck suppression of reniil as a 
cause of the raised blood pressure*'
Bearing in mind the differesice in duration of oral 
contraception in the 2 groups, the present study has shown 
the plasma concentrations of renin and renfn-suhs^ate to he 
siiailar ia nomuotemsive and hypertensive woauen (figures 67 
end 68)* However, in the hypertensive group 2 wcKaea showed 
increases of plasma angiotensin II concentration to above tlie 
ïiorsiîal range (Hgure 69) « and the meoai level of .circulating 
angiotensin II was hi^ ier, although this was of borderline 
statistical significasico* It remains doubtful \^ ietlier this 
small change in plemm angiotensin II concentration has any 
si^ifiaoat % hearing on the changes hi blood- pressure*
jfei animal exporimmts no evidence has been found for on 
increase in sensitivity to infused angiotensin in rats treated 
t-zitli on oestrogen-progestegen combination (Woods, 196?$ Bougies, 
Hull and Langfords, 1970), progesterone alone (Chesley and Stepper, 
19675 Hettiaratchi and Pickford, 1968) or ■ oestrogens alone 
(Hettiaratclii and Bickford, 1968) * Similarly, in a stu^ of 
two hypertoBsive women, no change in sensitivity to intravenous 
angiotensin occurred after wii^ idrawal of the oral contraceptive
in spite of a sigaificoat fall in blood préssùro ia one oese 
(Weir et el, 1971b).
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Oa the basis of the results of this study and of previous 
reports it seems milikely that the roaiii-aogioteHsin-aldostoronw 
system is playing a significant role in the oocasional 
development of hypertension ia women taking oestrogen- 
progestogen oral contraceptives.
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#8 studies presented here were stimulated by the reports 
of previous workers, which had suggested that alterations ia 
the renim-anglotemsiu-aldesterone system might he iiwolved ia 
'the aetiology of hypertmsive disease of prhguaaoy*
Oil reviewing the literature it .was found that, although 
some of the individual eompoaeats of 'Wie system had hoeu studied 
ia some detail, 'èlî© inter-relationships. in this system had not 
been clearly defined i&% uomial preguancy* Also, the 
circulating levels of angiotoBsin ÎI mid aldosterone, the 
prohahle active eud-produots of the reatia - renin-suhstratG 
reaction, had not boeu adequately measured ia aormej. îjregnaat 
wosîea*
Detailed studies of the chmiLges ia tSje plasma eoaceatmtions 
of renin, reain-àuhstrate, angiotensin II mid aldosterone were 
tliereforo undertoken in a large amber of normal pregnant wmea 
at all stages of gestation and the puorporim* ïîi view of 
the kmim. relationships in certain non-pregnant situations, an 
attempt was made to correlate the components of the renin- 
asigiotenein-aidoaterone systm one mth another and also with 
other metabolic and hormonal changes in pre^nmcy, especially 
sodium balance.
S*i»atistlcal correlations between circulating substances do 
not necessarily iiïipîy a cause end effect relationship* Also, 
the statistical signifioaneo of a true biological corrclatiom may 
be reduced by a dispersal of the data duo to technical sad 
biochemical factors* However, fairly simple direct 
correlations have been demonstrated in
179-
non-pregnàat subjects, and it might he eapected that the very 
marked changes in plasma concentrations of renin# renin- 
substrate # angiotensin II md aldosterone in pregnancy would 
give similarly concise relationships#
The results of the studies described in tl&is thesis 
have shorn# however# that this is not the case and have 
revealed much more complet intor-relationsliips in the pregnant 
woman than have been encountered in other situations# It 
seems very likely that the normal physiological relationships 
of the renin-angioteaoin-aldosterono systeia are being modified 
by the profound alterations in hormonal balance wîîich occur in 
pregnancy# for example iai progesterone mid oestrogen secretion* 
The rapid proliferation of the chorionic and trophoblastic 
cells be exerting a hitherto unknown influence on renin and 
aldosterone secretion in the very early days of pregnancy# 
and elucidation of the role of these substances may come from 
more intensive investigation of the primitive foeto-placental 
unit, The actions of angiotensin and aldosterone in maternal- 
foetal fluid end electrolyte exchange also requires detailed 
examination* Their role in overall matersial fluid mid 
electrolyte balance is still controversial# but it does socm 
likely that they are playing, at least a small port in the 
adaptive processes required for adequate foetal nutrition 
and well being*
In spite of a supei*ficial similarity# it has boon found 
that tlio changes induced by oestrogea-progcstogea oral
cîontraceptivos do not mimic those found in prcgnemey, apart
the incroasGS in plasma rcnin-substrate ooneentration.
The oastx’ogeii-progostogea oral eontraoôptivo has '«^ ierefore 
proved deficient as a possible model of the pre^ s^nt state 
Mut the effects of the oestrogen oompmuent have throm light 
on the origin of the raised reni^ i-snhotrato levels# Iteised 
blood pressnve in women %Ao are taking oral contraceptives 
does mot (q?pem* to he due to increased circulating levels 
of fHJgiotensin II or aldosterone# Mit tliia remalms to he 
GOiifis:^îed by further studies of these unceiaaoB patients*
If the plîysiologieal relationships in normal pregnancy 
are complex# the pathological relationships in hgpperteasive 
disease of pregnancy are no less so* The changées 
circulating levels of reni%,i;^ reBiu-s«hstrate# mîgiotonsin II 
and aldosterone have now hemi investigated in detail and all the 
components of the system have îseen found to he lower than those 
occmTiag In aoraial pregnmwy* l?hether these decreased levels 
of asigiotensiu II and aldosterone may he more active in the 
presence of #e altered fluid, electrolyte and hormonal 
balance of pregnancy remains to he answered hut this seems 
unlikely*
The present stu%' has shown that increased hlood levels 
of the pressor agent asigiotensin II and of the mineraîocorticoid 
aldosterone 0du m  longer he implicated in the pathogenesis of 
hypertensive disease of pregnancy* Their loRfored plasma 
concentrations may he a reflection of reduced placeu'tai functioa*
On the other hand, it is possible that the renisi-cmgioteneiam 
aldosterone system is ?>©i»g amppreseed by asi excess of 
eircBlatlKg mimeralocortieoid udiich has yet to be identified, 
'tominatioa of the role of %}lasm MG mâ .#E in the aetiology 
of pregaaney hypertension appears to he the next step in tlie  
search for Professor Ammd Bouth^ s toxin" of 6o years ago.
Over these years many suhstaaoes have hoen examined by 
sophisticated laboratory;' teoMiques, orly to ho eventually 
discarded# asid the md^m of pre-oelampsia remains as ohalleoging 
as ever#
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3*8 3.7 3.3 3.9 %,0 3.9 4,0
4,0 3.8 3.8 3.7 S.3 4.6 3.8
3.9 3.1 3.3 3.9 5,6 3.3 3.7
4.1 3.4 3*7 3.6 3.0 4.9 4.8
4.5 ■ 3.9 3.7 3,6 4.6 3.7
4.1 4.3 3.3 3,0 3.4 4.0
3.8 3.8 3.6 4.0 4.3 4.1
4.1 3,4 4.8 3.4 4.S 3.7
5.3 3.4 3.6 3.7 3.9 4,0
1 3,3 3.8 3.3 3.6 4.0
î 4.0 3.1 3.3 3.6 4.5
1 3.7 3*7 4.0 3.6 4.1
1 3.7 3.6 3.7 4.6 4.4
3.6 3.6 4.8 4.8
3.8 3.8 3.7 4.0
3.0 3.3 3.9 4.5
4.1 3.7 3.9 3.7
4.0 3.5 4.9 3.9
3.7 3.8 3.3 5.0
3.6 3.8 3.4 4.8
3.4 3.4 3.7 3.7
4.0
3.8
4.0
! 3,73 3,70 j 3.72 4.18 3,78
1 «Î.3S 0.41 1 0.33 0.46 0.37
1 53 fîS j 44 29 m  I
mrÿk^V.N'i'i^WTg-”# »
■ o
Oostatioa Poa'fc-Partii'B
© - IS 13 - 26 87 - tern 8-2 6-12
S?1 870 ! 886 278 I 273 887
871 868 ■ 893 876 285 972
856 875 i 877 277 873 281
870 ■ 878 880 873 876 280
880 878 873 275 278 882
871 879 ' 871 873 ■ 286 875
871 874 875 ' 871 277 879
866 273 874 879 275 878
876 871 873 879 881
878 271 278 285
878 878 870 278 286
877 ' 878 ■ 885 S6D 279 1
871 879 873 280 293
871 876 873 882
875 871 282
873 275
878 278
878 288
878 281
873 283
876 282
87# 282
' 871 286
876 273
878
878
ÉTn»*n»l,i.j n „j,. - III #n #' T#,#*#! ;■ >
871,8 874,1 274,0 279,7 SSÎ.%
5,4 . 3.5 4,9 4,2 5.%
15 1 14 Î 34 24 13
pwES»
Orine Soilinia Oouoentgatioa (mEn/ï).
' 0 - 18 13 - 26 27 - texfi) 0 - 2 6 — 12
’ ' g6 " 123 73" j 181
^7no*,r»fWMMAfES
178
92 : 152 168 1 119 j 54
72 1 185 73 I 195
186 1 142 66 j 140 i
1 169 106 184 j 128 1
1 113 97 j 124 1
1 96 1 181 1 144 !
1 77 1 107 j 77 i
i 204 1 167 123 1
î 89 ! 83 107 1
174 i 177 i
130 1 93 i
97 84 ij
93 73
77 a s
138 65
6a 104
66 137
48 135 !
56 183
i
106 129
1^ 111
157
127
1#2
89.0 130.2 102,0 115,9 187.8
87.1 2449 40,7 3 3 * 8 48.8
4 5 22 25 10
■
1
IfeiUio.. Fotaoaitmi Ooacentratioai
.Ooataiion iiopt-tete
0 - 12 13-26 27 - term 0-2
1-. __ ______ 6—22
26 : 68 33
1
1 60 62 1
W ; 86 58 55 ^  i
37 1 17 33 20 10
69 w 59 58 46 1
s 58 85 44 j
43 S8 41 1
32 42
[ 39 58 SS
58 55 3?
44 41 37
76 68 '
58 43
# ■ 48
38 62
47 45
51 48
38 38
23 42
31 63
58 87
42 46
34 42
35
57
____ ____
39
1
43.0 1
1
58.7
i
44.4 j
1 46.5
.
42.2
B. 18.3 1 30.4 ; 28.4 1 24.6 11.6
4 _________1___ 4_________; 22 I 25 Ml
1 1
Blood Urea Gonoeatratiea fex/lGG mlj*
— ‘^•^^T‘ ^ ~ r ' “"'-~-~r-Tr “ ^ —r~r ^ T in r «--T t-~Tr-T^n—Ti ■' n ié ^ " w  ©mi  Jw i i im i i i  iw iiT ii
Gcsiatiosi
0-28 13 - 26 
_____  __
87 - teffiii 0 - 8 6 —
19 19 19 16 16 35
17 14 15 80 33 30
14
18
14
9
13
12
83
19
88 
: 38
88
88
13 18 18 16 81 80
17 14 17 19 31
15 15 14 85 83 38
18 10 17 30 30 34
2 5 13 16 18 85 26
13 18 88 11 i 31 28
16 20 16 81 15 87
SB 21 13 81 ! 80 48
16 84 17 83 i 85 83
SO 16 7 17 ! 88 88
17 16 85 17 1 83 40
SB 16 80 16 j 88
BO 83 83 14 I 23
17 84 10 j 88
14 11 15 1  83
84 85 11 1 28
17 10 18 j 14
17 88
34
13
22
I 85
!
i 27
19 15
1 7
15
1 20 
I 17 
1 3 %  
22 
30 
19
1 ,
17.6 18.8 17.2
! * " ^ 
23.7 89.
3.3 5#5 4.6 3.1 6.
83 84 43 29 15
Î2
■AiîAmi'i SIS— «taxpaakak-ma*
Sonmi CréâtAsülEtQ Umioeatmtipn (îüg/lGO ml),
(kifâtaMm. CV/g©1 
1 2  13 - 86 0 — 2 6 «iuGm
57 70
50 70
#
0,60 
0.50
60
0.90
60
60
0.8070
60
57
60
60
50
60
Croatiaiino Clearasige (mls/miu),
Pi
6 m
Gecata'iioïi (ifeGkr Paf)twlarteî-.
0-12 13-26 27 - tem 0 - 2  1 6-12 i
198 m 131 78 1 63
¥7 ISS 139 4S I 56
% 138 98 99 ! 8%
131 167 136 87 j 87
133 86 107 73 lis
176 111 107 ; 53
86 103 : ÎC8 ;
116 : 87 ; 9% !
74 91 !
139 71 i ^
112 82 i i
104 ; 128 ;
138 91 !
52 63 1 1
186 ’ î%9 j j
102 1 67 !
m ! 118 j
112 i 69 1 ;
93 ; 66 i i l
134 ! SI j '
147 i 103 i ,
107 i 79 : : :
#à'#T )#lM*T#1CMPi
162 ; 87 ' : 1
168,7 121*6 117.7 87,8 02.1
5S.7 33.0 28*3 : 89.3 22.8
23 8
TABLE 14 * GorroiatioBs — All Pregamioy Smmlee,
m r Significmiee
Benin Substrate 145 0,119 p ^ 0.1
ïlesiiîi Angiotensin II 65 0.071 p > 0*1
leaia Aldosterone 68 0.064 p > 0,1
Substrate Angiotensin II 77 i 0.033 p > 0*1
Substrate Aldosterone 72 1 +0*245 p < 0.05
âagiotQïïsis'i II Aldosterone 52 0.009 p < 0*1
Progesterone Benin 25 0,001 p > 0,1
Progesterone Substrat© 25 +0.685 p < 0,001
Progesterone Angiotensin II 26 +0*551 p < 0,01
Progesterone Aldosterone 10 0,433 P > 0,1
Benin % Substrate Angiotensin II 65 0.123 p > 0.1
llonin s Substrate Aldosterone 65 0,141 p > 0*1
Plasma Sodium Benin 140 0*028 p > 0,1
Plasma Sodium Substrate 138 0*037 p > 0*1
Plasma Sodium Angiotensin II 72 0*014 p > 0,1
Plasma Sodiuai Aldosterone 65 +0*257 p < 0,05
Plasma Potassium Benin 142 0*084 P > 0*1
Plasma Potassim Substrate 140 0*142 p > 0.1
Plasma Potassium Angiotensin II 71 0.141 p > 0*1
Plasma Potassium Aldosterone 67 0,158 p > 0*1
TABLE 14 - continued
__________ T_______ _ _______________r_______ _
n
*-iia—f-itfTiiri i^ »<r»>
SignifieoBCQ
Osmolality Koain m 0.017 p > 0*1
Osmolality Substrate 90 0.098 p > 0,1
Ofjmolality Angiotensin II 16 +0*578 p ^  0*@8
Osmolality Aldoatorene 50 0,858 0*05 <p <0.1
Urea Beiâisi 187 0,088 P > 0.1
Urea Substrate 125 0,110 P > 0,1
liroa Angiotoasin II 59 0,036 p > 0*1
Uroa âldostoroae 45 0.101 V > 0*1
• (îfutyi,- «frn tr
Oroatinine BjQivln 1C6 0.061 P > 0.1
Oreatisiiae Subatrate 108 0,068 p > 0*1
Oreatiniiie AngiotensiB II 16 0*329 p > 0*1
Oreatisîine Aldosterone 51 0*088 p > 0*1
k— — -------— «
Croat* Clear* Benin 50 6.050 P ;> 0*1
Croat. Clear# Substrate 45 p o.oi
Croat# Clear# Angiotensin II 13 0.012 p > 0*1
Croat* Clear* âldosteroBO 81 0.H9 P > 0,1
#n#i H#W# y# r*# i'*n # 'i# A # iiw #  #  A##*#"# a#n Winm
Urine Codinm Bonlîi 46 0.19& P > 0*1
Urine Sodiuva Subatrato 44 0*106 p > 0*1
Urine' Sodium Aïiglotensiiî II 5 0,598 p > 0*1
Uriae tkJdiiiia Aldosterone 81 0,081 p > 0.1
MWf* W »,NW* » '  # r* - ,« rr# M # A b É M  -une. *u w  *k ïe 4 .* ï4 » s t£ .t^ , F*, tb%»LUj4w
Urine Fotaseium Bénin 45 0.019 p > 0*1
Urine Petaseim# Sabotraie 43 0.076 P > 0*1
Urine Potassium Angiotenain II 4 0.884 p > 0*1
Urine PoteGQlum Aldosterone 80 +0.446 p /: 0.Ü5
«^ifc£t*K:au.»4hMt>
Plasma Sodium I-rogeoterone 30 0.008 P ;» 0*1
Plasma Fotaesiiffis Progesterone 89 0.086 F > 0*1
Usrmü Urea Progeateroao 30 0*866 p 3> 0*1
TABSiE 14 — eoaiinued
a V
v*‘>—•M*»>1wr»*Wjr*tW»<MWai«M»WA»
Sl^ ificesae©
Plasma Bioarb* Benin 13 0.264 p >0,1
Plasma Biearb* Sabstraie 12 0.008 p >0.1
Plasma Biearls* Angiotensin II 28 0.346 p >0*1
Plasma Biaat%* Aldosterone 2 *# p 0*1
Plasma Biearb* Progesterone 6 0.746 0.03 <p <0*1 ■
Urine Oostriol Benia 34 0.039 p >0*1
Urine Uestri©! Substrate 32 0.170 p >0*1
Urine Oestriol Angiotensin II — tm —
Urisse Oast3^ i<*l Aldosterone 13 9,266 '
■iW 141,1*11^
g >0.1
*1 I>PU Wi‘.*«w Wr«n'ffW LVm#W
Plasma Sodiura Osiuolaliiy 91 40.267 p<0.0g
Plasma patassiam Osmolality 93 0.191 0.(© <g<0.1
^ Statiatioally at 5^ level#
Correlation.? — for each trimostes?*
Trimester
1
I I
S II
p.p.
.1.1
n i
p.p,
RKMLUMkma.#
121 
p * p ,
I 
I I  
jm  
p.p,
I
I I
I I I
p.p.
fcjwK
11
'.P,
Angiotensin
te
te
te
ABgioteneiB
te
te
«
ibigioteneiià
te
M
te
ângiotensin
te
te
le
âlctofîtorone
te
te
#
Aldosterone
Sî
te
ce
Aldosterone
tt
îi
te
Ik)2&in
tî
(î
te
Siibatrato
w
te
te
n
03
18
17
38
25
16
10
KeBiïicxiSùbs traie
ri 
tf 
tf
âldostorone
te
le
te
lienin 
«
te
«
Substrate
îî
o 
le
33
88
11
2
28
18
39
J)
30
13
llGBiu U Substrate
M
te 
»
23
SigaiTioanoe
0.0086
w*
o.ow'i
+0. f-flfï
+0.3703 
0.158& 
0.8168
+0.6057
h32
0.1738
0.1468
0.4774
[B7
0.2374 
G. 1031
+0.3057 
0.3038
0.8037
0.1073 
0.:^48
0.4408
p&O .l
F >0.1  
0.1 
p < 0.0!
P < 0.03 
F ? O .I 
P >0.1
0,85 <p <0.1
F > 0.1 
p > 0.1 
p >0.1 
F >0.1
p> 0.1 
p>0.1 
p > 0,1
p<0,03
P >0.1
p >0.1 
p >0.1
*a.Je4eeemiMi
F >0.1 
p> 0*1 
p >0.1 
F >0.1
?#i^4 
).0816
.^33^ î8
p> 0.1 
p > 0 * l  
p >®.l 
p> 0,1
TABLE 15 - ,  çoBtiaued 
CowoMiiono for caotà triiuoàtéî?
Trimester n r Sigoifieonce j"mwf—TiRW-iw #s<ii>^i» "I iiii#i 4## «.«#, ifttiBifmW-ViCTWvrti—■
I Aldosterone Plmma Sodlna 30 0.8220 p> 0*1
II H » 17 40.4134 o.o5<p<o.l
III « tt 24 40.5505 p<0.01
P.P. t n 11 0.1126 p>0.1
I Aldos'torone Plasma Potassiiiai 31 0.0087 p> 0.1
II n 16 0.2699 p>0*l
III « t 23 0.1388 P>0*1
P.P. n t
twir’iii .'mill ;wj;*PKa»
13 0.2080 p>0.l
I Aldosterone Osmolality i; 0.1477 p>0*l
II « If 12 0.3630 p>0*l
III n tt 21 0.2067 p>0.1
P.P.^ * tt 9 0.327a P>0*1
I Benin Substrate 45 0.0856 p>0.1
II * tt 34 0.1319 p>0.1
III tï tt 78 0.0385 P>0,1
P.P. « »9 30 0.0357 p> 0,1
I Benin Sodinm 41 0.1160 p>0.1
II n tt 29 0.2150 p>0,l
III n « 72 0.0784 p> 0,1
1 P.P. n tt 26 0.5224 p< 0,01
1 ^ Benin Potassimi 41 0.0635 p> 0,1
1 II « tt 29 0.1459 p > 0,1
1  n i « tt 74 0.1632 p >0.1
1  p.p. »? tt 28 0.3258 0pQ5<p<0.1
coatigmeA 
CoaLTOÎatioaa t o t each trimester
, ,
frimostex’
I
I I
I I I
F.Pi'
lleain
*
It
It
Osmolality
1»
«
ft
n
17
13
6%
23
r
0.0^70
0.1169
0.0S92
0.09&2
Si^ificoace
0^ 1 
0.1 :
p?0.1, 
p? 0.1
I Aigioteasia SoOiom 3^ 0.2737 p>0.1
I I ti Ï» 23 0.1792 p';^ o*i,
. Ill « « 13 0.2631 . P> .1
P.P.’ n n 6 0.2880 p> 0.1
I MgictoBsiB Pctassioa 53 0.1399 p>0.1
1$ tî « 23 0.1629 p> 0.1
. Ill w « 13 0*1219 py 0.1
P#P* ft If 6 0.2626 p>0.1
, * Statistically sigai£ieant at levels
T-ABLEi 1^ 'é Plasma DOC Coaccatyation (ma/lOO ml)* 
Gestation ( weeks ) Fost^ portua
0-12 1 13 - 26 27 - termwi.ti*gjnrtiar'j?Tvtfiy_iTj'^ iT^'iswfiRS c3ifî*itocï 0 - 2  weeks
19.0 26.? 19.9 17.3
14.0 24.4 34.7 10.1
19.0 14.6 20.0 20.1
13.0 20^ 6 20.0 11.3
13.0 17.1 33.0 8.8
13*0 16.3 10.0 14*8
33.3 12.0 14.7
9.1 33.0 11.6
16.0 7*0 9*2
18.0 16.0 6.1
15.0 11.0
23.0
______________
13.9 19.2 20.3 12.4
2*6 6.7 10.1 4.3
6 11 12 10•B^ rc>nu.«-IMII I pw.llf If—
IvII 
II V  III 
I V XII 
III V P.P.
t = 1.1613 
t = 0.3621 
t o 1.0904 
t B 2.3443
Cl5 ) 
( 21 )
( 16 ) 
( 20 )
0.1
p ;> 0.1 
p > 0.1 
p < 0.03
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Ü
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rH
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o 00m
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ir\
m
t<4
ir\
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rHiH
rH O
o
m
r>
-p
rH i-H-P
to oVOo
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o
l>
rH
VD ‘
Om
CO
rH OÎ
o
OJ
o
rH
O rH
O
00 00
H rH
O -P
iH
rH
rH
rH
rH rH
O
ïab lG  ,  Plasma Benin C oncentration  (u u its /X ) ,
l^ypertension -> Albnminnria Normal
Caso % e Parity Gast? Benin Caso Age Parity Gest^ ïleniii
L*G# 17 0 36 20.7 B.P. 17 0 36 26.2
J.C, IB 0 36 35.3 19 0 36 36.1
C*L. 19 0 37 11.7 V/.M, 00 G 38 57.0
H*iï. 20 0 58 48,6 N.%. 21 0 38 85.8
S.B. 20 1 32 38.0 M.B. 21 1 32 65.3
S.B, 26 0 37 32. S C.B. 26 0 30 18.9
M.C. 28 0 35 9.4 J.M. 28 0 30 20.1
J.B. 29 0 34 25.9 v.n. 26 0 30 33.1
E.K. 26 0 39 52.0 G.G. 25 0 4Ü 52.9
H*Y. 26 0 58 23.7 B.C. 25 0 40 36.8
M,J, 25 1 35 30.6 K.P. 25 1 34 39.0
iS*Ii. 25 2 32 26.0 8.8. 26 2 32 46.6
H. S. 28 >î» 28 20.4 J.n, 28 2 26 37.5
A,McI. 27 2 38 29.5 S.IÎ. 30 2 36 32.0
A#W# 35 0 28 44.8 M.K. 35 0 24 43.3
M.N. 37 0 34 16.4 S.T. 28 0 30 75.7
A.H, 36 1 30 22.6 A.McB. 35 1 33 51.3
S.K. 58 3-'r 28 71.3 B.B. 40 2 30 48.7
J.B. 35 3-i* 38 23.2 M.G. 41 2 34 40.0
c.c. 20 0 36 28. 3 S.T. 20 0 36 30.0
Mean 26.7 34.4 30.6 26.8 33.2 43.8
i  X S.B. 6.6 3.6 14.8 6.7 17.3
ÏÊïtîle # Plasma RoniBWM)ûtrv\to Concantri'itlen (iïM),
%portexwioa *v Al'bawimsria NoMiml
Caso %o : Parity I (ïOïjt?
! Benin 
1 Sr.lïîstrfâiô Caae iAge ! Pa^ri.ty ! Qeet î^
: Benin i 
1 8ubstrate|
— - - — '- -- --- J , Il r . ^ r
_ J
L.G. 17 ! û 1 36 1 2.47 B.P. il? « i 36 1,69 1
J.C. 18 : 0 j 36 1 3.38 19 0 36 3.30 i
O.L. 19 0 37 2.69 M.MeP, 20 0 38 2.80 1
M.C. 23 ü 31 3.&4 J.M. 21 0 30 3.64 i
SO u 38 1.07 H.%. 21 0 38 4*88 !
S.E. SO I 32 2.7U M.D. 21 1 38 3.08
B.B. 26 0 37 3,46 M.M. 25 0 38 3.47
J.B. 29 0 % 2.01 C.B. 26 0 30 3.10
B.K. 26 0 39 3.10 w.G. 23 0 40 5.73
H.¥. 26 0 38 2.96 B.C. 25 0 40 4.15 i
M.J. 25 X 33 4.19 .K,F, 25 1 34 6#S3 i
B.B. 25 2 32 3,44 S. S. 26 2 32 3.35 !
U.S. tm 3+ 1.50 J.B, 28 2 26 j 3.73 i
A.W . 35 ü 28 2*36 S. T. 28 ü 30 1 2.73 1
M.N. 37 0 34 2.03 M,K. 35 0 36 3,05 'f
A.H. 36 I 30 1,11 A.McB. 35 l 28 2*93 j
S.K. 38 34' 28 3,80 B.fî. 40 2 30 1.40 !
C.C. 2if 0 36 3.40 B,T. 20 0 36 7.48 !
--------- 1
Mean 26.0 33#8j 3.76 ! 25.4 33.91( 3.73
* 1 S.lA 6.7 ! 3.7 1
]
0.93 I ! 6.1 <1.3 1.52
! •i '! i 1
Tfiîïlâ  .  Plasma Ans^iotensin I I  Conceniawfction, (m /m l)
■ III ^nr.Miii-.ii-<«iiiimMi> ni .**wacwn<w»w%««*iii»»>.npni i i n i ■
Jjypertension + AlBumiiiuria Normal
Case
l
Age Parity Gostî ikigio.  XX Case Age Parity Gest^
rowwu.Mtjm.ifT.nuT,
Anglo.II
C.L, 19 0 37 20 M . P . 19 0 30 132
J.C. 18 0 36 25 W . H , 20 0 38 67
L.G, 17 0 36 10 K.McQ. 21 0 38 21
M.C, 23 0 31 16 L.W. 23 0 30 28
M.C. 28 0 35 18 J.M. 28 0 38 43
A,W. 35 0 28 10 M.K. 35 0 24 38
A.H. 36 1 30 7 P.P. 36 1 36 220
C.C.
Na.ti*‘.»m»ftfji.warTv>'»t;gsa ur-
20 0 36 13 J.H. 21 0 30 77
Mean 24.5 33.6 14.9 25*4 33.0 78.2
il S.D.
NlV » j ™«vi6 I teMU™..#*.-
7.6 3.'i 6.0
mfc>nVi«>mvwRm
6.8
*l.dW<A.UW.MFÏ*Fe<uttxm*^sxi(ttr<cM
5.2 67.4
wimis^i**diU;eÉiajnik*waü»lirwi«rei*
Table gî • Plasma Aldosterone Concentration (miig/lOO ml).
Jïjnpertension Mbnminuria
Case Age Parity
L.G.
s . a .
M.C.
B.K. 
H.y. 
M.J. 
S.E, 
H.S. 
A.McI, 
A,W. 
S.K, 
J.B,
Keoii 
il S.D,
TWflfctiwtwwMSfjatiflawxt
17 
20 
28 
26 
26 
25 
25 
28 
27 
35 
38 
35
27.5 
6,1
0
1
0
0
Ü
1
2 
3'î’ 
2 
Ü
3"r
Gestm
36
32
35
39
38
35
32
28
38
28
28
38
33.9
4.2
Aide,
9.0 
25.5
44.0 
15.7
7.0
13.0
26.0 
12.0 
23.0 
22,0 
29.0 
50.0
23.0
13.3
HormaJ
Case
n . aMwn£«nxKB4a.m.T».
Age Parity
fMUnft. |»,wci%.ntem.ara., ^aM>
r n Gest, Aldo.
E.P, 17 0 I 36 33.0
M.B. 21 1 32 40.1
S.T. 28 0 36 44.0
G.Oo 25 0 40 36.4
P.H. 23 Ü 34 21.0
P.H, 23 1 34 218.0
M.Q. 22 2 34 67.1
C.G. 31 3'J* 24 45.1
J.G. 24 34" 30 17,0
M.K. 35 0 24 17.8
A.K. 32 '34- 26 21.5
D.McD, 31 34- 38 50.1
. «-
26.0 32.3 50.9
««luwuay M«l\iiRti5UtLfc'i*«ti
5.4
ibi««A*«»ï^n»vnu»«<p*r.-c;ar<
5.3 54.7
T«k*3W«reMiieii*ciroi.<™uveîa
Tal)le Plasma Sodiiini Gonconti’ation (inE<i/l)
Hypertension AlHuininuri.
Case Parity Gest, Parity Gestï Sodium
H,n, 20 139 21 129
136 139
IÏ.Y, 38 V.Il 136
134
131 133
A.McI J O
M.N,
33 130
2R OR33
SoK, j-l- 133
28
283d 28 138
27.6 33.9
3.7 3.1
Table S3. Plasma Potaeaiimi Goacenttation (m&i/l).
Hypertension -i- Albuminuria
Caso ! Geet, Po tas Case Parity Potas
20 3.8
H.Y, 4,0
M.J.
2,7 3.3
M.M, 3.3
M,C, 4.0
M.C
28 28 3.6
28 28 4.0
3.66
24
Plasma OamelBlity (momykg)
%pe3fte»aiOB + AlbtimiBuria Hormal
Case Age Parity Gest? OsmoX? Cme Age Parity Oest? Omel^
tm . 20 0 38 278 E.P. 17 Q 33 273
S.33* 26 0 37 277 B.W, 19 0 36 375
J.B. 29 0 34 279 B.7. 20 0 32 272
ÎI.Y. 26 0 38 272 M.MoD, 20 0 37 271
M.J. 20 I 35 27a K.P, 85 1 34 272
S.E. 23 2 32 273 B.S. 26 2 33 270
A.M0I# 27 2 38(T) 282 S.B. 30 2 36(t) 273
Î-Î.N, 37 0 34 281 H.Z. 21 0 36 268
S.K. 26 0 39 274 0.G. 25 0 40 273
Mem
ixs.B.
26.8
4.5
36a
2.4
277.1
3.5
22.6
4.2
^.7
2.6
271.9
2.0
.
WÎS& 25
Blood Brea Concentration i!«e/X9AMsl^
1
>ertension 4 Albuminuria Norîital
Case
wWS:el*Mil*:itiU.»TD«Ht^wrtW «-
Age 1Paiity Gest? Urea Case jAge 1Parity
Wirextr^rweetKTitre.A’iw i
Gest? Urea
lun. 20 0 38 23 N,2, 21 0 38 16
J.B, 29 0 3h % C.B, 26 0 30 21
n.Y, 26 0 38 14 M.M, 25 0 38 14
M.J. 25 1 35 30 K.F. 25 1 34 14
S,H, 25 2 32 20 8,8. 26 2 32 12
A, Me I, 27 2 38 20 S.B, 30 2 36 17
, M.N. 37 0 34 35 8.T, 28 0 36 18
E,K, 26 Ü 39 42 B.C. 25 0 40 26
M.C, 23 0 31 32 B.T, 20 0 32 15
S.K. 3S: 3-Î" 28 36 B.G, 32 3-s- 29 9
A,W,
—  —
35 0
fc— «■e*aaa»TiTjM,
28 28 ¥,H. 26 0 30 10
Mean 28,3 34.1 28.7 24.11 34.1 13.6
t l  S,D, 5.9 4.0 8.3 8,!
Î
3.8 4.9
ttSfteuwBwwmifuw^Meia: «■w*WtiCT™*m»ei n itin
1
Sam»rwjrfy^i.i,i-rnjm.n.n?-.r^»ii
Soruni Creatinine
Hypertension -h Albuminuria iNOMial
Case Age Parity Gest?
Ui«»iRrai*iaeietts*irtj*u nfiia
Créât. Case
J» Mr.-k.aghWPPMKwaM'
1  Age
JlSKSSSM telSl4JÎ!.fcJ«»
Parity Gestî Great*
n.B. 20 0 38 1.45 M.g. 21 0 38 0.50
J.B. 29 0 34 Ü.90 M.McD, 20 0 34 0,70
1I.Y. 26 0 38 0.55 O.B. 22 0 39 0.70
M,J. 25 1 35 0.70 K.P. 25 1 34 0.70
8J%. 25 2 32 0.80 S. S. 26 2 32 0.60
A, Mela 27 2 38 0.75 8.B. 30 2 36 0.70
M.N. 37 0 34 1.10 3.W. 19 0 36 0.60
B.E. 26 0 39 0.90 D.C. 25 0 40 0.80
M.G. 25 0 31 0.90 B.Ï. 20 0 32 0.60
Soîi# 38 34- 28 l.OU B.C. 32 29 0.45
an 34.7 0.91 24.0 35.0 0.63
S.D, 5.7 3.6 0.25
a.'ctTB-yusjiM^garKBf jw
4.4 3.5 0.11
TABLB 87 
Creatinine Clearance (mls/min)
_  Hypertension Albuminuria
Greatn.
Normal
Gest^ *
i
Case Age Parity j Gestî Case Age Parity Great. I
H.H, 20 0 38 75 M.%. 21 0 36 147
J.Bo 29 0 54 69 MMcD 20 0 32 52
II.Y. 26 0 38 142 G.B. 22 0 39 107
M.J. 20 I 35 92 K.P. 85 1 38 94
S.R. 25 g 38 84 8.8. 26 2 32 162
A.McI, 27 2 38 100 S.B. 30 2 36 98
M.Ne 37 0 34 34 D.C. 25 0 28 80
E.K. 26 0 39 86 S.Ï. 2Ü 0 32 112
»« e.»weu«iw iJtti ad#sww«=lrf*
Mean 
il S.Do
26.9
4.8
36.0
2.6
85.2
jO.'i
83.6
3.5
3'i.l
3.7
106,5
34.9
m m m  soDim coNCjcm'miioN
(mEci/l)
H yp erten s io n  4- iH b im iim iria Normal
--------
Case Age Parity Gest?
Urine
Sodium Case 1 Age Pai’ity Gestî
Urine
Sodium
n.B. 80 0 38 22 N,ia, 21 0 36 36
J.B. 89 0 34 82 M,McD, 20 0 32 97
II.Y, S6 0 38 94 G.B, 22 0 39 66
M.J. 25 1 33 101 K,P. 25 I 38 79
8.E, 25 2 52 112 8,8, 26 2 32 138
A.McI. 27 2 38 132 8,B. 30 2 36 168
M.N. 3? 0 34 170 B.C. 25 0 28 113
E.E, 26 0
iVWimWOM imKLVMMWay WMA
39 124 E,T. 20 0
ba*a«*«,Mm#w«%«A=Wb:»,wa!iA3w
32 68
.ean 26.9 36.0 107,1 23,6 34,1 98,1
1 S.B, 4,8 2,6 45.3 3,51 3,7 39,2
K'nWrtinFtMIBLIBSiW* Ia>fewatJcas™an»ik*kiBuf,;-i ________ Î
TâBMS 29
Urine Potassium Concentmtiou,
  -          —  ^'
(mEq/l)
I^ ypertei
warn
îsion •> Aibumiaurja Normal
Urine Urine
Case Ago Parity Oestî Potassium Case Ag0
♦# Jc.l5y!,M3M.tINfe 6fi
Parity Gest? Potassium
H.H. 20 0 38 15 w.z. 21 0 36 58
J.B. 29 0 34 61 MoMcD. 20 0 32 49
H.Y. 26 0 38 37 G.B, 22 0 39 55
M.J, 25 1 35 51 K,F, 25 1 38 55
S.E. 25 a 32 36 8.8, 26 2 32 29
A.Meï. 27 2 08 68 S.B, 30 2 36 58
M.N. 37 0 34 80 D.C. 25 0 28 43
E.K. 26 __0 39 49
MWJ n ■fa- -1 «-7-f.iTr,- •« ——^ \
E.T,
-.KkVf
20 0
necctKRlKlLfMwwvaOf
32 32
,t pnyg=j- Tir<r r-.f
ian 26,9 36.0 49,6 23,6 J>4,1 46,6
S.D. 4.8 2,6 20,5 3.5 3,7 11.0
--— ^ —
,?ÂBLE 3Û
m m Œ  QBSTIIIOL EKCmTlON 
(ug/24 hr).
lijrpertensiYC*«et»fie™x*T*'rw«AaeK*isBi:on ‘h Albmiimiria
Normal
Caso Age Parity Gesti} Oeatriol Case Age 1Parity Gest?
i
1 Oestriol
U.IU 20 0 38 23,600 N.2. 21 0 36 10,000
J.B. 29 0 3^ 3,600 B.T. 20 0 38 10,500
1I.Y. 26 0 30 28,730 G.D. 22 0 39 16,000
M.J. 29 i 33. 6,730 K.F. 23 1 38 14,300
S. il. 29 9 32 3,300. 8.8. 26 2 38 23,600
A.Mcï. 92 2 38 27,000 8.B. 30 2 36 16,300
M.M. 37 0 34 3,300 D.C. 23 ü 28 11,100
hrS.re.fMK.Il-»WlMat!tUYTW»B
ean 97.0 3%^ 14,643 94.1 34#è 14,600
Il S.D. 5.2 2«4 11,137 3.4 3*9 4,773
'. . # fWMamW&tRWWM T< j»Mi i.jijrt«eyWWt. vftWîl t**utem:siira»»vwca*
îiypertensive Disease of
Correlations
»Airi.ita'jyj*=aRC*?i<a5SfW*.3inivfltes.vewwKiiit*ieei.tii**Br»^io.ri
n Significance
Benin j Substrate 22 0*039 'i> > Ovl - ^
Benin Ang;iotensin II 10 0.106 P > o#i
Benin Aldosterone 18 0.060 p > 0*1
rwuc*to JRtwraswiMiies
Substrate Angiotensin II 40.756
ttrratnriM.«vj*4!,««mauar<uc>MUfc-4«AïawH«i'rBS w MJtr «-i -a t»a
p < 0*02
Snbstrate jUdosterono 19 40*416 0,05<p< 0#l
Angiotensin II 1 Aldosterone
#c**
8 0*177
»jrtcu8,#Wja.vni*T*uaicTOa*>t*Æ».*..iw>»».Ti»:>-j-Ltfni .  uu- .=* '<
p > 0.1
kBi*xvrn«M=*tMih.M'teliar*>*9ce«tAie AXM a»»
Benin x Substrate 1 ilngiotensin II 0.227 p ;> 0*1
Benin x Substrate Mdostorone 18 0.055 P > c.i
Plasma Sodium Benin 20
»  *awra»t«efct
40.390
Ilasma Sodium Substrate 18 0*089 p > 0*1
Plasma Sodiun ibigiotensin II 6 0*664 p > 0*1
Plasma Sodiimi Aldosterone 17 0,106 P  0*1
Plasma Potassium
WMjrfrMif^yB3tt«fc3ahgaK:«:B*wfi*tw
Benin 21
ic6Mt»SFM: p*uri*«F##.'afV7.Vw4iM M*ai#ai*#h3*#
0.047
( t ta = n u * 'w .T .n » ""  ■:!
p > 0*1
Plasma Potassiuiii Substrate 19 0*267 p > 0*1
Plasma Potassimii Angiotensin II 6 ■ 0*550 P  >0.1
Plasma Potassium Aldosterone 16 0.276 p > 0.1
.U-finv HUl>.^ Jin»WTl .  [TT»*-MlgB.tegMVi»^W iMWWWHO*'»**.* >n
Serum Urea Benin 17 0.353 P > 0.1
Serum Urea Substrate 16 0*069 P > 0*1
Serum Brea ikigiotenain II 3 0*778 p > 0.1
Serum Urea Aldosterone 17 0*416 p > 0.1
Serum Creatinine Benin p > 0.1
Serum Creatinine Substrate 15 0^*710 p < 0.01
Serum Creatinine Angiotensin II 9
Serum Creatinine Aldosterone 11 0*272
«  tg-OTiAm,
p> 0.1
Great# Clear# Benin 14 0.188 P > 0*1
Great# Clear# Substrate 12 0 , 1 1 0 p > 0*1
Great# Clear# /aigiotenain II 0 -
Cx’eat# Clear* Aldosterone 9 «Ü * 664 0*05< P<.ü.l
—
Hyperteirîsivo Disease ©f j^ regnonoy
Corrolations
Urin© Sodium 1 B,enin 14
Urine Sodium 1 GiiUatrate 12
Urine Sodiuiï) ! Angiotensin II 0
Urine Sotlium Mdostorono 9
Urine Potassium IWiin 14
Urine Potasniwi Substrate 12
Urine Potasaluia An^ riotensin II 0
Urino Potassima Aldosterone 9
Urino Oest^ l^ol }k%iin 12
Urine Oostriol ;jub8trato 11
Urine Oostriol jkr;lotonsin 11 0
Urjjio Oeotriol Mdostei'one 9
Ih'ino Pi'otein Benin 19
Uriim Protein Sidistrate 18
Urine l^ otein Aiigioteimjui .El 11
Urino Protein Aldoatorone 17
Systolic Benin 19
Systolic Substrate 18
Systolio Angiotensin II 11
S^ MîtoXic Aldosterone 17
Diastolic Alenin 19
Piastoiic ' Hnbstrnto 18
uiastollc jlngiotensin II 11
Diastolic Mdostorone 17
StatieMoally oignifieomt at ^ 0
Simxxicmico
p > U. l
p >  0 * 10*107
0.135
J.I99
P>0.1 
n ;> 0*1
IL #2 P > 0,1
0*430 p > 0.3
ü.Wl :>o,i
0,435 () > 0,1
0,173 } :> 0,1
ü*iæ Dj> 0,1
P >  0,1
0,3413 n > 0,1
U.2U7 p 0.1
P >-'04l
0,004 p ;> 0,1
0,294 p > 0,1
0,173 P >  0,1
0,103 )>0,1
0,041 P ^  0,i
0,364 P > 0,1
Correlatlms in tatdms oral coatrac.eiGit-i'g^ s,
Comparisoas
—«wirf.-owyt-.inin IWI i *
r
Degrees o t 
ivQQûm
J=LZCnZ==5U.i3=r&m .
Sigsifioaaoe
Keaia Substrate 0,228 17 p> 0.1
îtoisa Angioteasia 0.130 3 p>0.1
Emiim Aldosteroae 0.391 8 p.>0.1
ÂBgiotmeia (Substrate- 0.043 8 p >0.1
Angiotsmsia llenia x Substrate 0.133 3 p>0*l
Angioteasia Mâostorcme m. ##
AldosteroB© Substrate 0.301 8 p > 0.1
Aldosterono Beriia x Substrate 0,378 8 p>0.1
mi
<o
r-4S
/\
•rl CVl
